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ABSTRACT 
This project involved the development and evaluation of techniques with regard to their 
potential use in the identification and investigation of toxic injury, particularly in instances of 
focal damage, and the development and investigation of a new model for focal renal papillary 
necrosis (RPN) induced by ethoxyquin. A problem in animal toxicity studies is that compounds 
such as those which induce RPN may only produce focal lesions, and thus these lesions may be 
overlooked. Much interest is focused on the development of RPN induced with analgesics and 
non~steroidal anti-inflammatory drugs (NSAIDS) in both humans and rodents, due to 
controversy about the pathogenesis of this lesion. 
The techniques evaluated for potential use in toxicity studies were: perfusion fixation with and 
without dye perfusion; histology with evaluation of step-serial sections; urinary sediment 
analysis; and scanning electron microscopy (SEM) with correlative histology of the same 
sample. Two well-known models of experimental RPN, 2-bromoethanamine (BEA) and 
indomethacin, were used to investigate these techniques in the kidney. Urinary sediments and 
Particularly SEM with correlative histology proved useful, and were used in investigating 
ethoxyquin as a model for RPN. Transmission electron microscopy (TEM) was performed to 
study the time course of lesion development with ethoxyquin and establish the initial target 
sites within the papilla. Haematology, clinical chemistry of blood and urine, and histological 
assessment of all tissues were also conducted to confirm that ethoxyquin did not induce any 
extra-renal effects which might preclude its use as a model for RPN. 
The results suggested that the development of RPN with ethoxyquin follows the same course 
as the two well-established models, BEA and indomethacin, and the sequence of events 
reponed in man. However, ethoxyquin, in contrast to the two established models but in 
common with analgesic-induced RPN in man, induces RPN following multiple oral dosing, 
and has potential as a chronic model for this lesion. Furthermore, the likely mechanism of the 
development of RPN induced with ethoxyquin is similar to that proposed for analgesics and 
NSAIDS. The use of ethoxyquin as a model for RPN may therefore help to provide important 
information for the identification, mechanistic basis and subsequent treatment of RPN in man. 
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CHAPfER 1. INTRODUCTION 
Investigation of the causes, mechanisms of damage and possible treatments of many diseases 
in man requires animal research and the use of animal models. Research and development in 
the pharmaceutical industry is a prime example of this; adequate human data are not available 
for most hazardous substances, so risk analyses must rely on information obtained from 
laboratory studies of rats or mice. The inference that the results of animal experiments can be 
applied to humans is a fundamental principle of all toxicological research [Hard et alI993]. 
The use of animal models enables the possible mechanisms of diseases such as renal papillary 
necrosis (RPN) to be investigated and possible treatments or preventive measures to be 
evaluated [Whittingham et al1989, Burrell et aI1990]. There is also an important requirement 
to develop sensitive and specific methods for the early identification of lesions such as RPN, 
both for animal studies (to help defme the spectrum of events and any contributing factors) 
and for patient care and prognosis [Bach & Bridges 1985, Bach & Hardy 1985, Murray & 
Brater 1990, Price et aI1996]. 
This introductory chapter flrst describes the aim and scope of toxicity studies in the 
pharmaceutical industry and the role of histopathology within toxicology. The problem of 
identifying focal lesions in such studies are described and illustrated by discussing two tissues, 
the brain and the kidney. The chapter then concentrates on the renal papilla and the specific 
ISSue of RPN (primarily a problem in man but also reported in domestic animals), the role that 
experimental models play in studying the mechanisms proposed to be involved in the 
development of this lesion, and the aims of the project. 
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1.1 TOXICITY STUDIES 
The prime objective of the Pharmaceutical Industry is the production of safe, efficacious 
drugs. To help achieve this, a great deal of time and effort is spent on pre-clinical toxicity 
studies before the compound can be used in patients. The aim of such studies is to define the 
deleterious potential (evaluate the safety) of the compound in a rodent and non-rodent species 
(usually rat and dog respectively). This is a complex, multi-disciplinary effort involving drug 
metabolism and pharmacokinetics, clinical examination, clinical chemistry, haematology, 
biochemistry and pathology. 
Studies are conducted by following written protocols in accordance with strict regulatory 
requirements and guidelines. Drug safety is an important aspect of the research and 
development of novel pharmaceuticals and it is essential that toxicity studies are conducted to 
a high scientific and technical standard. There is a legal requirement for safety studies intended 
to support drug registration to be conducted according to the principles of "Good Laboratory 
Practice" (GLP). Study protocols are therefore designed to comply with GLP requirements, 
and detail every aspect of the work to be included in the study, any amendments that were 
made in this work, and the timescales involved. They are backed up by written Standard 
Operating Procedures (SOPs) to ensure that all aspects of a study are completed satisfactorily 
and reliable data are produced. Of equal importance is the need for studies to be designed, 
conducted and reported to the highest scientific standards in order to accurately defme the 
toxicological profile of a compound and make a reasoned extrapolation of the potential risk to 
man. 
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Toxicity studies have 3 principal objectives [Zbinden 1991]. The first of these is to define the 
spectrum of toxicity of a compound by detection of any adverse affects. The second is to 
extrapolate the results to predict the likelihood and consequence of such findings in other 
species, particularly man. The third objective is to predict safe levels of the compound, 
especially for use in man. 
Types of toxicity studies performed can be divided into 2 categories; regulatory studies and 
mechanistic studies [Klaasen 1986]. Regulatory studies are the standard type of toxicity study 
and are concerned directly with the toxicity testing of a compound, covering the 3 objectives 
Outlined above, to detect any adverse effects of a drug and the likely risk to man. Regulatory 
studies can vary in duration from single dose studies to multiple administration studies of up to 
2 years duration for rodents, longer for some non-rodent species. Historically, study duration 
has been divided into four main categories (with some overlap) as detailed below [Klaasen 
1986]. 
• Acute: This is defined as single or repeated exposure to a compound over a 24 
hour period and is generally the first toxicity test performed on a new compound, 
usually performed in the rat, mouse and sometimes rabbit. It is designed to provide 
information on the effects following a single administration of a range of doses, up 
to and including those causing systemic toxicity. Results obtained from the acute 
study are important in setting dose levels for subsequent multiple administration 
studies with the compound. 
• Subacute: This is designed to obtain information on the toxicity of a compound 
following repeated administration, usually for up to 14 days, in the sa~ species as 
17 
used in acute studies. Subacute studies are aimed at establishing the appropriate 
dose levels for subsequent subchronic studies. 
• Subchronic: The duration of subchronic studies can vary from 14 to 90 days, and 
is of sufficient length to support human administration of the compound. They are 
usually conducted in two species, rodent and non-rodent (usually rat and dog) by 
the route of intended exposure in humans. 
• Chronic: Long-term or chronic studies are performed similarly to subchronic 
studies except the period of exposure is longer. The length of exposure is partly 
dependent on the intended period of exposure in humans. If the compound is 
planned to be used for short periods of time (e.g. antibiotics) a chronic study of six 
months may be sufficient, performed in a rodent and non-rodent species. However, 
if the compound has the potential of lifetime exposure in humans a chronic study of 
up to two years duration (in rodents) will be required. Carcinogenicity studies are a 
specific type of chronic study. Such studies are designed to assess the carcinogenic 
potential of a compound and are usually conducted in rats and mice, extending over 
the average life span of the species (usually 2 years). 
Mechanistic toxicity studies are concerned with elucidating the mechanisms by which the drug 
ex.erts its toxic effects as there is an increasing requirement by regulatory authorities to do this. 
An understanding of the mechanisms of toxic action contributes to the knowledge of basic 
phYSiology, pharmacology, cell biology and biochemistry. Results of such studies can lead to 
the development of sensitive predictive tests which will be useful in obtaining information for 
risk assessment to support regulatory studies, or rational therapy for toxic symptom~. 
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A more flexible and scientific approach is necessary to improve the predictive value and cost-
effectiveness of toxicological investigations. General features of the investigations in any 
toxicity study are the large quantity of material to be prepared and examined and the 
corresponding logistic demands this places on laboratories and scientists. It can be the case 
that a lot of time and detail is given to some aspects of a study which may not actually add a 
great deal to the overall findings, so it is important to critically assess techniques or evaluation 
methods to help decide where best to concentrate efforts. Any developments in either 
preparatory or examination techniques which help do this are extremely valuable, and constant 
efforts are made to develop rapid, reliable diagnostic methods. 
L2 ROLE OF HISTOPATHOLOGY 
Pathology data make up an essential part of the toxicological information submitted to 
regulatory authorities to support the registration of a compound [Dua & Jackson 1988]; the 
interpretation of the pathology and other safety data generated from toxicity studies forms the 
basis for decisions about the safety of a compound. Histopathology is the fmal phase of any 
toxicity study except those solely designed to assess lethality. It involves the detailed 
examination of the cellular structure of a wide range of tissues for each animal included in a 
study uSing gross examination and light microscopy, often also including histochemistry, 
lIl1munocytochemistry and electron microscopy. At the end of the study period for a particular 
compound, a complete dissection is carried out, with weighing of major organs and up to 50 
tissues being preserved in a suitable fIxative, usually 10% neutral buffered formalin. These 
tissues cover all organ systems. From these, Haematoxylin and Eosin (H&E) stained sections 
are produced and examined by a pathologist, along with any extra techniques that have been 
performed (immunocytochemistry, electron microscopy). 
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Histopathology therefore involves the preparation and examination of a significant quantity of 
material, particularly in carcinogenicity studies where at least 400 animals are involved. It is 
important that assessment of tissues for any pathological change is carried out in a reliable, 
consistent and reproducible manner, and there are various important factors to consider in 
achieving this. 
It is desirable to use a fonn of grading to categorise any damage seen as this allows dose-
responses of any compound-related effects to be studied. The pathologist should have a clear 
idea of the criteria he or she is going to use for this grading, and an adequate understanding of 
the pathological process involved. Histological assessment by grading is a subjective 
procedure open to bias and is therefore often better carried out under "blind" conditions (no 
prior knowledge of dose groups). However, this in itself can cause problems: some findings 
reported in a blinded review may be insignificant background changes or normal variations 
[Black 1991]; or subtle changes may be missed which are only detectable by comparing 
COntrols against dose groups [Iatropoulos 1984]. A possible solution to this is to undertake an 
initial "unblinded" review of a portion of the tissues from control groups to establish 
background information before starting the blinded assessment [Black 1991]. 
Another potential source of bias in pathological assessments, which can be a serious problem, 
is a change in the diagnostic parameters or "diagnostic drift" [Newman 1979, Greaves & 
Faccini 1984], which can result from factors such as a break in continuity of the assessment or 
a change in the awareness of the pathologist. It is therefore advisable to re-examine some of 
the slides to ensure there are no such variations. Peer review of the slides and report by 
another pathologist is also recormnended to minimise any subjective bias and improve the 
20 
consistency of the reported findings [Black 1991]. The use of different diagnostic terms can 
also be a serious source of confusion [latropoulos 1984, Dua & Jackson 1988]. To avoid 
controversy over diagnoses and reduce inconsistencies both within a report and between 
pathologists, a "Standardised System of Nomenclature and Diagnostic Criteria" has been 
introduced by the Society of Toxicological Pathologists as a reference guide. 
A final, very important, source of bias is sampling [Greaves & Faccini 1984, Eustis et al 
1994]. If extra sections have been taken for further examination from selected animals only, 
for example those with gross lesions or an indication of possible necrosis in the initial section, 
these animals will have had comparatively more tissue examined than others in the study. To 
eliminate this bias, either extra sections should be taken from all animals or only one section of 
tissue examined from those animals which were re-sampled [Eustis et al 1994]. More 
importantly, this problem can also occur in reverse in that insufficient sections may be 
examined, which leads to an under-estimate of the presence or extent of any lesions [Dua & 
Jackson 1988]. 
This is of particular importance in cases of focal lesions, where the likelihood of identifying the 
presence of a lesion will vary depending on its size and the frequency with which it occurs. It 
may be necessary to examine serial sections of the tissue involved to get an accurate picture of 
the presence and incidence of a particular lesion, for example in the case of renal papillary 
necrosis with some non-steroidal anti-inflammatory drugs [Arnold et a11974, Bach & Bridges 
1982]. Also, grading of treatment-related changes can also be difficult in cases of focal lesions, 
since the severity of the effects may not necessarily be related to the size of the lesion. 
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1.3: FOCAL LESIONS 
The problems of accurately identifying the presence and relationship of focal lesions can be 
illustrated by examining two organs, the brain and kidney. Both are specialised systems 
involved in maintaining homeostasis and are common target sites for adverse chemical effects. 
1.3.1: Brain 
The brain is a highly complex organ with anatomical and functional specialisations, one or 
more of which may be susceptible to chemical injury [Greaves & Faccini 1984, Glaister 1986, 
Chang 1995]. The brain is selectively protected from polar chemicals by the blood-brain 
barrier, but is vulnerable to the effects of non-polar chemicals that can cross this barrier 
[Glaister 1986]. Since pharmaceutical compounds are specifically designed to cross lipid 
barriers to improve absorption from the gastrointestinal tract, and neurologically active 
compounds are of great therapeutic interest, it is perhaps not surprising that neurological 
effects are fairly common in regulatory toxicity studies. Also, the brain is relatively lacking in 
toxicant metabolising systems compared to other tissues, which can be an advantage or a 
disadvantage depending on whether the parent compound or a metabolite is the primary toxic 
mOlecule [Glaister 1986]. 
The brain consists of various cell types with different functions and therefore different 
biochemical targets for toxicants. The neurone is generally considered the most sensitive cell 
because of the glucose-dependent high metabolic activity associated with active ion transport. 
Neurones are also particularly susceptible to anoxic effects, either from hypoxic insults 
(whether from a direct effect on cellular respiration or indirectly by effects ori the blood 
SUPply) or post-mortem anoxia. Apart from the main cell body, most neurones are associated 
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with structural entities such as axons, dendrites, neurofllaments and synaptic tenninals, all of 
which are also subject to alterations under toxic conditions [Chang 1995]. 
The brain poses particular preparation problems because of its susceptibility to post-mortem 
changes, which can make diagnosis of subtle effects difficult [Duchen 1984, Lamberts & 
" 
Goldsmith 1986, Greaves & Faccini 1992]. Adequate histopathological assessment of the 
brain requires appropriate sampling, good fixation and careful histological technique [Greaves 
& Faccini 1992]. Immersion fixation in formalin is widely used for the brain and is generally 
regarded as adequate. However, a good knowledge of possible artefacts produced by the 
process is essential [Duchen 1984], and perfusion fixation may be required for more detailed 
characterisation of lesions or definition of no-effect levels [Lamberts & Goldsmith 1986, 
Krinke 1988, Greaves & Faccini 1992]. In animal toxicity studies, particularly when studying 
agents with activity in the central nervous system, sectioning of the brain may require use of a 
metal mould or matrix to accurately locate particular cerebral nuclei or fibre tracts at risk of 
damage. 
The Use of multiple sections is important for the location of focal lesions ht the brain, which 
may be easily missed due to their location and/or size. Examples include cerebral tumours 
[Dua & Jackson 1988, Greaves & Faccini 1992], and infarcts (focal areas of ischaemic 
necrosis) which can occur in the brain of aged rats [Barbolt & Everett 1990] or as a toxic 
effect [Krinke 1988]. Also, the presence of infarcts in the valves of the heart can cause 
micro thrombi which may detach and lead to infarction in the small vessels of the brain. The 
correlation of such effects to accurately identify the cause of the brain infarct can therefore be 
difficult as both may be focal in nature. 
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As discussed above, the susceptibility of the brain, and particularly neurones, to post-mortem 
changes can further complicate the identification of focal lesions, since it can be difficult to 
determine whether an area of neuronal necrosis is due to a toxic effect (ante-mortem necrosis) 
or to post-mortem autolysis. It is therefore important to fix the tissues as soon as possible after 
death to help distinguish between the two. 
1.3.2: Kidney 
The kidney is also a frequent target for the toxic action of chemicals [Bach & Bridges 1982, 
Glaister 1986]. The main reasons for its susceptibility are related to the large fluid transfers 
associated with elimination of waste products and xenobiotics and with body water, electrolyte 
and acid-base homeostasis. The histopathological assessment of the kidney in toxicity studies 
generally relies on a single section, cut through the middle of the kidney to include the papilla 
tip [Eustis et al 1994]. The identification of cortical lesions in the kidney is relatively easy 
since a large area of the cortex is present in a section, but identification of lesions in the papilla 
is more difflCult [Arnold et al 1974, Bach & Bridges 1982, 1985]. Papillary lesions can be 
missed for several reasons: the lesion may be absent from the standard section examined if this 
section does not include the papilla tip; if present, there may be insufficient tissue to allow 
identification of the lesion; or the lesion may be focal, as with focal renal papillary necrosis of 
the kidney caused by analgesics and non-steroidal anti-inflammatory drugs [Bach & Bridges 
1982, 1985], discussed further in Section 1.6. 
llistological identification of focal lesions presently relies upon serial or step-serial sections 
[Arnold et al 1974, Bach & Bridges 1982, 1985, Greaves & Faccini 1992]. However, the 
preparation and examination of serial sections is a very laborious, time consuming process. 
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Therefore, any developments which reduce or obviate the need for such a detailed examination 
and help with the detection of focal lesions would obviously be important [Bach & Bridges 
1982 & 1985, Price et aI1996]. 
The examples discussed above of brain infarcts and renal papillary necrosis are important focal 
lesions which are induced by several compounds and disease states [Krinke 1988, Ng et al 
1989, Parker & Watson 1990]. They are therefore good models to use in the investigation and 
development of techniques for use in helping to identify focal lesions. Ideally, any 
developments which are useful should be applicable to any focally damaged tissue and 
potentially contribute to the knowledge of the lesion in question. 
Focal ischaemia (infarction) in the hippocampus region of the brain is a useful model to use for 
preliminary assessment of techniques (such as perfusion fixation) since it is caused by blockage 
of the small vessels supplying this area and subsequent ischaemia, and is particularly sensitive 
to post-mortem changes caused by inadequate preservation techniques. Electron microscopy 
may be required in toxicity studies for the detection of subtle effects in the brain, but such 
effects may be masked by post-mortem changes. Development of perfusion techniques using 
the brain, to optimise tissue preservation, will therefore also be of use for subsequent toxicity 
studies which require the investigation of nervous tissue. Techniques which appear to be 
potentially useful using the brain could then be applied and developed using models of renal 
papillary necrosis, which is an important lesion in the toxicology of analgesics and anti-
inflammatory drugs. 
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1.4 THE RENAL PAPILLA; BLOOD SUPPLY AND SUSCEPTIBILITY 
The ways that an individual organ can react to injury are limited and are detennined by its 
anatomy and physiology. A number of diverse agents can therefore produce a similar pattern 
of injury. The kidney, which receives almost 25% of the cardiac output, is a common target 
for toxic chemicals since a large amount of any substance present in the blood will be carried 
to the kidney [Moffat 1982, Bach & Bridges 1985, Bach & Hardy 1985]. The marked 
, 
susceptibility of this organ to damage is also due to its capacity to extract toxic substances 
from the filtrate and to accumulate them to critical concentrations in the tubular epithelia [Fent 
et aI1988]. Active transfer of certain compounds from the plasma to the tubular lumen may 
lead to higher concentrations in the proximal tubule cell than in the plasma. Also, 
biotransfonning enzymes are present in the kidney which are capable of metabolically 
activating drugs and chemicals. The main metabolising systems are cytochrome P450 mixed 
function oxidases in the proximal tubule cells, and prostaglandin endoperoxide synthetase and 
lipoxygenase in the inner medulla and renal papilla [Glaister 1986, Hawksworth et al 1994]. 
The metabolising systems in the papilla can co-oxygenate a variety of substances with 
arachidonic acid to produce reactive metabolites capable of covalently binding to cell 
macromolecules. 
SChematic illustrations of the basic arrangements of the structures and tubules within a kidney 
lObule and the arrangement of intrarenal blood vessels are shown in Figures 1.1 and 1.2 
respectively. The function of the renal papilla is the concentration of urine, therefore any 
Substances or metabolites excreted or generated by the kidney will be concentrated within the 
tubules of the papilla. Any substance concentrated in the papilla may also 'modify the 
distribution of other substances [Burry & Hopkins 1977]. Under normal circumstances, the 
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blood flow to the papilla approximates only 4% of that in the renal cortex due to the unique 
blood supply of the kidney and its counter-current mechanism. 
The blood supply to the papilla is derived from two sources, the vasa recta and the branches of 
the arteries in the adventitia of the minor calyces [Black 1986]. The vascular bundles formed 
in the outer medulla decrease in size as they descend towards the papilla tip, where only single 
vessels remain. The net effect is that the papillary blood supply is poor compared to the rest of 
the medulla and the kidney cortex. The papilla is therefore considered to be more sensitive to 
ischaemic damage because of the reduced oxygen delivery to this area. It has also been 
suggested that the kidney, and particularly the papilla, has a lower rate of protein degradation 
than the liver and may therefore be more prone to damage from metabolites of compounds 
such as paracetamol, which covalently bind to tissue proteins [Mudge et al1978]. 
L5 RENAL PAPILLARY NECROSIS IN MAN 
Renal papillary necrosis (RPN) in man is a clinical and pathological syndrome which is a 
common finding in end stage renal disease and occurs as a secondary phenomenon in a number 
of diseases [Parker & Watson 1990]. It was fIrst described over 100 years ago in a case of 
ureteric obstruction [Friedreich 1877], and the radiological changes associated with RPN were 
fIrst described in 1937 [Poynter et aI1974]. However, the characteristic radiological changes 
(ring shadows, horn-like extensions or clubbing of the calyces, medullary cavities) are not 
always evident unless RPN has reached the stage where all, or part, of the papilla has become 
detached [Harrow 1967, Kincaid-Smith 1969]. Recently, renal sonography and computerised 
tomography have been shown to be useful diagnostic aids which may help in identifying the 
presence of RPN [Weber 1985, Gupta 1990, Braden 1991, Saifuddin & Bark 1991]. 
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The clinical features of RPN are variable, but usually include fever, flank pain, pyuria, 
haematuria, low-grade proteinuria and diminished urine concentrating ability. Urinary tract 
infection is a concomitant finding in the majority of RPN cases. The progression of RPN is 
insidious and as much as 60-85% of renal function may be compromised before the symptoms 
become obvious. 
The development of RPN in man has been classified into three stages [Burry & Hopkins 1978, 
Lindvall 1978]: 
1. Early papillary necrosis or necrosis in situ, where the damage is less extensive and there is 
no detachment of the necrotic tissue. 
2. Partial or intermediate papillary necrosis, where the central part of the papilla only is 
necrotic and may detach. 
3. Advanced or total papillary necrosis, where the whole papilla is necrotic and often detached 
from the body of the kidney. The kidney is often reduced in size and the surface may appear 
ridged. 
The earliest morphological features of RPN are degeneration and then necrosis of the fine 
elements of the medulla (renal medullary interstitial cells, capillaries and thin loops of Henle), 
followed by progressive necrosis of the covering epithelia of the papilla, collecting ducts and 
ducts of Bellini. Only the tip of the papilla is affected in the early stages of RPN. This 
progresses to include the whole papilla with increasing necrosis. Secondary degeneration and 
glomerular sclerosis occur in the cortex after the entire medulla is damaged.' Urothelial 
hyPerplaSia is a common sequel to papillary necrosis [Bach & Hardy 1985]. 
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The recognised causes or factors associated with the development of RPN are summarised in 
Table 1.1. Diabetes mellitus is the most common cause ofRPN, being the major factor in 56% 
of all cases (the incidence of RPN in diabetics is 4 - 5%, compared to an incidence of 0.2 -
0.6% in non-diabetics) [Eknoyan et al1982, Parker & Watson 1990]. 
Table 1.1: Underlying causes ofrenal papillary necrosis 
COmmonly reported factors Less common factors 
Diabetes mellitus Chronic alcoholism 
Analgesic abuse Severe jaundice 
High dose non-steroidal anti-inflammatory drug Dehydration in children 
treatment 
Sickle cell haemaglobinopathy 
Dehydrated newborn infants (often jaundiced) 
Upper urinary tract obstructive uropathy 







Renal vein thromboses 
Haemophilia 
Renal artery stenosis 
Pericaliceal haemangioma 
~Watanabe .& Sakaguchi 1969, Hendry et a119n, Bannister & Hatcher 1973, Kaude et a11976, Pandya et at 
B9?6, Loune et al 1977, Kozlowski et al 1978, Kincaid-Smith 1979 & 1989, Wortmann et al 1980, Bach & 
ndges 1982, Chabrel et al 1982, Eknoyan et al 1982, Mitchell et al 1982, Odita et at 1983, Roberts et at ~~83, Zielinski 1983, Allen et at 1986, Bailie 1986, Pitts & Van Thiel 1986, Henry et al 1988, Gradus et al 
89, Groop et a11989, Shapeero 1989, Gupta 1990, Parker & Watson 1990, Lindop et al1991] 
AnalgeSic abuse accounts for 15% of RPN cases [Eknoyan et al 1982] and is therefore an 
ltnPOrtant cause, but it was not diagnosed until 1953 [Spuhler & Zollinger 1953] and did not 
emerge as a major aetiological factor until the late 1950's I early 1960's. It has been proposed, 
and' 
IS generally accepted, that the emergence of analgesic abuse as a cause of RPN was a 
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result of the widespread sale and promotion of analgesic preparations over the preceding 20-
30 years [Kincaid-Smith 1979]. 
1.6 ANALGESIC NEPHROPATHY 
Analgesic abuse has been the term traditionally used to describe RPN associated with 
analgesics, although the more general term "analgesic nephropathy" is often used, which 
covers the categories of analgesic abuse and high dose non-steroidal anti-inflammatory drug 
treatment. There is also a well-established association between analgesic abuse, hypertension 
and gastrointestinal irritation and ulcers [Arnold et al1974, Wiseman & Reinert 1975, Clive & 
Stoff 1984, Rainsford 1988, Wrenn et alI991]. 
Analgesic nephropathy is one of the few preventable causes of end-stage renal disease, usually 
associated with the chronic intake of analgesics or, more recently, non-steroidal anti-
inflammatory drugs (NSAIDS). It is important that the correct diagnosis is made, since if the 
intake is discontinued renal function can stabilise or improve [Wilson 1972, Fourie et alI982], 
and where renal function is not restored the progression of the disease is generally very slow 
[Kasanen 1967, Goldberger & Talner 1975]. However, establishing the correct diagnosis can 
be difficult as patient histories can be unreliable. especially if there is a social stigma associated 
With abusive or excessive drug consumption. 
It is often difficult to establish exactly what drugs have been taken and in what quantity, so the 
criteria for "abuse" of analgesics is poorly defined. The level of intake necessary to induce 
RPN has been defined variously as 1-2 tablets daily for more than 2 years [Prescott 1966], 8 
Or more aspirin or combined analgesic tablets per day [Lalli 1972], a cumulative dose of over 
lkg [Kasanen 1967], or between 1 and 35kg [Goldberger & Talner 1975, Gregg et al 1989a]. 
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Reasons underlying an excessive use of analgesics/NSAIDS include such factors as arthritis, 
headaches or migraines, painful periods, or mood altering effects of constituents such as 
Codeine or caffeine, psycho-social reasons, and family history [Prescott 1966, Murray 1973, 
Gregg et al1989a, Dahniya et aI1992]. 
-
Generally, there seems to be a greater prevalence of RPN in women than men, and in adults 
Over the age of 40 [Burry 1967, Kincaid-Smith 1979], although there are exceptions 
[Segasothy et al 1990]. Analgesic nephropathy has been a major problem worldwide 
[Goldberger & Talner 1975, Prescott 1976, Kincaid-Smith 1989, Elseviers & DeB roe 1994a 
& b], demonstrating wide geographical variations both between countries (around 1% in the 
UK, 15% in Australia & 22% in South Africa) and within countries (1 % in west & south 
England, 12% in west Scotland). There are several possible reasons for this difference; 
variation in the extent of analgesic abuse (the intake of such drugs is reported as higher in the 
lower social classes), extent of advertising, and climate [Prescott 1966 & 1976, Bach & 
Bridges 1982, Kincaid-Smith 1989]. 
There could also be major variations in factors which modify susceptibility to RPN. Elderly 
patients and those with an underlying renal insufficiency or disorder are considered to be more 
at risk from analgesic nephropathy as they may already have compromised renal function or 
consume more analgesics [Black 1986, Murray & Brater 1990, Stilman & Schlesjnger 1990]. 
The incidence of RPN has been generally reported to be higher in countries with hotter 
climates [Kincaid-Smith et al1968, Prescott 1966 & 1976, Lalli 1972, Kincaid-Smith 1979 & 
1989, Gregg et al 1989a]. It has been proposed that this is because of a contributory 
dehYdration effect on the kidneys, making them more susceptible to the nephrotoxic effects of 
analgesics and NSAIDS [Cochran et al1967, Nanra 1976, Prescott 1976]. This hypothesis has 
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been supported by several research reports implicating dehydration as a contributory factor in 
RPN seen in premature babies and children [Bannister & Hatcher 1973, Wortmann et al 
1980], elderly patients [Stilman & Schlesinger 1990], in horses [Gunson 1983, Gunson & 
Soma 1983] and domestic cats [Wolf et al 1991a]. Research involving the effects of diuresis 
and antidiuresis on RPN in rats also supports this association between dehydration and RPN 
[Fuwa &'Waugh 1968, Black 1986]. 
Whatever the reasons for the differences in distribution of and susceptibility to RPN, and it is 
likely that multiple factors are involved, it is also likely that the reported incidences of 
analgesic nephropathy are higher than figures suggest because of the problems in diagnosis 
and in establishing intake of drugs, as discussed earlier. Analgesic nephropathy continues to be 
a serious problem in many parts of the world, particularly in Belgium where there has been 
only a slight decrease in incidence in the last 15 years [Elseviers & DeBroe 1994a & b]. 
The majority of early reports of RPN implicated phenacetin as the causative agent of papillary 
necrosis in analgesic mixtures. leading to its withdrawal in the early 1970's [Burry 1967]. The 
potential nephrotoxicity of the other products was largely overlooked. Phenacetin was 
replaced by its main metabolite paracetamol and there was an initial drop in the number of 
reported cases of analgesic-associated RPN, although the incidence did not reduce as much as 
expected [Nanra 1976, Kincaid-Smith 1989, McCredie & Stewart 1988]. There is a general 
Consensus that the original theory proposing phenacetin as the sole analgesic responsible for 
RPN Was incorrect since RPN continued to be reported with analgesics that did not contain 
phenacetin. It has also been stated that the risk of RPN with phenacetin is 18-20 times greater 
than with other analgesics [McCredie et a11982, McCredie & Stewart 1988], but this quoted 
risk (and in fact most reported cases of RPN caused by phenacetin) concerned phenacetin as 
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part of a compound mixture rather than alone. It was therefore unwise to discount the other 
components of mixed analgesics as factors, particularly since the incidence of analgesic-
induced RPN was not markedly reduced with the replacement of phenacetin by paracetamol in 
compound analgesics. 
Combined analgesic preparations have been more commonly associated with RPN, especially 
those containing aspirin, paracetamol and caffeine. It is proposed that this is due to synergistic, 
interactive effects of the drugs involved, although combined preparations are also thought to 
be more habit-forming because of the mood-altering and addictive features of components 
such as caffeine and codeine [Arnold et al 1977, Duggin 1980, Henry & Tange 1987, 
Rainsford 1988, Kincaid-Smith 1989, Champion de Crespigny et al 1990]. Powder 
preparations have been reported to be more potent than tablets because of their more rapid 
absorption [Prescott 1976, Kincaid-Smith 1989]. However, more cases ofRPN may have been 
reported with powders because they are considered more "acceptable" to take regularly, 
especially in cases of genuine abuse, and powders are more easily available and therefore 
pUrchased more often than tablet preparations [Kincaid-Smith 1989]. 
It Was hoped that the incidence of analgesic-induced RPN would decline following the 
recognition of this as a cause of end-stage renal failure, increased awareness of the condition 
and legislation and advice warning against the chronic intake of high doses of analgesics. The 
prescription and use of NSAIDS increased to replace some uses of analgesics. However, RPN 
has been increasingly associated with the prescription and intake of high doses of analgesics 
and NSAIDS for recognised illnesses such as ankylosing spondylitis [Lourie et al1977] and 
various types of arthritis in adults [Wiseman & Reinert 1975. Munn et al1982, Colome-Nafria 
et al1991] and rheumatoid arthritis in juveniles [Wortmann et al 1980. Allen et al 1986, Bailie 
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1986]. Furthennore, cases of RPN have been reported following intake of various NSAIDS at 
Commonly prescribed doses. Those compounds so far associated with RPN include 
benoxaprofen, fenoprofen, flurbiprofen, naproxen, phenylbutazone, ibuprofen and 
indomethacin [Arnold 1977, Eknoyan et a11982, Erwin & Jones 1982, Bach & Hardy 1985, 
Kincaid-Smith 1989, Murray & Brater 1990, Colombe 1991, Colome-Nafria et a11991, Price 
et a1 1996]. It is therefore clear that analgesic-induced RPN is still an important problem 
[Mann et al1993, Elseviers & DeB roe 1994a &: b, Price et al1996] 
1.7 RPN IN DOMESTIC ANIMALS 
Renal papillary necrosis also occurs in horses, cattle, sheep, goats and dogs [Todd et al1975, 
Gunson 1983, Gunson & Soma 1983, Faulkner et al1984, Wabke 1986], pigs [Gregg 1989b], 
cats and tigers [Wolf 1991]. Reports of NSAID-induced RPN have been made in various of 
these "domestic" animals and support the observations in humans. The earliest reports in 
veterinary literature of a significant correlation between RPN and administration of NSAIDS 
(phenylbutazone andlor flunixin meglumine) were in horses. A retrospective study of 16 
horses where RPN was found at necropsy showed that almost all had been treated with 
NSAIDS [Gunson 1983]. A second retrospective case control study, where records of drug 
administration were available, revealed an incidence of 2.6% RPN in all horses necropsied at a 
large animal clinic [Faulkner et aI1984]; twenty-five of the thirty affected horses had received 
NSAIDS and the relative risk of horses developing RPN after treatment with these drugs was 
calculated to be 16.6. 
In both studies, a large proportion of the affected horses had been dehydrated or their water 
lIltake had been compromised. Furthermore, a subsequent study in horses determined that a 
redUction in water intake precipitated RPN in 5 horses given normal therapeutic doses of 
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phenylbutazone [Gunson & Soma 1983]. Similarly, two domestic cats and a tiger pup which 
developed RPN had been treated with analgesics and/or dehydrated [Wolf 1991a]. These 
reports add further weight to the hypothesis that dehydration may be an important factor in the 
development of RPN. All of these reports have also suggested the inhibition of prostaglandin 
synthesis as a possible key factor (discussed further in 1.9.5), 
1.8 EXPERIMENTAL RPN 
Renal toxicity is caused by compounds of different chemical structures, acting by a variety of 
biochemical and/or physiological mechanisms. For assessment of nephrotoxicity, it is necessary 
to differentiate between functional changes, such as increased water reabsorption following 
dehydration, and deleterious toxic changes which mayor may not be reversible. Toxic agents 
are characterised by the potential to cause irreversible damage, although they may also have a 
reversible toxicity. Compounds may first exert their toxicity by means of reversible effects on 
kidney cell function without cellular destruction or functional impairment [Bach & Bridges 
1985]. At higher doses, toxic agents may also lead to pathological changes and cell necrosis 
with functional compensation for the impairment of the kidney. Alternatively, the damage may 
be too extensive to allow fo; functional compensation and renal failure develops. All drug-
related nephrotoxicity begins with biochemical and/or physiological alteration of the kidney 
before leading subsequently to cellular degeneration and necrosis. It is therefore important to 
detect nephrotoxicity in the early stages of alteration before cell necrosis and consequent 
functional impairment occurs, so that progression to this stage can be prevented or minimised 
[Bach & Hardy 1985, Murray & Brater 1990]. 
Adequate human data are not available for most hazardous substances, so risk analyses must 
rely on infonnation obtained from laboratory studies of rats or mice. The inference that the 
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results of animal experiments can be applied to humans is a fundamental principle of all 
tOxicological research [Hard et al 1993]. However, there can be specific cases where rats 
respond differently to other laboratory species or man, which raise questions regarding the 
applicability of rat data to other species, including humans [Hard et aI1993]. Although in vivo 
data are essential to help elucidate the mechanisms of drug-induced RPN, extrapolation of 
results from animals to man is difficult, and the relevance of using animal models to clarify the 
factors involved in the development of analgesic associated RPN in humans has been 
questioned for various reasons as discussed below [Rosner 1976, Molland 1978, Bach & 
Bridges 1982 & 1985, Bach & Hardy 1985]. 
The administration of analgesics and NSAIDS to laboratory animals, particularly rats, with the 
aim of better defining the course of cellular changes has often caused highly variable renal 
lesions and marked extra-renal toxicity, such as gastrointestinal tract necrosis [Molland 1978, 
Bach & Bridges 1982 & 1985, Bach & Hardy 1985, Bach 1991]. It has often been difficult to 
stUdy animal models and interpret research data due to irreproducible or variable lesions, often 
caused by inadequately identified variables such sex and strain of animal used, route of 
administration, vehicle, dosage regimen and diet [Bach & Hardy 1985]. Some animal species 
Or strains have been shown to be more resistant to RPN than others [Bokelman et al 1971, 
Owen & Heywood 1986, Whittingham et al 1989]. However, different strains of rats have 
often been used in various investigations, with little data produced until recently on inter- and 
intra-species sensitivity, making it difficult to compare the findings from some publications. 
Animal models have been shown to be more susceptible to the gastrointestinal effects of 
NSAlDS (ulceration, irritation) whilst being relatively resistant to the papillotoxic effects of 
these compounds [Bach & Bridges 1985, Bach & Hardy 1985, Black 1986]. The major 
37 
criticism of the relevance of animal models is that large quantities of analgesics or NSAIDS 
must generally be administered to rodents to produce the effects seen in man [Molland 1976, 
1978, Bilyard et a11990, Bach & Bridges 1985]. However, it has also been reported that some 
compounds, given in comparable dosage regimens to those used in man, have produced RPN 
in rodents [Molland 1976 & 1978, Nanra et al 1980, Burrell et al 1991a]. Furthermore, in 
those patients who have abused analgesics, their level of intake may well have been in excess 
of the recommended dose over a period of years. 
Laboratory animal models still provide the only means of studying the nephrotoxic effects of 
these compounds and the early development of RPN. Use of these animal models enables the 
Possible mechanisms of this disease to be investigated [Whittingham et a11989, Burrell et al 
1990]. There is also an important requirement to develop sensitive and specific methods for 
the early identification of RPN, both for animal studies (to help defme the spectrum of events 
and any contributing factors) and for patient care and prognosis [Bach & Bridges 1985, Bach 
& Hardy 1985, Murray & Brater 1990, Price et alI996]. 
A model which has often been used in studies dealing with RPN, particularly in our 
laboratories, is the anti-inflammatory agent indomethacin [Arnold et al 1974, Wiseman & 
Reinert 1975, Jackson & Lawrence 1978, Molland 1978, Munn et alI982]. This causes acute 
RPN which is most often focal in its pathological appearance, as is analgesic-induced RPN in 
man. Indomethacin is therefore a useful model which can assist in studying the mechanisms 
involved in the development of the lesion, identifying the early stages of damage induced with 
fOcal RPN and in assessing and developing techniques which will help in this. However, two 
problems with using indomethacin are that the RPN induced with this compound is of variable 
incidence, and it induces marked gastrointestinal effects in rodents after a single dose. 
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The sensitivity of laboratory animals to the gastrointestinal effects, coupled with their relative 
resistance to the papillotoxic effects of some NSAIDS and analgesics, has meant that various 
compounds other than analgesics have also been used to create RPN in rats, without the risk 
of extrarenal lesions, with the aim of extrapolating the findings to those caused with NSAIDS. 
2-Bromoethanamine hydrobromide (BEA) causes extensive RPN reproducibly within 24-48 
hours after a single intravenous or intraperitoneal dose, and has allowed the progression of the 
primary lesion to secondary degenerative changes involving fibrosis, scarring and glomerular 
sclerosis to be followed. This acute model for RPN shows similarities to changes that have 
been reported in the clinical condition in human analgesic abusers and in animals dosed 
chronically with analgesics and NSAIDS [Molland 1978, Elliot 1986, Bach & Bridges 1985, 
Gregg et al1989c, 1990a & b, Bach et al1991]. BEA is therefore commonly used as a model 
for RPN in studies that attempt to clarify the sequence of events leading to RPN or develop 
techniques for its early detection. 
However, experimental models of RPN, such as indomethacin, are not always reproducible, 
and the analytical techniques used lack sensitivity so that identifying the events prior to 
necrosis is very difficult. At present, accurate diagnosis of the presence of focal RPN relies on 
examination of serial histological sections which is very time consuming [Arnold et al 1974, 
Bach & Bridges 1982, 1985]. It is therefore important to develop techniques to help improve 
the detection of this lesion (and focal lesions in other tissues). New models of focal RPN 
which are more reproducible and lack extra-renal toxicity are also potentially of great value in 
adding to the infonnation available regarding the development of RPN and the mechanisms 
inVolved 
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1.9 MECHANISMS OF RPN 
Although the drugs which may induce RPN continue to be well documented, there is still 
much debate about the pathogenesis and possible mechanisms of drug-induced RPN and 
particularly the early changes which precede development of the lesion. Knowledge of such 
changes could contribute greatly to the diagnosis and prevention of this cause of renal disease. 
Several hypotheses have been proposed to explain the development of drug-induced RPN 
[Duggin 1980, Bach & Bridges 1982, 1984 & 1985, Bach & Hardy 1985, Gregg et a11989a, 
Hawksworth et alI994]; these are discussed below. 
1.9.1: Counter-current concentration mechanism 
The Counter-current concentration mechanism is a widely accepted physiological process. The 
proposed hypothesis for this as a mechanism for RPN is that, as a result of normal counter-
Current concentration, a concentration gradient develops for the compound, increasing from 
the Cortex to the papilla, and the concentration achieved in the papilla is then sufficient to exert 
a direct toxic effect [Ljundquist & Richardson 1966, Burry et a11977, Bach & Bridges 1982]. 
This proposed mechanism is supported by the fact that experimental induction of RPN is 
increased by dehydration [Jackson & Lawrence 1978, Black 1986], and the finding that the 
initial sites of injury correspond to those areas believed to be sites of maximal concentrating 
ability, i.e. the papilla tip. This is the case with paracetamol [MoHand 1978]. 
lIowever, there are a number of anomalies such as the distribution of aspirin within the kidney, 
Which is localised within the nephron [Molland 1978]. Also, the validity of this hypothesis is 
less significant considering the fact that loss of urine concentrating ability. is a very early 
clinical effect in human analgesic abusers and is an early consequence of dosing animals with 
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analgesics [Bach & Bridges 1984, Henry & Tange 1989]. It has therefore been suggested that 
active urine concentration may be an important factor, but it does not explain the 
toxicodynamics or molecular mechanism underlying the lesion [Bach & Hardy 1985]. 
1.9.2: Ischaemic injury 
Medullary ischaemia is often cited as a possible mechanism in the pathogenesis of RPN. As 
discussed earlier, the medulla, and particularly the papilla, is poorly perfused compared to the 
Cortex and functions at a relatively low oxygen tension, which predisposes it to anoxic injury. 
Microvascular degeneration and medullary ischaemia have been strongly favoured as the 
pathophysiological changes that explain the focal nature of RPN [Harrow 1967, Kincaid-Smith 
et al1968, Nanra et al1973, Nanra 1976, Rosner 1976, Bach & Bridges 1985, Heyman et al 
1988 & 1991], but microvascular occlusion is not a pre-requisite for acutely induced lesions in 
animals [Bach et aI1983]. 
Medullary ischaemia has often been demonstrated in experimental analgesic nephropathy and 
correlated with evidence of medullary dysfunction, such as impaired concentrating ability and 
sodium conservation [Nanra et al 1973, Stilman & Schlesinger 1990]. Administration of 
analgesics and NSAIDS may alter renal haemodynamics by virtue of their inhibitory effect on 
vasodilatory prostaglandins, described further in 1.9.5 [Arnold et al 1974, Jackson & 
LaWrence 1978, Fong & Cohen 1982, Bach & Bridges 1985, Stilman & Schlesinger 1990, 
Wrenn et aI1991]. Also, it has been suggested that the gastrointestinal ulceration induced by 
NSAIDS and analgesics may predispose the papilla to ischaemia because of lowered tissue 
perfusion and dehydration [Wrenn et alI991]. It has been proposed that any alteration in renal 
haemodynamics resulting in decreased papillary blood flow would lead to ischaemia [Molland 
1978, Fong & Cohen 1982]. Cristol et al [1993] demonstrated that the formation of the 
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endogenous vasodilator nitric oxide was also important, not only for the maintenance of renal 
blood flow but also for the recovery and maintenance of renal blood flow after ischaemic 
injury. However, there is conflicting evidence regarding the effects of papillotoxins on blood 
flow; no net change in blood flow was observed with the experimental model, BEA [Solez et 
a11974, Sabatini 1984]. 
Medullary ischaemia is therefore often cited as a possible mechanism in the pathogenesis of 
RPN, but it is very difficult to separate the microvascular changes from the other degenerative 
pathology. It is therefore impossible to determine whether the microvascular changes seen in 
chronically developing RPN in man and experimental animals are the primary pathological 
event, preceding RPN, if they run parallel with, or if they are secondary to necrosis. 
L9.3: Immunotoxic effects 
Early reports suggested an immunological basis for the pathogenesis of RPN because of the 
slow onset of the lesion and the large variability of human analgesic abusers and experimental 
animals exposed to analgesics and NSAIDS [Harrow 1967, Bach & Bridges 1984]. However, 
there is no convincing evidence to support this view and it is now generally accepted that this 
IS not involved in the pathogenesis of RPN [Bach & Bridges 1984 & 1985, Bach & Hardy 
1985]. 
1.9.4: Changes in intermediary metabolism 
High concentrations of several analgesics have been reported to depress or disrupt renal 
intennediary metabolism [Mudge et al 1978, Bach & Bridges 1985]. However, since the 
inVestigations reported were confined to mitochondria of cortical or corticaVmedullary origin, 
and the biochemical functions of cortical and medullary tissue are very different, it has been 
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proposed that they are not necessarily relevant to RPN, which is a medullary lesion. In order 
to clarify whether changes in intermediary metabolism are involved in the development of 
RPN, it would be necessary to look at the effects of compounds on the medullary cell types 
affected in the early stages of this lesion [Bach & Bridges 1985]. However, it may be that the 
reported effects on intermediary metabolism are involved in rendering the kidney more 
susceptible to the papillotoxic effects of the compounds. 
1.9.5: Inhibition of prostaglandin synthesis 
Another proposed mechanism of RPN is a direct pharmacological alteration of renal medullary 
(papillary) prostaglandin synthesis. Prostaglandins are ubiquitous substances which function 
mostly as "local hormones", or prostanoids [Molland 1978, Clive & Stoff 1984, Stilman & 
Schlesinger 1990]. They are unsaturated fatty acid compounds derived from essential fatty 
acids; the most important precursor of prostaglandins is arachidonic acid. Their biological 
activity is exerted primarily at the site of synthesis, since they have a short half-life in the 
circulation [Janszen & Nugteren 1972, Muirhead & Pitcock 1980]. Furthermore, they are 
synthesised immediately before release (on demand), initiated by the liberation of arachidonic 
acid from the phospholipid pool of cell membranes. Figure 1.3 is a schematic representation of 
the arachidonic acid cascade and formation of prostaglandins, including the proposed 
pathways for the oxidative activation of NSAIDS and analgesics (discussed below). 
The kidney is extremely active in the synthesis and metabolism of prostaglandins. 
Prostaglandin synthesis occurs in both the cortex and medulla; the major medullary 
prostaglandin is PGEz, produced in the renal medullary interstitial cells [Muirhead et al 1972a, 
Zusman 1977]. This prostaglandin directly contributes to the effects of natriuresis by inhibiting 
reabsorption of sodium and chlorine [Muirhead et a11972b, Muirhead & Pitcock 1980]. but its 
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major role is as a vasodilator, helping to maintain adequate blood flow. Prostaglandins have 
only a minor role under normal physiological conditions but are crucial for the maintenance of 
renal perfusion following a haemodynamic insult [Henrich et a11978, Cristol et alI993]. 
Analgesics and NSAIDS produce much of their therapeutic and adverse effects through 
inhibition of prostaglandin synthesis, by inhibiting cyclo-oxygenase (Figure 1.3); indomethacin 
and aspirin are both well-documented inhibitors of prostaglandin synthesis [Molland 1978, 
Dunn & Zambraski 1980, Clive & Stoff 1984, Mamett et al 1984, Zenser & Davies 1984, 
Bach & Bridges 1985, Gregg et al 1989c, Hawksworth et al 1994]. It has therefore been 
proposed that it is this inhibition of prostaglandin synthesis which is the major factor in the 
development of RPN. Inhibition may reduce vasodilation, as discussed earlier, and may lead to 
the metabolism of arachidonic acid via the lipoxygenase pathway (Figure 1.3, discussed further 
below), resulting in the production of leukotrienes which can have profound effects on renal 
haemodynamics. However, the perturbation of the renal system may be very complex, and 
factors other than the inhibition of PGE2 may be involved in the development of this lesion 
[Dunn & Zambraski 1980, Bach & Bridges 1984 & 1985, Bach & Hardy 1985, Kirkova et al 
1995]. 
1.9.6: Metabolic activation 
Metabolic activation of chemicals to reactive intermediates which injure cells is recognised to 
be a primary event mediating the toxicity of a variety of industrial, environmental and 
therapeutic chemicals [Bach & Hardy 1985]. Metabolic activation of xenobiotics is thought to 
occur via the formation of free radicals, strongly electrophilic intermediates or· chemically 
unstable metabolites which give rise to reactive and possibly damaging products (reactive 
intermediates). Endogenous material such as polyunsaturated fatty acids, of which there are 
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high levels in the papilla, can also be converted to potentially damaging reactive intermediates 
under certain circumstances [Bach & Bridges 1985]. 
As mentioned above, the reactive intermediates generated by metabolic activation are usually 
strongly electrophilic. Proteins, lipids and nucleic acids contain nucleophilic regions and are 
therefore targets for these electrophilic intermediates, and the reactive metabolites covalently 
bond to cellular macromolecules. Marked depletion of renal glutathione (GSH) and extensive 
covalent binding in the papilla and cortex have been reported after a single high dose of 
paracetamol [Mudge et a11978, Mohandas et al 1984]. Also, paracetamol has been shown to 
bind covalently to proteins only in those tissues which exhibited cellular damage (kidney, liver 
and lung) [Bartolone et al 1989]. 
Metabolic activation of xenobiotics can occur in the kidney via cytochrome P450, glutathione 
transferase, prostaglandin synthetase or lipoxygenase. However, the medulla has no detectable 
P450 activity [Zenser & Davies 1984], so it is unlikely that this enzyme is involved. Levels of 
reduced glutathione (GSH) are lowest in the inner medulla, so the activity of the glutathione-
related enzymes in the inner medulla and papilla would be expected to cause little interference 
to prostaglandin synthetase-mediated co-oxygenation and metabolic activation [Mohandas et 
al1984]. Metabolic activation could therefore occur via the prostaglandin synthetase (PGS) or 
lipoxygenase pathways. These involve the co-oxygenation of xenobiotics in association with 
the metabolism of arachidonic acid (Figure 1.3). 
M.uch work has concentrated on the role of PGS in the development of RPN [Zenser et al 
1983, Marnett et aI1984, Mohandas et al1984, Bach & Bridges 1984 & 1985, Bach & Hardy 
1985, Gregg et al 1989a, Bach 1991, Hawksworth et al 1994, Stewart et al 1994]. PGS is 
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Figure 1.3: Schematic representation of the arachidonic acid cascade including the proposed 
pathways for the oxidative activation of NSAIDS and analgesics. and the generation of free 
radicals via lipid peroxidation 
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Other prostaglandins Thromboxane 
Abbreviations: 
AA = arachidonic acid; GSH = glutathione; HETE = hydroxyeicosatetraenoic acid; 
HPETE = hydroxyperoxyeicosatetraenoic acid; 
NSAID = non-steroidal anti-inflammatory drug; O2- = superoxide anion; 
OR' = hydroxyl radical; PG = prostaglandin; PUFA = polyunsaturated fatty acid . 
. 
F AP = fatty acid peroxides; PGG2, PGH2 = prostaglandins G2 and H2 
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present in significant quantities in the papilla and medulla, and displays an increasing gradient 
from the cortex to the medulla. Recently, increasing attention has been given to the role of 
lipoxygenases in RPN, which have also been shown to display a marked cortex to medullary 
gradient [Bach & Bridges 1985, Miyazawa et al 1985, Kirkova et al 1992 & 1995, 
Hawksworth et al 1994, Stewart et al 1994]. Furthernore, it has been reported that the 
arachidonic acid-dependent co-oxygenation of compounds in the human kidney occurs mainly 
via lipoxygenases, whereas in rat this occurs via PGS and lipoxygenase, suggesting a species 
difference in the renal metabolism of these compounds [Hawks worth et al1994, Stewart et al 
1994]. 
The presence of high levels of polyunsaturated fatty acids in the papilla, mainly in the 
interstitial cells, predisposes these cells to lipid peroxidation in the presence of locally 
generated reactive intermediates. The reactive intermediates produced via PGS or 
lipoxygenase therefore have the potential to cause lipid peroxidation and lead to cell death 
[Bach & Bridges 1984]. Normally, reduced glutathione (GSH) protects the cell from 
alkylating agents and lipid peroxidation, as shown in Figure 1.3, but the medulla and papilla 
have low levels of endogenous GSH. It has been suggested that the low levels of reduced 
glutathione may render the inner medullary region particularly vulnerable to damage from 
metabolic activation, since once reactive intermediates are generated these will not be readily 
Inactivated [Duggin 1980, Mohandas et al1984, Gregg et a11989a]. 
Metabolic activation is therefore currently regarded as the most likely mechanism for 
analgesic-induced RPN, but it is not certain whether this occurs by the PGS or lipoxygenase 
pathways, or a combination of effects. It is also possible that a number of these proposed 
mechanisms (medullary ischaemia, intermediary metabolism, inhibition of prostaglandins and 
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metabolic activation), acting in combination or as a cascade effect, are responsible for the 
development of RPN. 
There is therefore still great interest and research concerning the possible mechanisms leading 
to the development of renal papillary necrosis which remains an important cause of end-stage 
renal failure in man. There is also a need to develop techniques which aid in the early diagnosis 
of RPN. Furthermore, there is an obvious need to identify anti-inflammatory and analgesic 
compounds with the lowest possible risk of producing RPN. It is clear that there is a fine 
balance between the benefits and harmful effects of these compounds; an understanding of the 
mechanisms involved in the latter, and advances in the early diagnosis of any lesions, will help 
in both patient care and in developing drugs with a lower risk of RPN. 
Lto AIMS OF THIS STUDY 
The aims of the first part of this study were to develop and evaluate techniques which may 
help in the diagnosis of toxic injury, particularly in instances of focal damage, and assess the 
applicability of these to toxicity studies. The brain, specifically the hippocampus, was used as 
the preliminary model for assessing initial techniques since it is a well-known site of focal 
ischaemia [Coyle 1976 & 1978, Krinke 1988, Ng et al1989] and is particularly susceptible to 
artefactual damage caused by inadequate preservation techniques. The brain studies were 
conducted as part of the M.Phil phase of these studies; only work which led into techniques 
Used in the kidney has been included. 
Those techniques which showed promise with the brain and were applicable to other tissues 
Were then evaluated, along with further techniques, for use in the kidney, using 2 well-known 
models of experimental RPN, BEA and indomethacin. RPN is an important lesion in the 
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toxicology of analgesics and one in which the identification of focal lesions has caused 
problems. Once useful techniques were identified, these were applied to help investigate a new 
model of experimental renal papillary necrosis. The results obtained from this could then be 
compared with those obtained with the two well-established models. 
The second part of this study was aimed at developing a new model of RPN, using the 
antioxidant ethoxyquin. The aims of developing this new model were two-fold: i) to develop a 
reliable, reproducible experimental model for focal RPN, with no/minimal extra-renal toxicity, 
and ii) to compare the progression and features of the RPN induced with ethoxyquin with that 
seen with the two other experimental models (BEA and indomethacin) and in man, thereby 
contributing to knowledge of the pathogenesis and possible mechanisms of this type of 
damage. 
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CHAPTER 2. PRELIMINARY BRAIN WORK 
2.1lNTRODUCTION 
As discussed in the introductory chapter of the thesis, histological identification of focal lesions 
presently relies upon serial or step-serial sections of the tissue in question, which is a very laborious 
process. Developments in techniques which help reduce this need would be important assets in both 
histopathology and toxicity studies. Furthennore, optimal preservation of tissues is important for 
histopathological assessment, particularly electron microscopy, where post-mortem changes may 
mask an underlying treatment-related effect or make diagnosis difficult. 
The hippocampus region of the brain is a useful model to use for preliminary assessment of 
techniques aitred at optimising tissue preservation and visualising the vasculature of a tissue, as it is 
a clearly structured part of the brain which is sensitive to post-mortem changes caused by 
inadequate preservation techniques and is a potential site for focal ischaemia [Walaas 1983, Krinke 
1988]. Also, since the brain is an important target organ in toxicity studies, development of 
perfusion techniques using the brain will also be of use for subsequent toxicity studies where 
investigation of nervous tissue is required. The work described in this chapter was conducted as 
Part of the M.Phil studies; only the most relevant work, leading onto work conducted in the kidney, 
is included. 
The hippocampus is a simplified, phylogenetically old part of the cerebral cortex with a unique 
structural organisation, which is a corrnnon site for anoxic damage in the brain [Walaas 1983, 
I<rinke 1988]. The characteristics of hippocampal nervous systems have been investigated in the 
Illechanism of action of various toxicants [Walaas 1983]. The hippocampal region occupies most of 
the ventroposterior and ventrolateral walls of the cerebral cortex. Six distinct structures make up 
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the hippocampal region (Figure 2.1): the entorhinal cortex (ERC); parasubiculum; presubiculum; 
subiculum proper; Ammon's Hom (CA1-CA3); dentate gyrus. The last two structures comprise the 
hippocampus proper - most studies have been concerned with these areas. Walaas [1983] has 
written a comprehensive description of the hippocampus and its anatomical structure. 




Adequate fixation of tissues is vitally important for obtaining good morphological preservation of 
structures at both light and electron microscope levels. The brain is particularly susceptible to post-
tnonem necrosis, so rapid fixation is vital. Lamberts & Goldsmith [1986] compared the effects of 
various fixatives aIld methods on the ultrastructural morphology of rat brain. They preserved brains 
by vascular perfusion and/or imrrersion in nine different fixatives. They found that irrnnersion 
fixation was best in the median eminence (outside the blood-brain barrier) and close to the 
hyPothalamus surface. Perfusion fixation gave adequate preservation of the arcuate nucleus and 
tissue within the blood-brain barrier. Perfusion fixation is used in the majority of studies concerning 
the central nervous system and particularly the hippocampus, although this can cause problems in 
tOxicolOgical studies if any other organs are required to be sampled unfixed (e.g. for biochemistry). 
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Extensive light and electron microscope investigations have been carried out to obtain infonnation 
regarding cellular structure and interconnections within the hippocampus in various species, with 
the aim of extrapolating the findings to human hippocampal structure and establishing the relevance 
of using the various animal models. Frotscher et al [1988] compared the fine structure of identified 
neurons in the hippocampus of the baboon to that in connnonly studied small laboratory animals. 
They found, perhaps as expected, that a much more complex dendritic pattern and synaptic 
organisation of these neurons exists in primates. 
Despite this observation, the hippocampal fonnation of small laboratory animals is still used as a 
model structure for studies of general neurobiological phenomena due to the relative simplicity of 
neuronal composition, with the main cell types arranged in densely packed layers, and the fact that 
well known afferents tenninate in the hippocampus and dentate gyrus in a laminated, almost non-
overlapping manner. Ng et al [1989] looked at the frequency and distribution of changes in the 
hippocampus from hypoxic insults, comparing man with rat. They compared can:liac arrest, 
hypoglycaemia and status epilepticus as the cause of insult. They found the CAl region was the 
ltX)st frequently affected in hypoglycaemia in man. In rats, CAl and CA4 were damaged first after 
global ischaemia and status epilepticus, with dentate gyrus affected first in hypo glycaemia. The 
pattern of selective damage was therefore similar in man and rat, supporting the view that rats are a 
Useful model for hippocampal damage. 
1'0 enable damage observed in hippocampal cells, particularly with anoxia, to be correlated with 
Changes in blood supply, knowledge of the vascuIarisation of the hippocampus is nece~sary. Coyle 
[1976 & 1978] highlighted the vascular patterns of the rat hippocampal fonnation and the spatial 
features, mapping the distribution of the major arteries and veins using silicone injections and 
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double injections of indian ink and fluorescent material. The aim of Coyle's studies was to 
detennine which arteries and veins could be paired and to map spatial positions to gain better 
impressions of vascular and neuronal relationships. 
Coyle [1976 & 1978] found the CAl region of the hippocampus to be the most poorly vascularised 
and the outer 2/3 of the dentate gyrus to be more vascular than the inner portion. He proposed that 
it is this poor vascularity that predisposes the CAl area of the hippocampus to injury under certain 
circumstances, ego anoxia. Krinke [1988] emphasised that the hippocampus is very vulnerable to 
secondary ischaernic effects (after damage has occurred in other areas), and interpretation of 
hippocampal lesions is therefore frequently controversial. As a general rule, CAl-3 is most 
sUsceptible in secondary anoxic ischaemia, while CA4 and the dentate gyrus are most affected by 
primary toxic effects of certain compounds. 
The hippocampus is therefore a highly sensitive area to the effects of anoxia induced by various 
disease states and toxic substances, but the precise mechanisms of action on the hippocampus are 
largely unknown. The use of animal models for the type of hippocampal damage seen in humans 
attempts to; (i) clarify the causes of cell damage, and (ii) provide suggestions for treatment or 
prevention of damage in susceptible individuals. Research on the functioning and morphological 
appearance of the various structures within the hippocampus in normal and diseased animals 
Continues to be of value in understanding and elucidating the mechanisms of damage. 
The aim of the work detailed in this chapter was to evaluate various techniques which may assist in 
stUdying focal lesions, using the brain as a preliminary model The hippocampus is a potential site 
for fOcal ischaernic lesions in the brain and is very sensitive to the effects of poor or SUb-optimal 
fixation, due to its susceptibility to post-mortem changes via anoxia, as discussed earlier. Perfusion 
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fixation provides a method for optimal preservation, but the qUality of the results obtained is 
dependent on the flow rate used. The effects of perfusion fixation at various flow rate were 
therefore assessed to detennine the optimum flow rate for preservation of the hippocampal cells. 
Dyes have often been used to study the vasculature of tissues and vascular damage [Coyle 1976 & 
1978]. Perfusion with dyes to visualise the vasculature of the hippocampus was therefore evaluated 
to assess its potential use in investigating the involvement of the vasculature in the development of 
lesions in future studies with the brain or in other tissues where this might be an issue. The 
techniques which proved useful with the brain were then applied and developed for the kidney, 
another site of focal necrosis which causes problems in pathological evaluation. 
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2.2 MATERIALS & METHODS 
2.2.1: Materials 
2.2.1.1: Chemicals and Suppliers 
All buffer salts, fonnaldehyde (40% stock), alcohol, xylene, cedarwood oil and paraffin wax were 
obtained from BDH Merck Ltd., Hunter Boulevard, Magna Park, Lutterworth, Leicestershire. 
Neutral buffered formalin (10%) and all histological dyes used in the Haematoxylin & Eosin 
staining and dye perfusion methods were obtained from Pioneer Research Chemicals, Unit 7, 
Commerce Park, Whitehall Industrial Estate, Colchester, Essex. 
Electron microscopy fixatives, chemicals, and grids were obtained from Agar Scientific Ltd, 
Stansted Rd., Essex, u.K. Dyes used in the toluidine blue staining method were obtained from 
BDH Merck. "Sagatal" anaesthetic was obtained from Rhone- Merieux, Spire Green Lane, 
Harlow, Essex. Heparin ("Monoparin") and local anaesthetic ("Lignavet"), used in perfusion 
experiments, were obtained from CP Pharmaceuticals Ltd. Wrexham, and C-Vet Ltd. Bury St. 
Edmunds, respectively. 
U 1.2: Animals. housing conditions and dosing regimes 
AIl rats used in the experiments in this chapter were obtained from Charles River (UK) Ltd., 
Manston Rd., Margate, Kent. Animals were housed at a temperature of21 ± 2°C, relative humidity 
of 55 ± 10% and 12 hours light/12 hours dark lighting. Animals were fed with a standard certified 
rOdent diet (RMM diet, Special Diet Services, Cambs., UK), both this and water were provided ad 
libitum 
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2.2.2: Perfusion fixation 
Each rat (weighing approximately 4OOg) was tenninally anaesthetised with sodium pentobarbitone 
(Sagatal, 0.2ml/kg) and the body cavity opened to expose the beating heart. Using a syringe, ImL 
of prewash solution 1 (0.9% saline containing heparin (25 units/mL), local anaesthetic (''Lignavet'', 
O.4mglmL) and sodium nitrite (lOmglmL» was injected into the left ventricle, simultaneously 
cutting the right atrium The alxlomina1 aorta was tightly clamped above the diaphragm using artery 
forceps to allow the flow of perfusion solutions through the upper body only. A 25 gauge cannula 
Was inserted into the ventricle in the origin of the aorta, clamped in place and 50mL of prewash 
solution 2 (0.9% saline containing heparin (25 units/mL) and Lignavet (O.4mglmL» passed through 
the heart, flushing out any remaining blood, using a Welhned syringe pump set at the prescribed 
flow rate; five different flow rates were used for comparison - 22, 11, 9, 7.5 and 5 mUminute. One 
hundred mL of Karnovsky's fixative (0.1M phosphate buffer (pH 7.4) containing 2% fonnaldehyde 
and 2.5% glutaraldehyde) was then passed through the heart via the same cannula and flow rate. 
After successful perfusion, the brain was removed and the hippocampus region was sulxlivided for 
standard histological and electron microscopical (EM) examination to evaluate the effect of the 
perfusion rate used on the morphological structure. To study the effect of irrnnersion fixation, the 
hippocampus from one animal was removed without being perfused, sulxlivided for histology and 
EM examination, and processed in the same way as the perfused samples. 
Tissue for histology was immersed in Karnovsky's fixative overnight and processed to paraffin wax 
using a Bayer VIP automated tissue processor (50, 80, 95 and 2 x 100% ethanol, 3 x xylene, 1 
hour each at 40°C; paraffin wax 3 x 2 hours at 60°C). Tissues were then embedded into paraffm 
blOCks using a Tissue-Tek embedding centre. 7J.l.m sections were cut and stained with 
fIaematoxylin and Eosin (H&E, Irethod in Appendix 1) for evaluation. Tissue for EM was 
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sulxlivided and innnersed in Kamovsky's fixative for a further 2 hours. Tissue pieces were then 
post-fixed in 1 % osmium tetroxide in O.lM phosphate buffer pH 7.4 for 1 hour and rinsed in O.IM 
phosphate buffer. Samples were then dehydrated through graded alcohols to 1,2 epoxypropane (25, 
50, 75 and 100% alcohol, 15 min each, 30 min 1,2 epoxypropane), and infiltrated in CY212 resin 
overnight before embedding and polyrrerisation in araldite blocks (48h at 60°C). 
Semi-thin (1f.llll) and thin (60-9Onm) sections were cut transversely through the hippocampus using 
a Reichert Ultracut E ultramicrotorre. Semi-thin sections were placed on glass slides, stained with 
1 % toluidine blue in 1% borax (method in Appendix 1) and the structure observed with a light 
microscope. Thin sections were collected on 3nnn copper mesh grids, stained with uranyl acetate 
and lead citrate and observed using a Siemens 102 transmission electron microscope at an 
accelerating voltage of 80kV. 
,t,2.3: Vascular visualisation 
This was a modification of the brain perfusion rrethod detailed in 2.2.2; the same solutions were 
Used for perfusion. Animals were perfused as in the method outlined in 2.2.2 with both prewash 
solutions, then perfused with either 50rnL of fixative solution containing dye, or 50rnL of dye 
alone. The dyes used for perfusion to assess their applicability for visualisation of the vascular 
SUPply were inruan ink, carmine, neutral fast red, methylene blue and pennanent ink, used 
separately. The dyes were chosen either on the basis of previous reported use of these dyes or the 
size of dye particle (dyes composed of smaIl dye particles were preferred, to ensure they could be 
perfused into small capillaries), 
After perfusion was complete, the brains were removed and irnrrersed in Kamovsky's solution for 4 
hours to complete the fixation process. Whole brains or Imm-thick· sections through the 
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hippocampal region (cut using a "Harvard" rat brain matrix and skin graft blades) were dehydrated 
by hand through graded alcohols (25, 50, 75, 90 and 100% 30 mins each) and cleared in several 
changes of cedarwood oil for at least 48 hours. Slices were placed on glass slides, innnersed in 
cedarwood oil and the extent of vasculature successfully perfused was observed with a dissecting 
microscope. In order to correlate this information with histology, the most successfully perfused of 
these 1mm slices were embedded in paraffin wax using a Tissue Tek embedding centre and 4/lIll 
sections cut and stained with Haematoxylin and Eosin for observation. Some whole brains perfused 
with dye were left intact, dehydrated by hand as above and cleared in cedarwood oil to gain an 
Overall picture of brain vasculature. The remaining whole brains were sliced and processed to 
paraffin block as described above . 
.t.2.4: Retrospective electron microscopy 
Rat brain tissue previously fixed and stored in 10% neutral buffered formalin for 3 months was used 
to assess the qUality of preservation for potential retrospective examination of structurally altered or 
necrotic tissue. The brain was subdivided, using a "Harvard" rat brain matrix and skin graft blades, 
into hnm thick slices and pieces of hippocampus dissected out. Tissue pieces were then dehydrated 
and embedded in araldite resin blocks for electron microscopy as described. in 2.2.2. Thin (6Onm) 
sections for electron microscopy were cut using a Reichert ultramicrotome, mounted on copper 
mesh grids and observed using a Siemens 102 electron microscope at 80kV. 
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· Figure 2.2.: Toluidine blue 
l~l.m resin section (x600) of 
immersion-fixed pyramidal 
cells (dark cells arrowed). 
I 
, . I , . 
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Figure 2.4: H&E stained 
section of pyramidal cells, 
perfused at 22mL/rnin. Note 
shrunken cells (arrowed). 
(x300) 
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Figure 2.3: H&E stained paraffin 
section of hippocampus, perfused 
at 22mLlrnin (x45). Note large 
spaces (arrowed). 
Figure 2.5: Electron micrograph 
of endothelial cell from 9mL/rnin 
perfused brain (x25,OOO). 
2.3 RESULTS 
2.3.1: Immersion fixation 
Light microscopy showed evidence of widespread shrinkage of pyramidal cells in the CA system 
and dentate gyrus. These irregular, densely stained cells were identified as containing pyknotic 
nuclei (Figure 2.2). Endothelial cells and vessel contents appeared shrunken. Electron microscopy 
cOnfinred poor ultrastructural preservation of pyramidal cells within the hippocampus. This was 
indicated by cells at various stages of autolysis, namely swollen mitochondria and cisternae of the 
endoplasmic reticulum (ER) and condensation of chromatin in nuclei. Electron microscopy also 
cOnfinned the shrinkage of endothelial cells seen at the light level 
1:3.2: Perfusion fixation 
At a perfusion rate of 22rnljrnin, light microscopy showed considerable perfusion artefacts, 
SPecifically dilation of the lateral ventricle and the vessels in the molecular layer of the 
hippocampus, detachment of the corpus callosum and shrinkage of cells in the CA system of the 
hippocampus and the dentate gyrus (Table 2.1, Figs 2.3, 2.4). Similar artefacts were seen at a 
perfusion rate of 11mUmin, although not as pronounced. 
A perfusion rate of 9mUmin showed reduced perfusion artefact with only slight detaclurent of the 
corpus callosum and some enlargement of vessels by light microscopy. Electron microscopy 
shOWed good preservation of endothelial cells, cell membranes and mitochondria with little 
shrinkage (Table 2.1, Fig. 2.5) At a perfusion rate of 7.5mUmin, light microscopy showed no 
dilation of ventricles or blood vessels and very good preservation of pyramidal cells with minimal 
shrinkage (Fig. 2.6). Electron microscopy conf'inred excellent preservation of pyramidal cells and 
Contents (Fig. 2.7). Glial cells and endothelial cells were also very well preserved (Fig. 2.8). 
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Figure 2.6 Toluidine blue-
stained lllm resin section 
from 7.Sm1/min hippocampus 
(xSOO). 
Figure 2.8: Electron 
micrograph of glial (g) and 
endothelial (e) cells from 
7.SmL/min perfused brain 
(x6000) 
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Figure 2.7: Electron micrograph 
of pyramidal cells of 7.SmL/min 
hippocampus (x6000). 
I,-
Figure 2.9: Electron micrograph 
of autolytic pyramidal cell 
from SmL/min perfused brain. 
Note shrunken nucleus (arrow) 
(x20,OOO) 
At a perfusion rate of 5rnljrnin, light microscopy showed good preservation of hippocampal cells. 
However, S01m shrinkage of cells was apparent and the perfusion rate was insufficient to clear out 
all blood cells from the vessels. In addition, the failure rate of perfusion with this flow rate was high 
(50%). Electron microscopy confinned shrinkage of sorre pyramidal cells with sorre evidence of 
autolysis (Fig. 2.9). 
On the basis of the results, a perfusion rate of 7.5 ml/min was selected as the optimum for 
preservation of hippocampal tissues. 
Table 2.1: Assessment of fixation quality in rat hippocampus following perfusion fixation 











pyramidal cells present * used 
- yes 2 
++ yes 2 
+++ yes 2 
+++ no 5 
++ no 3 
- = poor; + = moderate; ++ = good; +++ excellent 
(defined by electron microscopy investigation) 
* = artefacts such as dilation or rupture of 100mbranes (high pressure) or shrinkage 
(low pressure) 
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2.3.3: Vascular visualisation method 
The results obtained with the various dyes are sunnnarised in Table 2.2. 
Table 2.2: Results of perfusion of dye and fixative for brain vasculature 
Dye used Perfusion of dye in Perfusion of dye followed 
fixative by immersion fixation 
indian ink ++ +++ 
Cannine ++ -







Key: few or no arteries and veins perfused 
++ large arteries and veins perfused 
+++ large and small arteries and veins perfused 
, 
Perfusion of dye with fixative produced acceptable results using indian ink, cannine and neutral fast 
red, panicularly on whole brain preparations (Fig. 2.10). However, examination of Imm thick brain 
slices showed that many minor arteries were not highlighted using this technique. The best results 
Were seen when undiluted indian ink was perfused directly into the brain after prewashing. This 
highlighted many minor arteries and gave a better overall picture of the hippocampal vascular 
SUPply. It was clear that a number of the small transverse hippocampal arteries branched just below 
the pyramidal cell layer (Fig. 2.11). The vascular supply to CAl region appeared poor when 
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Figure 2.10: Whole rat brain 
(x8) perfused with carmine 
in fixative (ventral aspect 
Note vessels (arrows). 
Figure 2.12: H&E section of 
hippocampus from an indian 
ink perfused brain (x500). 
Vessels are clearly visible 
by presence of ink (arrows). 
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Figure 2.11: Indian ink perfused 
brain showing hippocampal cells 
(large arrow) and perfused 
vessels (small arrow) (xIOO) 
Figure 2. 13:Electron micrograph 
of pyramidal cell layer showing 
a dark cell (arrow). Note 
shrinkage space (s) (x6000) 
compared to other areas of the brain. Histological sections, when taken from tissue slices previously 
prepared for observation of vasculature, clearly showed dye present in the arteries and veins (Fig. 
2.12) 
.t.3.4: Retrospective electron microscopy 
Pyramidal cells were clearly visible in retrospectively examined tissue. SOtre cell bodies showed 
evidence of shrinkage, dense cytoplasm and pyknotic nuclei (Fig. 2.13) consistent with the 
artefactual "dark cell change" reported in immersion fixed hippocampus. There was also a degree of 
cellular disruption over and above that expected for immersion fixation. This was typified by 
mitochondria showing no cristae but containing amorphous material and sotre small circular 
granules. Endoplasmic reticulum was sparse and often artefactually dilated. Membranes were 
generally indistinct, profiles of myelin were present but difficult to observe in fine detail Nerve cell 
processes were also indistinct. Endothelial cells were shrunken, with defortred contents. In general, 




1.4.1: Perfusion fixation 
Perfusion fixation has been used by many workers for the preservation of rat brain tissue. However, 
a variety of perfusion rates have been used and in some cases the rate is not specified. The effect of 
varying perfusion rate on the preservation of rat brain, particularly hippocampus, has not previously 
been reported. Rates of up to 40mljminute have been used for perfusion fixation in the past [Auer 
et al 1984, Schmidt-Kastner & Hassman 1988]. These perfusion rates were used to study the 
effects of ischaemia and hypoglycaemia on the hippocampus and any abnormalities seen were 
attributed to treatment. However, these changes could be due to the high perfusion rates used since 
the micrographs show changes very similar to the perfusion-associated artefacts obtained with the 
higher flow rates used in the current project. In one case, no control animals were included in the 
stUdy, making it impossible to compare the treatment-related effects with control animals perfused 
in the same way [Simon & Schmidley 1986]. 
The results described in this chapter indicate that the optimal perfusion rate for good preservation 
of the hippocampus with minimal perfusion artefact is 7.5mUmin, using the method detailed. Since 
this method has been validated using control animals, it is reconunended that it be used in 
preference to innnersion fixation for both light and electron microscopy in future studies involving 
POtential hippocampal or other focal brain damage. A possibility for further evaluation in the brain 
Would be to compare the results of perfusion pump apparatus with those using fixed head of 
pressure equipment. This was done in the subsequent work with the kidney. The resultant 
technique has subsequently been applied with success to the brain, and used in a recent toxicology 
StUdy in the hamster which enabled the ultrastructural details of a specific effect in the brain to be 
Studied (unpublished observation). 
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&4.2: Vascular visualisation 
Perfusion of the brain with fixative solution containing dye highlighted major arteries and veins in 
the hippocampus. Perfusion with dye alone followed by inunersion fixation provided better results, 
picking up many of the minor arteries and veins as well as major ones. In all cases the most 
consistent results were obtained using indian ink as the dye solution. However, even here many 
capillaries were not filled when compared to results in the literature [Coyle 1976 & 1978]. 
StUdies of whole brains and of lrnm-thick slices through the hippocampus region were used to 
build Up a picture of the nonna! vascular pattern. The arterial supply to the hippocampus appears to 
be via transverse hippocampal arteries originating from the longitudinal hippocampal artery. This 
agrees with the vascular patterns described for the hippocampus by Coyle [1976 & 1978]. 
One of the great advantages of perfusing with dye and fixative is that it allows histological material 
to be processed from brain tissue previously prepared to display the vasculature, with very high 
qUality results. When dye is perfused in conjunction with fixative, electron microscopy can also be 
perfonned. This technique could be used in future studies where hippocampal lesions occur, or in 
other tissues where the vasculature is implicated in the occurrence of a lesion. Observations from 
previous studies with hippocampal lesions show a degree of vascular alteration associated with the 
lesion area. Using this method it should be possible to visualise alterations and identify the vessels 
inVolVed, and to identify whether the vasculature is primarily involved in the development of a 
leSion. 
Compared to most areas of the brain, the number of dye-highlighted arteries and veins in the CAl 
region of the hippocampus were few. This may reflect poor penetration of dye into the vasculature 
in this area or indicate that CAl is inherently less well supplied than other areas. The latter 
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explanation has previously been put forward as the explanation for the susceptibility of the CAl 
region to damage [Coyle 1978]. 
,t4.3: Retrospective electron microscopy 
Although only one animal was studied, the results agree with those in the literature, ruurely that for 
detailed ultrastructural studies fonnalin fixed tissue provides very poor results. Many ultrastructural 
changes appeared to have occurred post-fixation, during storage in the fixative solution. This may 
be due to the build-up of fonnic acid which attacks the tissue [Bancroft & Stevens 1982]. The 
ultrastructural changes seen over and above those expected from itnrrersion fixation alone are 
similar to those seen due to many pathological insults. Conclusions about the detailed pathology of 
the tissue would be very difficult. Furthennore, no infonnation is available about the storage of 
tissue for longer periods (several years) and tissue damage may be increased over this period 
This rrethod of observing "wet stored tissue" might be useful if only the assessrrent of the presence 
Or absence of certain cell types is required. In addition, the presence or absence of specific 
intracellular granules such as lipofuscin might be possible. It has been reported that good 
ultrastructural preservation can be obtained if histological material is taken from wax block to the 
electron microscope level [Bancroft & Stevens 1982], providing a further rreans of retrospectively 
eXamining damaged tissues for electron microscopy. Processing wax-embedded tissue for EM 
shOuld provide a better source of material since no further degradation of the tissue by the 
formation of fonnic acid (as occurs with tissue stored in fonnalin) wm have taken place. This 
technique of processing wax-embedded material for electron microscopy has subsequently been 
eValuated and used with success in several toxicology studies where ultrastructural con:firrnation of 
Observed histological changes was required. 
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2.4.4: Recommendations for Kidney work 
The work carried out showed that perfusion fixation can successfully be used in toxicology studies 
for light and electron microscopic examination of brain tissue, including situations where ischaemic 
damage is suspected, or when tissues are particularly susceptible to fixation artefact, as is the case 
in the brain [Lamberts & Go1dsmith 1986] and the renal papilla [Bohman 1974]. After optimising 
perfusion rates for evaluation of brain tissue using perfusion pump apparatus, the knowledge gained 
was. applied to the kidney. Optimal fixation of kidney is preferable for light and electron 
microscopy, particularly in toxicology studies where it may be necessary to study subtle changes, 
such as vacuolation, without having to distinguish these from immersion fixation artefact. Both 
perfusion pump and constant head of pressure techniques were used and evaluated to detennine 
which was preferable in tenns of ease of use and reliability. 
Perfusion with dye gave promising results for examination of the vasculature, especially when 
Combined with clearing slices of tissue in cedarwood oil and subsequent histology. These 
techniques were developed and further assessed in the kidney work. Cedarwood oil was used 
for the examination of cleared slices of kidney, prior to histological assessment, to assess its 
Use in aiding visualisation of vessels and damaged tubules. The technique of dye perfusion, and 
Subsequent histology, was modified slightly by using a different dye (trypan blue) and 
assessing various routes of perfusion to evaluate this as a means of identifying necrotic cells in 
the kidney rather than highlighting alterations in the vasculature. 
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CHAPTER 3. BROMOETHANAMINE AND INDOMETHACIN STUDIES 
J.l INTRODUCTION 
J.l.1: Experimental models of RPN 
Although renal papillary necrosis (RPN) is one of the most common drug-associated 
nephropathies, there is still much discussion regarding the possible mechanisms of drug-
induced RPN. Analgesic and non-steroidal anti-inflammatory drugs (NSAIDS) are capable of 
producing chronic RPN in both humans and animals, as discussed in the introductory chapter 
of this thesis, and laboratory animals treated with analgesics and NSAIDS have therefore been 
Used to investigate the development and possible mechanisms. However, since laboratory 
animals are particularly sensitive to the extra-renal toxicity (e.g. gastrointestinal effects) and 
relatively resistant to the nephrotoxic effects of analgesics and some NSAIDS [Gregg et al 
1989b, Wrenn et al 1991], the study of mechanisms of RPN using these compounds is 
difficult. Other experimental models of RPN have therefore been used with the aim of assisting 
in determining the events and mechanisms which lead to RPN in man. Two such experimental 
models are 2-bromoethanamine (BEA) and indomethacin, which can be used to induce 
extensive (BEA) or focal (indomethacin) RPN in an acute manner. 
41! 1; Bromoethanamine 
2-Bromoethanamine (BEA; NHzCH2CH2Br) is a low molecular weight, short chain aliphatic 
amine with pressor activity. It is readily soluble in water and is thought to rapidly undergo ring 
Closure to a more stable compound [Bach et al1980, Sabatini 1984]. BEA was first shown to 
cause experimental papillary necrosis in 1913 [aka] and has since been shown in several 
investigations to induce extensive, reproducible RPN in all animals within 24-48h of· a single 
intravenous or intraperitoneal dose of 5Omg/kg or above [Bach et al 1980, Bach & Bridges 
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1982, Powell et aI1991]. The most striking functional changes seen following BEA treatment 
are polyuria (excess urine production) and an inability to concentrate the urine. 
BEA is a well established experimental model of RPN and is considered a useful model for 
investigating the mechanistic basis of RPN and developing techniques to help identify RPN 
[Bach & Bridges 1982 & 1985, Sabatini 1984]. Investigations conducted using BEA as a 
model have tended to concentrated on identifying the course of lesion development with RPN 
and the primary cell types affected, and extrapolating the findings to RPN in man. Most of this 
work has been conducted in the rat, but pig [Gregg et al 1989b], hamster [Carlton & 
Engelhart 1989, Wolf et al 1992a], mouse [Gregg & Bach 1990, Wolf et al 1990, 1991b & 
1992b] and gerbil [Wolf 1992a] have also been studied . 
.3...1.1.2: Indomethacin 
Indomethacin is an NSAID which has been reported to induce RPN in combination with other 
analgesics in man [Jackson & Lawrence 1978, Clive & Stoff 1984]. It also causes focal RPN 
in rat following a single dose of 75mg/kg, within 48 hours of treatment [Wiseman & Reinert 
1975, Molland 1978, Bach & Bridges 1982]. However, in contrast to BEA, the incidence of 
RPN induced with indomethacin is variable, and lesions can often be missed due to their focal 
nature [Arnold et al 1974, Bach & Bridges 1982]. As this is often also the case with RPN 
induced by analgesics and NSAIDS in man, indomethacin is a good model for studying 
, 
Possible mechanisms and in developing techniques to identify and study focal tissue damage. 
One limitation of using indomethacin (or other NSAIDS) to induce experimental RPN is that it 
also induces gastrointestinal lesions in rats 48 hours after treatment of a single dose [Arnold et 
a11974, Clive & Stoff 1984], so it cannot be used in larger doses or for longer dosing periods. 
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.J..l.2: Development of renal papillary necrosis with BEA and indomethacin 
The pathological changes in the papilla produced with BEA are similar to those seen with 
analgesic nephropathy RPN in man and have been described in increasing detail [Hill et al 
1972, Murrayet al1972, Cuttino et al 1981, Bach et al 1983, Sabatini 1984, Gregg et al 
1990a & b, Gregg & Bach 1990, Wolf & Carlton 1990]. It was originally suggested that the 
fIrst effects are seen in the capillaries [Hill et al 1972], but it has since been proposed, 
following detailed time-course studies in rodents, that the earliest effects are seen in the renal 
medullary interstitial cells [Mattingleyet a11984, Bach & Bridges 1985, Bach & Hardy 1985, 
Bach et al1991, Gregg et al1990 a & b, Gregg & Bach 1990]. These show slight changes at 
4 hours post-dose (pyknotic or irregular nuclei and increased mucopolysaccharide staining), 
With focal necrosis apparent at 8 hours. Endothelial degeneration with platelet adhesion, and 
denudation of the covering epithelium of the papilla tip are also seen at 8 hours post dose. By 
12 hours the interstitial cells show marked necrosis. The platelet adhesion is marked at 18 
hours Post-dose, but only in the affected capillaries. Extensive degenerative changes within the 
papilla are seen at 24 hours post-dose with a greater area of the papilla affected. 
the pathological changes leading to RPN with indomethacin treatment have not been studied 
in as much detail as BEA, but the sequence of events is similar. The major difference, as 
mentioned earlier, is that RPN induced with indomethacin is focal in nature, and therefore the 
eXtenSive RPN reported with BEA in the later stages is not seen with indomethacin. 
J.:.LJ: Possible mechanisms of experimental renal papillary necrosis 
])espite much research into the pathological changes induced in the papilla with BEA and 
indomethacin, the mechanism by which this RPN develops is still unknown [Bach & Bridges 
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1985, Bach 1991, Wolf 1992b]. The possible mechanisms proposed mirror those suggested 
for RPN in man and can be summarised as follows: i) counter-current concentration 
mechanism; ii) immunotoxic effects of the compound; iii) perturbation of renal intermediary 
metabolism; iv) direct or indirect renal ischaemia and vasoconstriction; v) generation of 
biologically reactive intermediates leading to excess lipid peroxidation and cellular injury. The 
two most popular mechanisms quoted are renal ischaemia and generation of reactive 
Intermediates. 
Vasoconstriction has been proposed as the mechanism of RPN with BEA by several 
investigators [Cuttino et al 1981, Wyllie et al1972, Russell et a11987, Wolf et a11991b & 
1992a], but this suggestion has been disputed by ~thers [Solez et al1974, Sabatini 1984, Bach 
& Bridges 1984]. It has also been suggested that the most likely mechanism involved with 
REA-induced RPN is the generation of biologically reactive intermediates, leading to effects 
on peroxidative activity and lipid peroxidation in the interstitial cells. This would then initiate 
a cascade of events leading ultimately to RPN [Bach et al 1986]. Supporting this is the 
Suggestion that conditions within the papilla (such as the renal concentrating mechanism) may 
favour the concentration and subsequent dissociation of BEA into reactive alkylating species 
[Powell et aI1991]. 
Indomethacin is known to inhibit the vasodilatory prostaglandin PGE2, which is produced 
ll1ainly in the renal medullary interstitial cells and has a local action [Arnold et a11974, Jackson 
& Lawrence 1978, Melendez & Reyes 1982, Zenser & Davies 1984, Zenser et alI985]. It has 
therefore been proposed that this effect is involved in the development of RPN with 
indomethacin via alterations in renal haemodynamics leading to renal ischaemia [Jackson & 
Lawrence 1978, Henrich et a1 1978, Bach & Bridges 1984, Heymanet a1 1988 & 1991]. 
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However, indomethacin also has an inhibitory effect on prostaglandin synthetase, lipoxygenase 
and cyclo-oxygenase, present within the interstitial cells, so the mechanism of RPN with 
indomethacin may be via an effect on the interstitial cells with generation of reactive species, 
and Subsequent cascade effects [Bach & Bridges 1984, Marnett et al1984, Kirkova et al1992 
& 1995]. 
Whatever the mechanisms responsible for the development of RPN, and there may be several, 
there is still much discussion and research involved in detecting the lesion at an early stage and 
elucidating the mechanistic basis of this lesion. This will be useful for the identification and 
SUbsequent management of RPN in man, and in the design of new drugs which do not induce 
Such effects. 
J:.1.4: Detection and identification of RPN 
Experimental models of RPN are not always reproducible (as is the case with indomethacin), 
and the analytical techniques used may lack sensitivity so that identifying the events prior to, 
Or in the early stages of, necrosis is very difficult. At present, accurate diagnosis of the 
presence of focal RPN relies on the examination of serial histological sections which is very 
time-consuming [Arnold et al 1974, Bach & Bridges 1982 & 1985]. Any development of 
techniques which help in the diagnosis of RPN would therefore potentially be very useful, 
Particularly development of reliable non-invasive markers for nephrotoxicity. These could be 
Used to screen for the presence of lesions in animals and humans, ideally in the early stages of 
leSion development when recovery is still possible [Zbinden et al 1988, Price et al 1996] . 
.3.JA 1; Potential methods for investigation 
Drine is the major body fluid for the noninvasive investigation of damage and dysfunction to 
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the kidney [Stonard et al 1987]. Urinary sediments (cytology) have been used with some 
success in man and in animal studies to investigate and help indicate the presence of various types 
of kidney damage, but have often been compared with urinary enzyrre levels rather than with 
histopathology findings. They have been used in man for the diagnosis of transplant rejection 
[Madras et alI986], assessment of inflammatory state [Guthinger et alI977], detection of acute 
renal failure [Gay et al 1978, Mandai et al 1985, Mandai 1988, MandaI & Bennett 1988], 
aminoglycoside nephropathy [Coulon et al 1984], and interstitial nephritis [Pitone et al 1982, 
Spence et al1985]. 
Sediments were found to show a good correlation with pathological data in acute renal failure in 
children [Gay et al 1978]. MandaI and co-workers [1985, 1988, MandaI & Bennett 1988] 
investigated the usefulness of urinary sediments (using transmission electron microscopy) in 
detecting acute renal failure in patients with acute tubular nephropathy and aminoglycoside damage 
(both cortical effects). They found a good correlation between the type of sediment and the severity 
of the illness, and could distinguish between different cell types in the sediment. They also 
emphasised an important point when assessing urinary sediments; that the usefulness of sediments 
depends upon adequate collection and preparation methods. Coulon et al [1984] also found 
sediments useful for detecting aminoglycoside nephropathy and recommended their use as a non-
invasive marker. Spence et al [1985] used sediments to look for urinary crystals and casts in 
triamterene-treated patients (who can develop interstitial nephritis), and found them useful for 
shOWing a treatment -related brown precipitate in the urine. 
Jackson ~t al [1978] studied urine cytology in analgesic nephropathy with regard tc? carcinoma 
screening and recommended its use as a screen for possible carcinoma or dysplasia in analgesic 
abUsers with RPN (ie. those patients at risk of developing urothelial malignancies). Russ et al 
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[1982] also used urine cytology for the same purpose. Jackson and co-workers [1978] found that 
more severe cytology changes were observed in cases of more severe renal failure and suggested 
that urinary sed.iIrents might therefore also be useful to help detect RPN in patients. 
Urine sediments have been investigated in animal studies to indicate renal damage following 
treatment with the cortical toxins 2,2,4-trimethylpentane [Fowlie et al 1987] and mercuric 
chloride [Kennedy & Gail Saliya 1970], and the papillotoxins BEA and aspirin [Davies et al 
1968, Kennedy & Gail Saliya 1970]. A non-invasive nephrotoxicity screening test based on 
repetitive, quantitative urine analysis in rats has been proposed as a useful procedure to detect 
nephrotoxic chemicals acting by a variety of mechanisms [Fent et a11988, Zbinden et al1988]. 
Fent and Zbinden and co-workers [1988] looked at 17 reference substances, including the 
analgesics phenacetin and phenylbutazone, using female Sprague-Dawley rats. They studied the 
effects in the urine (volume, pH, enzymes, proteins, cells present) following treatment and then 
compared these with histology data. Elevated excretion of cells and occurrence of cylinders 
Were considered the most sensitive indicators of renal damage. The findings from these various 
stUdies suggest that urinary sediments may therefore be of potential value in the early 
detection of necrosis. 
Trypan blue uptake is routinely used to assess the viability of cultured cells (it is excluded by 
living cells and retained in necrotic cells) and has also been used to investigate zonal 
hepatotoxicity in perfused livers with good results [Belinskyet al 1984]. It may therefore be 
Useful in identifying areas of necrosis in the kidney, particularly in focal damage which may be 
missed in routine examination. 
Scanning electron microscopy (SEM) has been used successfully for the investigation of 
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bacterial infection associated with RPN [Cohen et al 1979 & 1981] and for studying 
morphological changes in bladder epithelium following acute toxicity [Okamura et al 1992] or 
treatment with proliferative agents [Shibata et al1989 & 1991, Anderson 1991]. However, no 
work has been reported using SBM for the investigation and detection of RPN per se. SBM 
may be of use as a large area of tissue can be examined at once, allowing examination of the 
Whole papilla rather than a thin section through this area. It should also be possible to produce 
histological sections from SEM material, to allow comparison of the appearance of a lesion 
with the two techniques. 
~1.5: Aims of the studies described in this chapter 
The aims of the work detailed in this chapter were to evaluate the methods mentioned above 
for their usefulness in identifying extensive and focal lesions in the kidney, induced using BBA 
and indomethacin respectively. Also, initial investigations were performed to assess the 
accuracy of the standard technique used to identify RPN, a histological section through the 
papilla tip [Arnold et al 1974, Bach & Bridges 1982 & 1985), using both BBA and 
indomethacin. 
The Usefulness of urinary sediments, when compared with histology, in determining RPN 24 
and 48 hours after treatment with BBA and indomethacin was investigated. Also, the use of 
cedarwood oil to clear kidneys during histological processing, for observation of vasculature 
and areas of necrosis within thick slices of tissue, was evaluated for its potential to help 
identify RPN. This had proven useful in allowing visualisation of the vasculature in the 
preliminary work carried out with the brain (Chapter 2), particularly when combined with dye 
PerfUSion techniques. 
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The dye perfusion method developed with the brain for visualisation of the vasculature was 
used for a different purpose in the kidney; it was applied to assess the usefulness of trypan blue 
perfusion for highlighting areas of necrosis in both extensive and focal RPN caused by BEA 
and indomethacin respectively. Different routes of perfusion were assessed to find the best 
means of getting dye into the kidney structures, particularly the papilla. The technique of 
clearing in cedarwood oil during histological processing to help visualise any dye present, 
which had been used successfully in the brain, was also performed with un-perfused and trypan 
blue-perfused kidney slices to determine whether this was also useful for identifying necrotic 
areas in the kidney. 
SEM was included in the investigations to assess its potential usefulness for identifying the 
morphological changes associated with RPN and studying its effects. The feasibility of 
Subsequently processing SEM material for correlative histology, and the quality and usefulness 
of the results obtained, was also assessed. The same principle of performing "secondary" 
histology to gain more information had worked well in the brain for examining brain slices 
Which had previously been perfused with dye, cleared with cedarwood oil, and evaluated by 
light microscopy. 
1'he ultimate aim of this chapter was to identify the techniques which may be of use in 
ide if' nt ymg RPN, to enable further assessment of these techniques in the subsequent chapter 
with a potential new model for RPN, the antioxidant ethoxyquin. Comparisons could then 
SUbsequently be made between the usefulness of the techniques, the effects of the three models 
(BEA, indomethacin and ethoxyquin), and the potential mechanisms involved in the 
development of RPN. 
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J..2 MATERIALS AND METHODS 
J..2.1: Materials 
12.1.1; Chemicals and suppliers 
All buffer salts, fonnaldehyde (40% stock), alcohol, acetone, xylene, cedarwood oil and paraffin 
Wax were obtained from BDH Merck Ltd. Neutral buffered fonnalin (10%) and all histological 
dyes used in the Haematoxylin & Eosin and Papanicolau staining methods were obtained from 
Pioneer Research Chemicals. Shandon Cytospin fluid was obtained from Life Sciences 
International, Runcom, Cheshire. Trypan Blue was obtained from Sigma Aldrich, Poole, Dorset. 
Electron microscopy fixatives, chemicals, and specimen stubs were obtained from Agar Scientific 
Ltd, Essex. "Sagatal" anaesthetic was obtained from Rhone-Merieux. Heparin ("Monoparin") and 
lOcal anaesthetic ("Lignavettt), used in perfusion experiments, were obtained from CP 
Phannaceuticals Ltd, and C-Vet Ltd. respectively. Bromoethanamine was obtained from Sigma 
Aldrich. Indorrethacin was manufactured and supplied in-house. Gum tragacanth (vehicle for 
indomethacin) was obtained from Red Carnation Gum Co., Sir John Lyon House, London. 
~ Animals, housing conditions and dosing regimes 
Female Sprague-Dawley rats from Charles River (UK) Ltd., Margate, Kent, each weighing 150-
200g, Were used in all experiments conducted with bromoethanamine (BEA) and indorrethacin. 
Animals were housed at a temperature of 21 ± 2°C, relative humidity of 55 ± 10% and 12 hours 
light/12 hours dark lighting. Animals were fed with a standard certified rodent diet (RMM diet, 
Special Diet Services, Carnbs., UK), both this and water were provided ad libitum. ~e practical 
WOrk carried out in this chapter was separated over several experiments for logistical reasons; the 
nUmbers of animals used in each experiment are detailed in Table 3.1. 
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Table 3.1: Number of animals used in BEA and indomethacin experitrents and numbers used for each technique 
Total Total 
Technique Numbers indomethacin Numbers 
BEA 
Histology 20(20) 6(3) 10 (5) 36 (28) 20 (20) 6(3) 10 (5) 36 (28) 
Serial sections 4 (4) - - 4 (4) 10 ( 0) - - 10 (0) 
Cedarwood oil 10 (10) 6 (3) - 16 (13) 10 (10) 6 (3) - 16 (13) 
Urine sediments 20 (20) - 10 (5) 30 (25) 20 (20) - 10 (5) 30 (25) 
Urine volwres noted No No Yes 10 (5) No No Yes 10 (5) 
Trypan blue - 6 (3) 10 (5) 16 (8) - 6(3) 10 (5) 16 (8) • 
SEM - 6 (3) 10 (5) 16 (8) - 6 (3) 10 (5) 16 (8) 
Secondary histo1ogy No Yes Yes 16 (8) No Yes Yes 16 (8) 
EXPERIMENT A C D - B C D -
The number of treated animals used for each technique is given first, the number of control animals is given in brackets. The numbers used are split into 
columns for each separate experiIrent conducted. ExperiIrents are coded A-D at the bottom of the table. 
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The dosing regime for BEA-treated animals was a single intravenous injection via the tail vein at a 
dose of 150 mg/kg in 0.9% sodium chloride; indOlrethacin-treated animals were given a single oral 
gavage (oral intubation) dose of 75 mg/kg in 25% gum tragacanth. The control animals for each 
treatrrent compound were dosed with the appropriate vehicle by the same route. Unless otherwise 
specified, all animals were killed 24 hours after the last dosing by an intra-peritoneal overdose of 
sodium pentobarbitone ("Sagatal", 0.2mUl00g body weight). 
3.2.2: Histology 
Animals were killed as outlined in 3.2.1.2, either 24 or 48 hours post-dose. Both kidneys were 
removed and innnerse-fixed separately in 10% neutral buffered formalin for at least 2 days. Thin 
slices «lrnm) through the centre of each kidney (containing the papilla) from 10 BEA-treated and 
10 indomethacin-treated animals were cut by hand using skin graft blades, dehydrated by hand 
through a graded alcohol series (25, 50, 75, 90 and 2 x 100% ethano~ 30 minutes each), and 
cleared in cedarwood oil for 48 hours to assess the use of this technique in aiding visualisation of 
vasculature and damaged tubules. Macroscopical and microscopical assessment of the cleared slices 
Was Carried out. After assessment of the cleared kidneys, the slices were infiltrated with paraffin 
Wax for 48 hours in an oven at 58°C and embedded in paraffin wax blocks using a Tissue-Tek 
embedding centre. 
Slices through the centre of each kidney from the remaining animals were processed through to 
paraffin using a Bayer VIP automated tissue processor (50, 80, 95, and 2 x 100% ethano~ 3 x 
xylene, 1 hour each at 40°C; paraffin wax 3 x 2 hours at 6Ooe), using the standard clearing agent, 
xylene, instead of cedarwood oil Embedding was carried out as above. Sections through the centre 
of each papilla were cut at a thickness of 4J.l.m using an Anglia Scientific microtome. Sections were 
Stained with Haematoxylin & Eosin (H&E, method in Appendix 1) on a Shandon Varistain staining 
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machine for histological assessment. The definition of kidney necrosis in each technique and the 
basis for categorisation was as follows: 
Cedarwood oil: Alterations in vasculature (condensed & reddened areas) and pale areas of papilla 
were recorded as abnonnalities. 
Histology: The grading system used for assessment of renal papillary necrosis (RPN) is detailed in 
Table 3.2 below. 
Table 3.2: Grading criteria for histological and electron microscopy assessment of renal papillaIy 
.n..ecrosis 
Grade Histological appearance 
Minimal slight damage to papilla tip with necrosis of interstitial cells and S01m epithelial 
cells in the loops of Henle, preservation of all ducts & tubules 
-Moderate loss of interstitial cells, derangement and necrosis of some tubules (mainly loops 
of Henle) but preservation of papilla structure, hyaline granules present in some 
collecting duct cells 
-Marked destruction of papilla structure within lesion; loss of interstitium, tubules and 
ducts (outline only remaining). In BEA-treated animals, the outer papilla shows 
loss of interstitium, with derangement of some loops of Henle and capillary 
endothelium Hyaline granules in collecting duct cells in less damaged areas. 
-
.l2.2.1: Additional Histology 
BEA-treated animals: 
~amination 
The initial assessment of BE A-treated kidneys as detailed in 3.2.2 above raised a question regarding 
Whether one kidney from an animal was a reasonable predictor of the other in terms of degree of 
necrosis. To answer this question, kidneys were randomised for re-examination and the degree of 
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necrosis in each kidney graded in tenns of "% damage", that is, the percentage of the length of 
each papilla with damaged structures (rather than complete necrosis); this was to give a 
"quantitative" aspect to the extent of damage to the kidney and allow statistical analysis. Following 
this re-examination, the kidneys were un-randomised and the gradings assessed to detennine how 
close the kidneys from one animal were in tenns of % damage. Statistical analyses (scatterplots and 
correlation coefficients) were perfollIcl to assist in this assessment. 
Step-sections 
Examination of histological sections as detailed in 3.2.2 identified some animals where the kidneys 
had not been sectioned through the actual papilla tip (no Ducts of Bellini opening out of papilla). 
The grading of these kidneys was also less severe. Further work was carried out in an attempt to 
determine how much the distance from the tip affected the extent of necrosis. 
Slices through the middle of the kidney were taken from both kidneys from two BEA-treated 
animals and processed separately to paraffin blocks using a Bayer VIP automated tissue processor 
as previously described. Sections were cut and collected every 20 microns through the whole 
thickness of the papilla from each kidney. These were then stained with H&E for assessment as 
deScribed above. 
Gradings of RPN were given a score of 0 - 3 to assist in the recording of results, and the relative 
Position of each section within the papilla was assessed and graded as detailed in Table 3.3. The 
aim of this was to detennine the amount of variation in damage throughout the papilla and 
Subsequently whether the extent of damage was consistent with the position within the kidney (ie. 
Whether the damage was worse nearest the tip). 
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Table 3.3: Details of system used for scoring of necrosis and section position 
Score Definition Position Definition 
0 Nonna! 1 section through tip, showing openings of ducts of 
Bellini 
1 Minimal necrosis 2 section through tip, but ducts of Bellini not present 
in section 
2 Moderate necrosis 3 section near to tip but not through 
3 Marked necrosis 4 section well away from tip 
Indomethacin-treated animals: 
Step sections 
Both kidneys from all treated animals killed at 24 hours were sectioned further after the initial 
histological assessment to detennine the likelihood of missing focal lesions if sections are only taken 
through the papilla tip. All kidneys were sectioned through to the end of the block; every third 
section was collected on slides and H&E sections prepared (resulting in up to 40 extra sections per 
block, 80 per animal). These "step serial" sections were then examined for presence oflesions. 
J.2.3: Urinary sediments 
Drine samples were collected into ice-cooled collecting vessels 0-8, 8-24 and 24-48 hours post-
dOse with BEA or indomethacin. Animals were housed in MS&D (modular systems & 
development) metabolism cages for urine collection. Aliquots of urine (0.25ml) were mixed with an 
equal volume of Cytospin fluid (to fix cells in the urine) and urinary sediments were prepared from 
these by centrifugation using a Shandon Cytospin according to the manufacturer's instructions (20 
ll'linutes at 1500 r.p.m). Sediments were stained prior to assessment with the Papanicolau 
histological stain, using a Shandon Varistain staining machine (method as detailed in Appendix 1), 
and the sections assessed by light microscopy to detennine types of cells present and numbers of 
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transitional epithelial and renal tubule cells where present. An increase in the number of epithelial or 
transitional cells compared to controls and the presence of renal tubule cells was taken as an 
indication of renal necrosis. 
In later experiIn!nts, urine samples were collected into ice-cooled collecting vessels 0-24 hours 
Post-dose as above and urine volumes were measured. Fixed urinary sediments were prepared as 
above. The number of transitional cells present in the sediment (including renal tubule cells) were 
noted microscopically by manually counting the number of cells in each x200 magnification field, 
for the whole sediment area. Cell numbers were then converted to give total cells present in the 
urine based on the volume of urine collected as follows: 
total cells = cell numbers in sediment x 4* x volume of urine collected (mL) 
(*aliquot of O.25mL corrected to ImL) 
StatistiCal analysis of the results (analysis of variance) was performed to determine the significance 
of any differences in cell numbers. 
J.2.4: Perfusion experiments 
Animals were killed as outlined in 3.2.1.2. Under deep Sagatal anaesthesia, kidneys were perfuse-
fixed by one of the methods below (perfusion pump or fixed head of pressure). After perfusion, 
kidneys were removed and processed to paraffin block using a Bayer VIP processor (processing 
CYCle as in 3.2.2) and H&E sections produced for histological assessment as detailed in 3.2.2. 
~1; Perfusion pump apparatus - local perfusion 
The abdomen was opened and the gastrointestinal tract gently pushed to the right hand side. The 
abdominal aorta was located and tied off with suture thread above the kidney as close to the aortic 
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branch as possible (limiting perfusion to the kidneys only). The aorta below the kidney was then 
lifted with curved forceps and thread placed underneath. A cannula derived from a 25 gauge needle 
Was inserted into the aorta and tied in place using the thread. The cannula was attached to a 60mL 
syringe containing a prewash solution of 0.9% saline containing heparin (25 units/mL) and 
"Lignavet" local anaesthetic (O.4mg/mL). The syringe was placed in a Wellmed syringe pump. 
Once the cannula was in place and tied, the a1xlominal vena cava was cut and the pump started. 
Various flow rates were used to compare their effects on preservation and morphology of the 
papilla; the rates used were 6, 10, 20 and 25 mUminute. After 50mL of the prewash had been 
PUmped through the animal, flushing out the blood, the cannula was clamped and the syringe on the 
pump changed for one containing Karnovsky's fixative (2.5% glutaraldehyde and 2% fonnaldehyde 
in O.IM phosphate buffer pH 7.4). The pump was restarted and the clamp removed, allowing 
fixative to perfuse through the kidney. After 30mL of fixative had perfused through, the kidneys 
were Co • 1 'gid lruryn . 
3"..2.4.2: Fixed head perfusion apparatus - whole body perfusion 
Fixed head perfusion apparatus was set up as shown in Fig 3.1. The solutions used for perfusion 
were the same as those used for 3.2.4.1 above. A sphygmanometer was used to monitor the 
perfusion pressure in mm of mercury (mm Hg) and a hand pump from the manometer used to 
tnaintain the pressure. The perfusion pressure used was 110 mm Hg. 
lJ nder terminal anaesthesia, the thoracic cavity of the animals was opened to reveal the heart and 
aSSOciated vessels and the rib cage deflected to allow access. The right ventricle of the heart was 
griPPed with toothed forceps and the apex of the heart snipped to give access to the left ventricle. 
A. rat gavage cannula was inserted through the left ventricle into the aorta and clamped in place 
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with artery forceps Gust above cut in ventricle). The inferior vena cava beneath the heart was 
immediately cut and the saline flow started. When all the organs had cleared of blood, flow was 
switched from saline to Karnovsky's fixative. After 3-5 minutes, when approximately 400ml of 
fixative had gone through, tissues were firm and the animal was rigid. Kidneys were left in situ for 
10-15 mins before removal to allow the fixative to penetrate the tissues further. 
Saline Cannula Fixative Manometer .Air reservoir 
Figure 3.1: Fixed head perfusion apparatus 
J.:.2.S: Trypan blue perfusions 
12.5.1; Assessment of perfusion route 
Pressure 
Adjuster 
Prior to using trypan blue with treated animals, 3 control animals were perfused with trypan blue, 
One by each of 3 routes to detennine the best means of ensuring trypan blue entered the kidneys. 
The routes assessed were: whole body perfusion; local perfusion via the abdominal aorta and 
retrograde perfusion via the ureter. The first 2 methods of perfusion were carried out as detailed in 
3.2.4 above except that O.2mM trypan blue solution was perfused instead of saline or fixative, 
ureteral perfusion was performed in a similar manner to local perfusion via the aorta, except that 
the cannula was inserted into the ureter below the kidney. 
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.3.2.5.2: Perfusion experiments 
Twenty four hours post-dose, contro~ indOIrethacin- and BEA-treated animals were given an 
intraperitoneal injection of pentobarbitone (Sagatal, 0.2 mU1OOg). Under deep anaesthesia, the 
kidneys of all animals were locally perfused via the abdominal aorta using perfusion pump 
apparatus set at 20 mUminute flow rate (as detennined in 3.204 and 3.2.5.1). Kidneys were 
perfused with 0.9% saline containing heparin (25 units/mL) and "Lignavet" (Oo4mg/mL) until 
cleared of blood and then for 5 minutes with 0.2mM trypan blue. The right kidney was tied off with 
Suture and the left kidney perfused with 0.9% saline to remove excess trypan blue for comparison. 
Both kidneys were then removed and immerse-fixed in 10% neutral buffered formalin for at least 2 
days. 
Kidneys were processed through to paraffin block, SOIre samples were processed by hand as 
described earlier (3.2.2) to enable them to be examined after "clearing" in cedarwood oa the rest 
Were processed using a Bayer V.I.P. tissue processor and xylene instead of cedarwood oil as 
clearing agent (as 3.2.2). Both H&E and eosin-only stained sections (to he1p identify any trypan 
blue present) were produced for histological assessment, using the criteria outlined in 3.2.2. 
J.2.6: Scanning electron microscopy (SEM) 
I<idneys from contro~ indomethacin- and BEA-treated animals (48 hours post-dose) were 
processed for SEM investigation after perfusion or immersion fixation. Samples were washed in 
distilled water to remove any buffer salts from the surface of the tissue, then dehydrated through a 
graded series of acetone (25, 50 and 75% acetone 20 mins each, 100% acetone overnight). 
Samples were then critical point dried for a minimum of 1 hour to remove any liquid from the 
tissues and replace it with liquid COz. Critical point drying was carried out using a Polaron critical 
Point dryer, this process replaces any liquid in the tissue with liquid COz. Liquid COz instantly 
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sublitres to gas at its "critical point" (36lC or 1200 p.s.i pressure), leaving dry specitrens with 
optimal preservation and minimal shrinkage. Samples were sputter coated with gold. in a Polaron 
SC500 sputter coater; coating the specimen with a thin layer of gold. conducts electrons and 
prevents "charging" (accumulation of electrons on the surface which distorts the image). 
Specimens were mounted on aluminium stubs with double-sided tape and examined in a Philips 
XUo SEM operating at lOkV, at magnifications from 20 to 10,000 titres. Both the internal and 
Surface structures of the papillae were assessed for any signs of derangement or necrosis. 
J..2.7: Correlation ofSEM and histology 
FOllowing SEM assessment. papilla samples were removed from the specitren stubs, placed in 
tissue cassettes and processed to paraffin wax. using a Bayer VIP automated tissue processor as 
detailed in 3.2.2. Samples were embedded in paraffin wax. blocks using a Tissue-Tek embedding 
centre. Sections (4f.lm-thick) were then cut on an Anglia Scientific microtome and stained with 
1I&E for histological assessment (both of tissue preservation and treatment effects) and to allow 
correlation with the SEM findings from the same samples. 
~.8: Statistical analysis 
SCatterplots and correlation coefficients were used to determine the significance of results in re-
ex.amination of the experitrental animals in section 3.2.2.1. 
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Table 3.4: Summary of histological findings: incidence and grading of renal papillary 
necrosis 
24 hours 48 hours 
control BEA indomethacin control BEA indomethacin 
R L R L R L R L R L R L 
Cedarwood oil: 
NAD 10 10 6 6 10 10 10 10 6 4 0 0 
Possible necrosis* 0 0 4 4 0 0 0 0 4 6 0 0 
Total animals 10 10 10 10 10 10 
Histology: 
NAD 20 20 0 0 8 10 19 20 0 0 8 7 
Mild necrosis 0 0 3 3 1 0 1 0 1 4 0 1 
Moderate necrosis 0 0 6 3 0 0 0 0 6 2 1 2 
Marked necrosis 0 0 1 4 1 0 0 0 3 4 1 0 
Total animals 20 10 10 20 10 10 
KEY 
BEA = Brorroethanamine R = right kidney; L = left kidney 
* = Necrosis interpreted as alterations in vasculature (congested & reddened areas). pale areas 
in kidney. 
NAD = no abnormalities detected. 
Numbers in table are number of animals affected. Total number of animals assessed for treatment 







All BEA-treated animals showed signs of necrosis varying from mild to marked renal papillary 
necrosis (RPN) on histological examination at both 24 and 48 hours (Figs 3.2a and 3.2b); mild 
necrosis affected only interstitial cells and some epithelial cells of loops of Henle, moderate necrosis 
affected interstitial cells and necrosis of some tubules, marked necrosis was typified by destruction 
of the papilla structure within the area of the lesion. Necrosis was bilateral in all BEA-treated 
animals, although the severity of necrosis varied between kidneys, as shown in Table 3.4. One 
notable feature in BEA-treated animals 48 hours after treatrrent was the presence of mitotic figures 
in collecting duct cells (and occasionally in preserved loops of Henle). No mitotic figures were seen 
in either control animals, indomethacin-treated animals, or in BEA-treated animals 24 hours after 
treatment. 
Assessment of the cedarwood oil-cleared slices at 24 and 48 hours showed reddening of the papilla 
due to congestion, suggesting renal damage in 10 of the 20 BEA-treated animals where this step 
Was carried out. No necrosis was apparent in the cedarwood oil slices from indorrethacin-treated 
animals. Histological examination of kidney sections from indomethacin-treated animals from both 
time points identified 5 treated animals with signs of necrosis of varying degree, ranging from mild 
to marked as described above for BEA lesions (Fig 3.3). Two of these had bilateral necrosis (Table 
3.4). 
91 
Figure 3.2a: Grades of papillruy necrosis induced with BEA- low power micrographs 
Nonnal papilla: magnification x 50. 
Moderate necrosis: Note loss of interstitial 
cells; degeneration of tubules in tip region 
but outline of structures still visible (arrow). 
Magnification x 50. 
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, 
Mild necrosis: note loss of interstitial detail 
(arrow). Magnification x 50. 
Marked necrosis: Loss of all structural 
detail in papilla tip area. Magnification x 50. 
Figure 3.2b: Grades of papillary necrosis induced with BEA- high power micrographs 
Nonnal papilla: magnification x 250. 
MOderate necrosis: Note loss of interstitial 
cells; degeneration of some tubules in tip 
region (arrow), collecting ducts still well 
preserved. Magnification x 250. 
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Mild necrosis: note loss of interstitial 
cells (arrow). Magnification x 250. 
Marked necrosis: Loss of all structural detail 
in papilla tip area with only ghosts of tubules and 
blood cells remaining (arrows). Magnification x250. 
I ' 
Figure 3.3: Grades offocal papillruy necrosis induced with indomethacin 
'. 
",. . - .. 
I ' • .' ; " '''1\ ' 
Nonnal papilla: magnification x 50. 
. '" _. ~, .. 
Moderate necrosis: Note loss of interstitial 
cells and degeneration of tubules in tip region 
(arrOw), collecting ducts still well preserved. 
lllagnification x 50. 
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Minimal/mild necrosis: note loss of 
interstitial detail in some areas (arrow). 
magnification x 50. 
Marked necrosis: Loss of all structural 
in papilla tip area with only ghosts of 
tubules and blood cells remaining. Papilla 
preserved distal to area of lesion. 
magnification x50. 
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FilWre 3.4a: Scatterplot of~ht versus left dama2e for BEA-treated 
kidneys 
Ir = 0.04 1 
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FilWre 3.4b: Scatterplot from 3.4a. showin2 position of sections 
relative to tip 
10 20 30 40 
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.3..3.1.1: Additional Histology 
BEA - treated animals: 
Re-examination 
The results indicated that there was no correlation between kidneys from the same animal in terms 
of degree of necrosis, expressed as % damage (r = 0.04), as illustrated by the scatterplot in Figure 
3.4a. There was a slightly greater correlation between kidneys if both sections were through the 
same region of the papilla (r = 0.09), although this was still not statistically significant; Figure 3.4b 
shows the same scatterplot with the points grouped to show where the left kidney section, right 
kidney section or both kidney sections were through the papilla tip. Therefore, although kidneys 
Were bilaterally affected with BEA, they were not necessarily affected to the same degree (the 
variation within an animal was as great as the variation between animals). 
Step serials 
Step serial sections showed that damage with BEA was most extensive at or near the papilla tip and 
lessened as the sections got further from the tip as shown by the graphs in Figure 3.5, plots of score 
and section position at each 20 micron step-section for each of the 4 kidneys sectioned. The 
diagrams in Fig. 3.5 illustrate the angle of the papillae in the blocks and the plane of the sections 
taken; both of these influence the pattern of the plots obtained. Diagram A shows the angle of the 
papillae from animal 1; papillae were straight and sections started distant from the tip before passing 
through it. Diagram B shows the angle of the papillae from animal 2, where due to the curved 
papillae, and hence the oblique angle, the sections started at or near the tip. 
The results support the general assumption that BEA damage is most extensive at the tip. It is 
important to note that this damage gradually lessened further from the tip in a similar manner for all 
kidneys sectioned (the necrosis score did not markedly alter until sections were well away from the 
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tip). The standard technique used to assess the extent of damage with BEA, a single section near 
. the papilla tip, is therefore robust, since the section does not have to be exactly through the tip, just 
within 60 J.lII1 of the tip, to give a reliable estimate of the extent of damage. 
Indomethacin- treated animals: 
Step serials 
The additional histology carried out on step serial sections from the 24-hour indorrethacin-treated 
animals identified papillary lesions in a further 5 animals (Table 3.5). Also, one animal which was 
Unilaterally affected with RPN in the initial section was identified as being bilaterally affected on 
funher sectioning. The outer cortex was also affected in sorre animals, but this was not thought to 
be treatrrent related (cortical scarring in 3 animals, one of which was bilaterally affected). The 
additional histology highlighted the fact that a high number of false negative results can obtained 
When relying on only one section through the papilla tip when looking for focal necrosis, due to the 
Variable nature of the lesion. 
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Figure 3.5: Necrosis score and section position for step serial sections through papillae from two 
BEA-treated animals 
Animal! Left kidney 
4 
o 
o ~ ~ ~ ~ § ~ ~ ~ ~ ~ ~ ~ ~ re ~ ~ ~ ~ ~ ~ 








o.~ -1"":: "'-=f='F=::;:p,:;;.~= 
AnjIIIlIl Right kidney 
o ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ re ~ ~ ~ ~ ~ ~ 
distance cut tbroogh block (mn) 
Score Definition Position Definition 
0 Normal 1 section through tip, showing 
openings of ducts of Bellini (Area 
Cribrosa) 
1 Minimal necrosis 2 section through tip, but ducts of 
Bellini not present in section 
2 Moderate necrosis 3 section near to tip but not through 










Animal 2 Left kidney 
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Diagram B: angle of 
papillae of animal 2 

























































No abnonnalities detected 
papillary necrosis present, not separated into grades 
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3.3.2: Urinary sediments 
BEA- treated animals: 
Urinary sedirrents from BEA-treated animals collected at 8 hours did not show any obvious 
differences to control animals, both contained similar types and numbers of cells and only one 
treated animal had renal tubule cells present in the sediment (Table 3.6 and Fig. 3.6, a plot of 
individual animals). SediIrents prepared from urine collected at 24 hours identified 17 BEA-treated 
animals with an increase in the number of transitional cells beyond the top of the range for controls 
(Fig.3.6). The sediIrents from the 3 other BEA-treated animals contained few cells of any kind and 
were within the control range. 
More sediments from BEA-treated animals had transitional cells present than did sediments from 
Controls (19 vs. 14 respectively, Table 3.6) and renal tubule cells were present in 13 of 20 treated 
animals compared to 0 of 20 controls. Furthennore, the rrean number of transitional cells present 
per animal per group was higher in BEA-treated animals (92 vs. 11 in controls). Correlating the 
reSults of the urinary sediments with histology observations, there was a very good relationship; all 
animals with increased cells in the sediment showed evidence of RPN on histological examination. 
The 48 hour urinary sediIrents taken from the remaining animals supported the 24 hour results in 
terms of incidence and increase in transitional cells, although the difference was less marked. ll1ere 
Was no difference between the number of animals with transitional cells present in the sediment and 
Only one treated animal with renal tubule cells present. However, the rrean number of transitional 
cells present in sediments was still increased in treated animals (49 vs. 25 in controls). 
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Table 3.6: Urinruy se<liIrent observations from BEA-treated animals: incidence table 
Observations 8 hour 24 hour 48 hour 
(n = 20/group) (n = 20/group) (n = 10/group) 
(presence of) Control BEA Control BEA Control BEA 
Polymorphonuclear 19 19 14 16 10 10 
leucocytes 
Squamous 20 18 18 20 10 10 
epithelial cells 
"-
Transitional 20 17 14 19 9 10 
epithelial cells 
Mean number of 25 40 11 92 25 49 
transitional cells in ±19.17 ±58.4 ±6.16 ±74.45 ±14.25 ±28.30 
sediment ( ± SD) 
-
Renal tubule cells 0 1 0 13 0 1 
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Control SEA Contra 1M Control SEA Control 1M Control SEA Contra 1M 
Treatment group 
Key: 1M - indorrethacin. Control groups plotted prior to respective t:reatIrent groups 
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Indomethacin-treated animals: 
No discernible difference was found in the types or numbers of cells present in the urinary 
sediments prepared from control and indomethacin-treated animals at 24 hours (Table 3.7 and Fig. 
3.6). At 48 hours the mean number of transitional cells present in the sediments from indomethacin-
treated animals was higher than those from control animals (mean number of cells = 65 vs. 34 in 
controls). However, this increase in the mean was due mainly to one animal as can be seen from 
Fig. 3.6; the range of cell numbers apart from this was the same for treated and control animals. 
Comparing the urinary sediment results with the histology findings, there was no obvious 
correlation, since those animals with necrosis on histological examination did not have the highest 
numbers of transitional cells in the sediment. 
Table 3.7: Urinan' sediment observations from indomethacin-treated animals: incidence table 
Observations 24 hour (n=20/group) 48 hour (n=lO/group) 
(presence of) Control indomethacin Control indomethacin 
Polymorphonuclear 20 20 10 10 
Ieucocytes 
Squamous 20 20 10 10 
epithelial cells 
~ 
Transitional 20 20 10 10 
epithelial cells 
I--
Mean number of 31 24 34 65 
transitional cells ( ±SD) ±19.49 ±19.03 ±21.42 ±39.90 
t--
Renal tubule cells 0 0 0 0 
'--
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Quantification of ceO numbers 
The later urine analysis experitrents involving detennination of the total number of cells excreted in 
the urine after 24 hours' treattrent gave similar results to those above (Table 3.8 and Fig. 3.7). In 
BEA-treated animals, the urinary sediments matched well with the histopathology assessments, and 
the animal with the lowest cell numbers in the urine also had the mildest lesions. The trean volutre 
of urine produced by the BEA-treated animals was significantly greater than the control animal 
values (p < 0.(01) with only 2 animals within the control range (Fig 3.7). Indotrethacin-treated 
animals showed no difference in trean urine volurre relative to controls (p > 0.05). However, there 
Was an increase in the number of transitional cells present in the sediments of indotrethacin-treated 
animals relative to control values due to the values from 4 animals (Fig. 3.7), although this was still 
not significant. The sediments from BEA-treated animals showed a marked increase in cell numbers 
oVer controls with all but 1 animal outside the control range. When the cell number was converted 
to total number of cells in urine sample, these increases becatre significant (p < 0.001). 
Table 3.8: Drinruy sediments. quantification of cell numbers 
-
Group (n=lO/group, Mean urine volutre Mean number of Mean total cell 
exceptBEA (ml) transitional cells in number (accounting 
n::::7) sediment (0.25 ml) for volume) 
Control 10.50 ±3.75 4.80 ± 4.29 211.60.± 197.38 
-
BEA 23.85 ± 9.23 *** 62.28 ± 82.93 3854.85 ± 2406 *** 
-
indomethacin 9.40 ±3.86 32.00 ± 39.44 1070.40 ± 1089.80 
-
l<E.Y: ***=p<o.OOl; treans given ± SD 
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3.3.3: Perfusion experiments 
3,3.3.1: Local perfusions 
Flow rates of 6 and 10 mUminute showed good perfusion of the cortex but insufficient perfusion 
of papilla (SOtre blood cells still remaining), especially at 6 mljminute. There was also shrinkage of 
surface epithelial cells and sOlm collecting duct cells. A flow rate of 20 mljminute showed 
structures to be well cleared of blood with only slight shrinkage of sOlm surface cells, whereas 25 
mlIminute showed SOIre rupture of vessels (overperfusion) and some holes were apparent in 
surface epithelial cells. 
3..3.3.2: Whole body perfusions 
All kidneys showed good preservation of the papilla structures with only slight shrinkage of sOIm 
surface epithelial and collecting duct epithelial cells. Capillaries were well cleared of blood. Both 
techniques worked well, although whole body perfusion was slightly more straightforward with no 
need to stop the perfusion to change solutions as was the case with the perfusion pump apparatus. 
J...3.4: Trypan blue perfusions 
1.3.4.1: Assessment of perfusion route 
local perfusion with trypan blue via the descending aorta gave the best results in that the kidneys 
qUickly turned a deep blue and the technique was relatively easy. Whole body perfusion required 
more dye and was unnecessary since only the kidneys required perfusion. Retrograde perfusion via 
the ureter was successful (kidneys turned blue) but was technically more difficult: this would be 
especially the case in younger rats with smaller ureters. 
~,2: Perfusion experiments 
AU animals were carefully monitored during anaesthesia to ensure that they maintained a steady, 
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deep level of anaesthesia and that death had not occurred before perfusion began. All control and 
indomethacin-treated animals perfused successfully (blood cleared rapidly and kidneys were evenly 
pale). The papilla of one indomethacin-treated animal showed the presence of a small blue spot of 
trypan blue when sliced. BEA-treated animals did not perfuse well and only the outer cortex 
appeared perfused when the kidneys were sliced open. 
Histological Assessment: 
Kidneys from all control animals were well perfused (with the possible exception of one animal 
Which had some red blood cells present in one papilla). Occasional interstitial cell nuclei in the 
COrtex and cortico-tredullary junction (and very occasionally in tredulla) were stained with trypan 
blue. The basement membrane of tubules in the cortex of all animals was also lightly stained with 
trypan blue (Fig 3.8a). 
Kidneys from BEA-treated animals did not perfuse well; the outer cortex only was partially 
perfused and there was evidence of congested vasculature in the inner cortex and outer papilla 
(large numbers of blood cells in the medullary ray area) (Fig 3.Sb). Some interstitial cells and 
Occasional tubule cells in the outer cortex (diffuse distribution) were stained with trypan blue. All 
papillae showed evidence ofRPN, although this could not be correlated with trypan blue presence 
due to the lack of perfusion. 
Kidneys from indomethacin-treated animals appeared to have perfused well (patent lumen of 
tUbUles, no blood cells in cortex), although some red blood cells remained in the papilla, suggesting 
incomplete perfusion in this area. Some interstitial cells, occasional tubule cells and basement 
Il\!mbrane of tubules in the cortex were stained with trypan blue. The papilla of one animal 
COntained 2 structures which were stained with trypan blue, although these were capillaries and not 
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figure 3.8: Results of trypan blue perfusions 
Figure 3.8a: Section from control animal perfused. with trypan blue. Note interstitial nuclei stained 
blue (arrows). H&E, x 50. 
Figure 3.8b: Section from BEA-treated animal perfused with trypan blue. Note lack of perfusion in 
eonico-medullary area, vessels still congested with blood (arrow). Eosin-stained, x250. 
I , 
Figure 3.8e: Section from indomethacin-treated animal perfused with trypan blue. Note blue-
Stained capillary, but no obvious necrosis. Eosin-stained, x 500. 
109 
related to any necrotic areas (Fig 3.8c). No other staining was seen in the papillae. No lesions were 
seen in any of the sections. Trypan blue thus seemed to be of no use in identifying necrosis since it 
could not be perfused into BEA-treated kidneys and stained areas in indorrethacin-treated kidneys 
that were not necrotic. It was therefore not used in further experirrents. 
3.3.5: Correlation of scanning electron microscopy and histology 
All kidneys processed for SEM showed good preservation of structures with minimal shrinkage of 
surface epithelial cells of the papilla. Control animal kidneys showed good morphology of all 
structures, with well preserved and defined tubules and surface epithelium Kidneys processed 
through to histology following SEM assessment showed excellent preservation of structures (Fig 
3.9 shows SEM and histology from the Satre sample). The only distinguishing feature from 
standard histology sections was the presence of a thin black line around the surface of the tissue 
(the gold coating applied during SEM processing) but this did not affect the assessment. All control 
kidneys appeared normal. 
SEM assessrrent of the surface epithelium of papillae from all BEA-treated animals showed a 
varying demarcated effect in that the epithelium of the inner portion of the papillae (nearest the tip) 
had no obvious cell surface structure (denuded, lost epithelial cells) whereas the epithelium of the 
Outer portion of the papilla was nonnal with well-preserved cell structure. An obvious border 
("Constriction line") existed between the affected inner area and the nonna! outer portion of the 
epithelium (Fig 3.10 shows this and the corresponding histology section). 
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Figure 3.9: 
A == SEM photograph from control papilla, showing good preservation of papillary structures (c == 
collecting ducts, arrow = capillaries) 
B == Subsequent H & E section (x 1(0) from same control papilla, showing good normal structural 
preservation. Note thin black line at edge of H&E section (arrow), this is the gold coat applied 
during SEM preparation. 
Figure 3.10: 
A ::: SEM photograph of papilla from BEA-treated animal. Note demarcation between normal 
surface epithelium and sloughed epithelium (arrow). 
B ::: Subsequent H&E section (x 100) from same papilla, showing same border between sloughed 
and normal epithelium (arrow). Mild RPN is also apparent, note loss of interstitial structures 
compared to controlH&E section in Figure 3.9. 
111 
SEM examination of the internal structure of all papillae from BEA-treated animals revealed 
evidence of RPN, varying from interstitial damage (shrunken cells and congested matrix) to total 
loss of all tubule structures (with thickening and congestion of cells and tubules). Comparing the 
internal alterations to the surface epithelial changes, the internal structure was not as extensively 
damaged as the surface epithelium of the papilla. All BEA-treated kidneys showed the classic 
histological picture ofRPN, and correlated exactly with the SEM observations (Fig 3.11 compares 
the SEM and histological picture of RPN with BEA). 
Kidneys from 3 indomethacin-treated animals showed possible signs of necrosis by SEM 
eXamination (loss of interstitial and some tubule structures) with alterations or distortion of 
interstitial structures in a further 6 animals. A small area of papillae of one of these animals showed 
only slight interstitial alteration ("foamy" appearance). The 3 indomethacin-treated kidneys which 
had shown signs of necrosis with SEM were confinned as having RPN or marked alteration 
(interstitial degeneration) in the histological sections of the same samples (Fig 3.12 compares SEM 
and histology). Furthennore, these 3 animals were 3 of the 4 animals with increased cell numbers in 
the urine, as reported in 3.3.3. Histological assessment of the SEM samples from the 6 animals 
Which had shown possible alterations in structure supported the SEM findings, except for the 
papilla which had been noted as having a "foamy" appearance by SEM; this appeared normal on 
histolOgical examination. SEM did not produce any false negatives when compared with histology 
from the same samples, even with small lesions. SEM therefore seemed to be a good guide to the 
eXtent of damage within the papilla and was an easy screening method to help in the identification 
of necrotic areas. 
112 
Figure 3.11: 
A :::: SEM photograph of papilla from BEA-treated animal: B = Subsequent H & E section (x 250) 
from same papilla, showing moderate RPN (arrow). Note the congested, disorganised appearance 
of interstitium and tubules in area behind tip in SEM photograph (arrow): this corresponds to the 
area of moderate RPN shown in the H&E section from the same sample. 
Figure 3.12: . 
A :::: SEM photograph of papilla from indomethacin-treated animal: B = Subsequent H&E section 
(x ~OO) from same papilla, showing mild, focal RPN (arrow). Note disorganised appearance of area 
of mterstitium immediately behind tip in SEM photograph (arrow); this corresponds to the area 





All BEA-treated animals showed signs of varying degrees of necrosis on histological examination, 
comparable to that previously reported in rodents treated with BEA by various workers [Murray et 
al1972, Mattingley et al1984, Bach & Bridges 1985, Gregg et all990a & b, Bach et alI991]. 
Necrosis was bilateral in all treated animals although not always of similar severity in both kidneys, 
suggesting that one kidney is a reasonable predictor of the other in tenns of presence of necrosis. In 
the animals where there was a difference in the necrosis grading between the two kidneys, the 
kidney with the most severe grading ("marked") had been sectioned through the papilla tip, which 
is the area most sensitive to necrosis [Duggin 1980]. Further sectioning of the kidneys graded as 
"mild" revealed that necrosis became moderate or marked when sectioned through the papilla tip, 
and therefore of similar severity to the contralateral kidney. This reinforces the importance of 
standardising sectioning for assessment of necrosis, as discussed by Bach & Bridges [1982 & 
1985]. 
Findings from the cedarwood oil-cleared kidney slices did not correspond well with the histology 
findings. Of the 20 animals treated with BEA, only 5 showed signs of damage in both kidneys. The 
Cedarwood oil-cleared slices were more reliable in the animals with marked necrosis on histology: 
10 out of the 12 kidneys with marked necrosis showed signs of damage in the cleared slices. 
lIowever, better correlation might have been predicted since the histology sections were taken from 
the cedarwood oil slices. One problem with the lack of sensitivity of the cedarwood oil slices was 
the thickness: in order that sufficient tissue was available to process and cut histology sections, the 
kidney slices had to be more than Imm thick. At this thickness, it was difficult to discern much of 
the kidney structure, even using Nomarski microscopy. 
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Re-examination of BEA-treated kidneys to detennine how close the two kidneys from each animal 
were in tenns of damage indicated that there was no corre1ation between them (r = 0.04). Thus, 
although kidneys were always bi1aterally affected with BEA treatment, they were not necessarily 
affected to the same degree (the variation within an animal was as great as the variation between 
animals). Step-serial sectioning, carried out to detennine how much the distance from the papilla tip 
affected the extent of necrosis, showed that damage was most extensive in the papilla tip region. 
This supports the general assumption that papillary necrosis induced with BEA is most extensive at 
the tip [Hill et al1972, Duggin 1980, Bach & Bridges 1982 & 1984]. It is also important to note 
that this damage became gradually less as the 1ateral distance from the tip increased in a similar 
manner for all the kidneys sectioned, since the damage score did not markedly alter until the 
sections were well away from the tip. The standard technique used to assess the extent of damage, 
a histological section near the papi11a tip, is therefore robust since the section does not have to be 
exactly through the tip, just in the tip region (within 60 Jlm of the tip), to give a reliable estimate of 
the extent of damage. 
Indomethacin-treated animals 
The histology findings from the initial and additional sections from the kidneys of indOIrethacin-
treated animals highlight the re1atively high number of false negatives obtained histomorphologically 
when relying on one section through the tip with this focal mode~ as discussed by Arnold et al 
[1974]. Initial sections from the 24 hour time point indicated 2 animals were affected, yet the extra 
Sections identified a further five. Such serial sectioning studies are very time consuming (1 day to 
cut and assess 1 kidney block) and not really feasible on a 1arge scale. However, the infonnation 
obtained is important in highlighting both the limitations of relying on a single section for studies 
inVOlving focal necrosis and reinforces the need for more reliable techniques in identifying such 
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damage [Arnold et al1974, Bach & Bridges 1982 & 1985, Price et alI996]. 
14.2: Urinary sediments 
Urinary sediments from BEA-treated animals gave a reasonable correlation with the histological 
findillgs and proved useful in indicating those animals where necrosis had, or was, occurring. 
Urinary sediments taken at 24 hours proved most useful in identifying possible renal papillary 
necrosis; 17 out of the 20 BEA-treated animals had some signs of necrosis; the sediments from the 
3 animals where necrosis was not evident were very scant, with few cells of any kind present, so 
these may not have been representative samples (or there may actually not have been any cells in 
the urine). At 48 hours the differences between BEA-treated animals and controls were less 
marked, although there was still an increase in the mean number of transitional cells present in 
sediments (49 vs. 25 in controls). 
The numbers of transitional and renal tubule cells present in the sediment from each animal 
generally gave some indication of the extent of damage present in the histology sections; those 
animals with the highest numbers of transitional cells showed either moderate or marked necrosis 
on examination of the histology sections. This supports work which looked at the significance of 
Urinary cell excretion with BEA and other renal toxins and found that there was a broad agreement 
between the numbers and types of cells excreted and the severity of damage [Davies et al 1968, 
Kennedy & Gail Saliya 1970]. The results from the urinary sediments suggest that most damage 
(measured by amount and type of cells passed out in the urine) occurs 8-24 hours after treatment 
with REA. This correlates well with the work of Davies et al [1968] and Kennedy & Gail Saliya 
{1970], Who also suggested that most of the damage following BEA treatment occ~ within the 
first 2 days of treatment 
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The initial results from examination of the urinary sediments from indomethacin-treated animals 
suggested that this technique was of little value in identifying focal papillary necrosis since the 
numbers and types of cells present in the seditrent were not obviously increased in treated animals. 
This is perhaps due to the nature of the lesions induced with indomethacin in terms of size and 
frequency. However, urinary sediments gave promising results with both BEA and indomethacin 
When the total number of transitional cells excreted was calculated. All urine samples from BEA-
treated animals contained high numbers of transitional epithelial cells (including renal tubule cells) 
and all kidneys had extensive RPN, coupled with a marked increase in urine volume (polyuria). 
POlyuria is a well-recorded feature of BE A-induced nephrotoxicity [Sabatini 1984, Bach & Bridges 
1985, Wilks et al1984 & 1986, Stonard et al1987] and has been reported as the earliest effect of 
BEA, occurring within 3 hours of treatment [Wilks et al1986]. Four indomethacin-treated animals 
had higher numbers of transitional cells relative to controls when corrected for total urine volume, 
and kidneys from 3 of these animals had some kind of abnonnality or necrosis present. 
Urinary sediments have been used in humans and in animal studies to investigate and help indicate 
the presence of various types of kidney damage, but have often been compared with urinary 
enzyme levels rather than with histopathology findings, as discussed in the introduction to this 
chapter. Of direct relevance are the findings of Jackson et al [1978], who studied urine cytology in 
analgesic nephropathy with regard to carcinoma screening and reconnrended its use as a screen for 
POssible carcinoma or dysplasia in analgesic abusers with RPN (ie. those patients at risk of 
developing urothelial malignancies). They used Papanicolau-stained preparations (as in the present 
eXpe~nts) and found a trend; more severe cytology changes were found in cases of more severe 
renal failure. They suggested that urinary sediments might therefore also be useful to help detect 
RPN in patients, a suggestion that is supported by the results of the present experiments with BEA 
and indotrethacin. 
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Fent et al [1988] and Zbinden et al [1988] assessed the use of "quantitative" assesstrent of the urine 
(volume, pH, enzyrres, proteins, cells present) and compared the results with histology data. They 
found that cell excretion and presence of cylinders were the most sensitive markers for detecting 
nephrotoxicity, but emphasised that cell excretion and enzymuria can fluctuate or disappear with 
continued treattrent. The findings of Davies et al [1968] and Kennedy & Gail Saliya [1970] and 
those of the present experiments are a good example of this transient cell excretion, showing that 
the biggest increases in urinary cell excretion with BEA occurred within the first 1-2 days of 
treatrrent and then reduced to control levels. Transient enzymuria was also reported following an 
initial dose of the cortical toxins para-aminophenol and mercuric chloride [Cottrell et alI976], and 
urinary enzytre treasuretrents were suggested to be of limited value because of this. Stonard et al 
[1987] have reconnnended the daily collection of urine samples to enable the onset of, and recovery 
from, renal lesions to be followed and to identify critical sampling titres so that such transient 
effects are not overlooked. 
Fent and Zbinden and co-workers [1988] emphasised that histopathological examination of the 
kidneys was an important source of infonnation regarding the nature, localisation and reversibility 
of lesions, but was a less sensitive screening tool than urine analysis. They connnented that since 
Urine analysis was perfonned during the course of their study and histopathology was performed at 
the end, a structural correlation with the urine findings was not possible. However, the present 
experitrents with BEA and indotrethacin involved urine analysis and histopathology over the Satre 
time periods, which made comparison of histopathology and urine findings possible; unne 
sediments generally correlated well with the histology findings. 
Fent and Zbinden & co-workers [1988] also highlighted the problems of using "unit volume" (cells 
per aliquot of urine) when expressing cell excretion; total urine volume nrust be measured and an 
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estimate obtained of total cells excreted to get an accurate measure of any effects. The results of the 
present experiIrent emphasised the importance of this. When cell numbers were corrected for urine 
volU1re (total cells excreted) the increase in cell numbers in the urine of BEA-treated animals 
becrure more significant, and sediments from indomethacin-treated animals showed an increase in 
total cell numbers which was not apparent when expressing cell number relative to unit volume. 
J.4.3: Perfusion experiments 
At lower perfusion rates using perfusion pump apparatus, there were indications that the perfusion 
pressure was not ideal for the papilla: the histology sections showed that some blood cells remained 
in the papilla, and the SEM preparations showed collapse of some structures, suggesting 
insufficient perfusion pressure. It has been demonstrated that higher pressure is needed for 
perfusion of the papilla compared to cortex, and that different regions of papilla require solutions of 
different osmolality [Maunsbach 1966, Bohman 1974], although the effects of different perfusion 
pressures were not investigated. It may therefore not be possible to obtain optimal perfusion of all 
structures within the papilla. 
The results of the perfusion experiments demonstrated that immersion fixation is preferable to using 
Perfusion fixation if the latter is at insufficient pressures, and provides acceptable results with SEM 
eXamination. If it is impossible to optimally perfuse the whole papilla, especially when looking at 
the whole structure as is the case with SEM, it may be that irnrnersion fixed material is preferable. 
This means that archive material which has been i.mtrerse-fixed is perfectly suitable for SEM 
assessment, and that this technique can be used in routine studies without the need for specialised 
fixation techniques. 
Comparing the methods of perfusion (perfusion pump and fixed head apparatus), local perfusion is 
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reconnnended where kidneys need to be treated differently to allow greater contro~ e.g. one 
perfused with dye and one not, or if only kidneys are required to be perfused and other tissues must 
be unfixed e.g. for biochemical analysis. Whole body perfusion is recorrnnended for rapid perfusion 
with minimal intervention necessary once perfusion has begun: this would be particularly suitable 
for transmission electron microscopy investigations. 
3.4.4: Trypan blue perfusions 
Perfusion with trypan blue was of little success, partly due to the problems with perfusion in the 
BEA-treated animals. This is in contrast to the success reported with trypan blue perfusion in 
identifying necrotic cells in the liver [Belinskyet al1984]. 
It was interesting (and perhaps not surprising as discussed below) to find that the lack of perfusion 
of the papillae of BEA-treated animals appeared to be due to a vascular effect in the inner cortex 
area, thus preventing perfusion of vessels in the papilla. This is a useful observation in terms of 
effects of BEA on the vasculature and subsequent development of lesions even if it means that 
perfusion cannot be used for such animals (back-perfusion via the ureter is an alternative but this 
Was a difficult and unpredictable means of perfusion), The observed vascular effects could be due 
to a number of conditions: vasoconstriction; congestion; thrombosis or some other blockage of the 
vasculature. The effects of BEA on the vasculature of the kidney have been investigated previously 
in attempts to identify the possible causes of RPN induced with BEA and extrapolate this to RPN 
in humans, often with conflicting results. 
Cuttino et al [1981] used microangiography and tubular micropuncture to investigate whether the 
cause of RPN was due to vasoconstriction of medullary vessels with ischaemic necrosis. Decreased 
perfusion of the vasa recta, with unobstructed tubules, was seen during the early stages of RPN, 
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with vascular obliteration, intratubular debris and tubular obstruction in the late stages. Cuttino et al 
[1981] therefore suggested that RPN with this model is caused by vasoconstriction rather than 
direct tubular toxicity. Russell et al [1987] reported that BEA induced an increase in vascular 
resistance and decrease in blood flow in the kidneys, leading to an increase in blood pressure. 
However, Sabatini [1984] found that medullary blood flow was not altered by BEA treatment, 
despite apparent engorgement of vessels. 
Wyllie et al [1972] investigated the effects ofresperpine (a catecholamine depletor which prevents 
vasoconstriction) on BEA-induced RPN and found it had a pronounced inhibitory effect on the 
development of the lesion. They suggested that vasoconstriction may therefore play a significant 
role in the development of RPN after BEA treatment, but stated that the evidence was incomplete. 
This work was supported by Wolf et al [1991b & 1992a] who also investigated the influence of 
reserpine. Wolf and co-workers [1991b & 1992a] suggested that vasoconstriction contributed to 
the development of BEA-induced cortical tubular necrosis in mice [1991b], and proposed 
ischaemic necrosis as the cause of BEA-induced RPN in gerbils [1992a]. However, Solez et al 
[1974] reported that although reserpine inhibited the development of RPN, it had little effect on 
rnxIullary plasma flow. They stated that their observations did not support the hypothesis that 
vasoconstriction is the mechanism for BEA-induced RPN, at least in the early stages of damage. 
They proposed the mostly likely mechanism to be concentration of BEA in the papilla, where it has 
a direct toxic effect. They suggested that reserpine decreased the incidence of RPN because of 
Stress or, ifBEA has a direct toxic effect on cells, it could prevent the uptake and storage of BE A 
These conflicting argUIrents regarding the role of vasoconstriction emphasise the problems in 
establishing the mechanisms of RPN, as discussed in the introductory chapter of this thesis. 
It Was hoped that perfusion of kidneys from BEA-treated rats with trypan blue would give a good 
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indication of the usefulness of this technique in identifying extensive RPN, but since the papillae did 
not perfuse this could not be verified. There were no such perfusion problems with the 
indotrethacin-treated animals. The histology sections from the indotrethacin-treated animals did 
not contain any areas of necrosis. However, due to the focal nature of the lesions produced with 
this compound, step serial sections are usually necessary to get an accurate picture of the degree of 
damage (as highlighted by Wilks et al [19861 and the additional histology carried out on 
indotrethacin-treated kidneys in the present experiments). 
The papilla of one indomethacin-treated animal showed two structures stained with trypan blue, but 
these appeared unrelated to any necrosis. Step serials through the remainder of this block may have 
eventually shown some necrosis in this area, however the aim of using trypan blue was to save time 
by highlighting areas of necrosis, not to necessitate time-consuming extra work to determine its 
usefulness. The lack of trypan blue staining may have been due to leaching out of the dye into the 
fixative on storage, or to too weak a concentration of dye. However, trypan blue staining was 
observed in some interstitial nuclei in the cortex of kidneys from control animals, where there was 
no evidence of necrosis. Therefore although trypan blue had been successfully perfused into the 
kidneys, it was retained in some healthy cells rather than excluded by them The results of these 
experiments indicate that trypan blue is too unreliable for use in routine studies, and it is therefore 
recommended that trypan blue not be investigated further for use in the identification of necrotic 
renal1esions. 
J..4.5: Correlation of SEM and histologv 
SCanning electron microscopy (SEM) gave very promising results with both treatment groups, 
Particularly when combined with secondary histology (reprocessing of SEM tissue for histology). 
AlI kidneys from BEA-treated animals were identified as having RPN by SEM and secondary 
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histology of the samples confirmed this. All gradings of RPN were generally in agreetrent. SEM 
eXamination of BEA-treated animals highlighted the sloughing effect on the surface epithelium and 
its relationship with the effects on the internal papilla structures. This effect of BEA on the surface 
epithelium correlated well with the histological sections which showed loss of epithelium from the 
papilla. Loss of surface epithelial cells, following initial hypertrophy, is a well docutrented effect of 
BEA [Bach & Bridges 1982 & 1985]. The observation that the surface changes occur where the 
tubule structure is nonnal suggests that the surface effects may precede and possibly be a 
contributory factor in the effects on the tubules and interstitium, by rendering the underlying 
papillary structures more susceptible to damage. 
SEM of the indotrethacin-treated kidneys proved very useful in identifying abnormal areas within 
the papillae. Not all of these were necrotic, but subtle changes in structure, such as gaps in SOtre 
interstitial areas, were detectable. All of the changes identified by SEM were confinned by 
secondary histology. SOtre of these kidneys were classed as "NAD" by primary histology, but this 
assessment was of only one half of the papilla (the other half was processed for the SEM/secondary 
histology). It is possible that the changes seen were only present in the part of the papilla used for 
SEM and secondary histology due to the focal nature of indotrethacin damage. Perhaps the most 
lIllportant observation is that SEM did not produce any false negatives, even with very small 
lesions. It is possible that SEM is of more use since a much thicker portion of papilla is viewed, 
giving a "three-ditrensional" picture of the necrotic area, thus providing the Satre amount of 
infonnation as several step serial histology sections through the papilla. 
SEM has been used by others, with successful results, to evaluate the changes in surface epithelial 
celIs of the renal pelvis following treattrent with proliferating agents [Shibata et al 1989] and to 
lOok at bladder epithelial changes following acute toxicity with tetraethylorthosilicate [Okamura et 
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alI992].It has also been used to examine infection of the papilla associated with RPN [Cohen et al 
1979 & 1981]. However, no references could be found for the use ofSEM to investigate RPN m 
~, nor for the combination of SEM and correlative histological assessment. 
SEM therefore seems to be an effective and potentially useful technique for identifying and 
investigating lesions in the papilla, particularly when combined with correlative light microscopy of 
the same tissue following SEM assessment. The results obtained from the correlative histology 
perfonned confinred that areas identified as "abnonnal" by SEM were seen to be affected in some 
way using histology. Perhaps more importantly, the technique of correlative SEM/histology from 
the same tissue has potential for other studies. 
J.4.6: Techniques recommended for further investigation 
The res~lts from both BEA and indomethacin experiments suggest that assessment of urinary 
sediments and SEM are both useful techniques which can aid in the identification of renal papillary 
necrosis in both extensive and focal RPN. Perhaps more importantly, SEM can be combined with 
secondary histology, (which is of equal quality to standard histology) so that no information is lost 
by performing this technique (SEM and histology are normally perfonned as mutually exclusive 
techniques). SEM can be perfonned on standard study material (i.e. tissue immerse-fixed in 
fOnnaIin) with no loss of detail, which makes this technique applicable to any routine studies where 
RPN or any other type of necrosis may be suspected. 
The next stage in evaluating these techniques was therefore to use them in conjunction with 
ethoxyquin, a papillotoxin which has not previously been investigated in detail as a model for 
RPN, and compare the results with those obtained in this chapter using the established models BEA 
and indomethacin. 
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CHAPTER 4. ETHOXYOUIN STUDIES 
4.1 INTRODUCTION 
~1.1: Ethoxyguin 
Ethoxyquin, 6-ethoxy-l,2-dihydro-2,2,4-trimethylquinoline, is a synthetic anti-oxidant which is 
commonly used for preserving animal feeds because of its ability to prevent oxidative 
degradation of vitamins and polyunsaturated fats [Skaare 1976, McIntosh et al 1986]. It is 
nOnnaily added to feed up to a maximum concentration of 150mg!kg feed (0.015%), which is 
considered a safe level [McIntosh et al 1986]. Its toxicity, metabolism and potential 
phannaceutical uses have been investigated in some detail over the last 30 years. More recent 
investigations have shown ethoxyquin to be capable of inducing RPN [Hard & Neal 1990 & 
1992, Manson et al1992] but its potential as a model for RPN, the development of RPN with 
ethoxyquin, and the early changes associated with this have not been investigated in detail. 
t.1.2: Metabolism and reported toxicity of ethoxyguin 
The first reported toxicological assessments of ethoxyquin were conducted by Wilson & 
DeEds [1959] and Wilson et a1 [1959] who looked at the toxicity of ethoxyquin and its 
absorption, metabolism and excretion. For the toxicity assessment [Wilson & DeEds 1959], 
ethoxyquin was given to rats by oral gavage at doses ranging from 125 to 1000 mg!kg. They 
repOrted deaths at l000mg/kg (5 of 7 rats), 800 mg/kg (2 of 5) and 640 mg/kg (1 of 5). The 
Clinical signs reported were loose stools, and "depression" at Day 2 of treatment. Dark urine 
was also reported in rats following ethoxyquin treatment, which was said to be due to a 
metabolite of ethoxyquin but was not discussed further [Wilson et al 1959]. The" toxicity of 
ethoxyquin in mice, using ip. dosing, was also investigated, with 5 of 7 deaths reported at 
1000 mg/kg but no deaths at 800mg/kg or below. They therefore proposed that rats were 
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more sensitive to the toxic effects of ethoxyquin. Rats have since been used almost exclusively 
in subsequently reported work with ethoxyquin. 
The metabolism work conducted by Wilson et al [1959] was carried out in rat and cow. They 
reported that ethoxyquin was rapidly and almost completely excreted in the urine and faeces, 
with little breakdown to CO2, suggesting a stable ring structure. Its distribution in tissues 
Suggested breakdown to a more soluble molecule (the metabolite mentioned above as the 
Possible cause of brown urine), but this was not expanded upon. Ethoxyquin was reported to 
undergo rapid metabolism and modification, with different spots demonstrable by 
chromatography in 24 hour urine samples. The turnover time of a single dose of ethoxyquin 
Was reported as 10 days; continuous dosing for 10 days gave increased ethoxyquin 
concentrations in liver and kidney, suggesting ethoxyquin metabolism occurs here. 
Further metabolism studies [Lin & Olcott 1975], which supported those of Wilson and co-
workers [1959], reported that ethoxyquin was easily oxidised to a very stable free radicaL 
ethoxyquin nitroxide (EQN), by the substitution of N-O' for N-H in its structure. This could 
therefore be the metabolite mentioned by Wilson & co-workers [Wilson & DeEds 1959, 
Wilson et al 1959]. Lin & Olcott postulated that the mechanism of action of ethoxyquin 
involved its free radical, EQN, which is a much more potent antioxidant than ethoxyquin itself. 
The distribution of 14C-ethoxyquin in adult male rats was investigated using whole body 
aUtoradiography and liquid scintillation counting [Skaare & Nafstaad 1979]. Ethoxyquin was 
giVen by oral gavage in arachis oil at a dose of 104 mg/kg. and its distribution was investigated 
oVer the period 30 minutes to 6 days post-dose. Ethoxyquin was found to be distributed 
throughout most tissues and the blood at 30 minutes post-dose. The highest radioactivity was 
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seen in the liver and kidneys (24 hours), gastrointestinal tract, and adipose tissue. This 
supports the previous suggestion that ethoxyquin metabolism occurs primarily in the liver and 
kidneys [Wilson et aI1959]. The hepatic peak was seen 8 hours post dose, at 24 and 48 hours 
levels of ethoxyquin were still raised in the kidney medulla, gastrointestinal tract and blood. 
Residues of ethoxyquin and its metabolites were still present after 6 days in some tissues 
(including the kidney cortex and the blood), supporting the proposed turnover time of 10 days 
for a dose of ethoxyquin [Wilson & DeEds 1959]. Skaare & Nafstaad [1979] also mentioned 
that ultrastructural effects were seen in the liver (proliferation of SER, dilated cisternae of ER, 
disorganisation of mitochondrial enzymes) following a single oral dose of 500 mg/kg 
ethoxyquin in a previous study [Nafstaad & Skaare 1978] and that ethoxyquin had previously 
been reported to be nephrotoxic at high doses by Wilson & DeEds [1959]. 
The fIrst long-term studies with ethoxyquin [Rudra et al 1974] investigated the effects of 
ethoxyquin and vitamin E in the diet on food intake and body weight gain over 500 days, using 
rnaIe weanling Wistar rats. Ethoxyquin was given in arachis oil in the diet at a concentration of 
0.5%. Decreases in body weight were noted, beginning after 280 days of treatment. These 
Were reported to probably reflect a toxic response since 4 of 5 rats died with severe kidney 
damage. However, the nature of this kidney damage was not discussed. Rudra et al [1974] 
repOned that no such damage was seen in mice treated with ethoxyquin and proposed, as 
Wilson & DeEds had earlier [1959], that there were interspecies difference in susceptibility, 
rats being more sensitive. Rudra and co-workers [1974] suggested that further work was 
therefore necessary to evaluate the hazard potential to domestic animals and man. 
Further Concerns regarding the safety of ethoxyquin were raised by McIntosh et al [1986] and 
lIernandez et al [1993]. McIntosh and co-workers [1986] suggested it was not necessarily 
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safe as a feed or diet additive, following acute intoxication of marmosets and rats fed high 
concentrations of dietary ethoxyquin. Due to an error, mannosets had been given ten times the 
normal amount of ethoxyquin in their food (800 p.p.m, or 0.08%), leading to the deaths of 30 
marmosets in 3 weeks. On examination, these marmosets were found to have centrilobular 
giant cells in the liver and haemolytic anaemia. McIntosh and co-workers [1986] therefore 
tested the toxicity of this level of ethoxyquin in rats, and reported decreased body weight but 
no pathological changes in liver, kidneys or blood. Hernandez et al [1993], using renal cortical 
slices from male rats fed ethoxyquin, found that it inhibited the uptake of organic anion and 
Cation tubular secretion. They suggested that the mechanism for this involved decreased 
ATPase activity and interference with the energy supply required, and suggested avoiding the 
exposure of animals to high ethoxyquin concentrations. 
~1.3: "Protective" potential of ethoxyguin 
Synthetic antioxidants, including ethoxyquin, have been investigated in toxicological and 
phannaceutical research due to their potential, by virtue of their peroxide and free radical-
Scavenging properties, to protect against chemical carcinogens in experimental animals. 
However, it has proven difficult to establish whether antioxidants are useful for this purpose as 
they have been shown to prevent some cancers but promote the development of others [Kahl 
1984, Rao et al1984, Tsuda et al1984a & b, Manson et alI987], ethoxyquin being a typical 
eXample of this. 
It has generally been reported that ethoxyquin helps to protect against liver neoplasia in rats 
induced by various agents; Tsuda et al [1984a & b] reported that ethoxyquin, at a 
ConCentration of 0.8% in the diet, inhibited hepatocellular carcinoma and reduced the number 
of hyPerplastic nodules normally seen with N-ethyl-N-hydroxyethylnitrosamine. Ethoxyquin 
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has also been shown to protect against hepatic tumours induced by ciprofibrate [Rao et al 
1984] and prevent aflatoxin B1- induced tumours [Manson et al1987] at a concentration of 
0.5% in the diet. It has also been reported to protect against the toxicity of carbon 
tetrachloride, dimethylnitrosamine and benzopyrene [Kahl1984]. 
However, it has also been reported that ethoxyquin enhances the appearance of cancer in the 
kidney in some of these studies. Ethoxyquin was found to significantly increase the incidence 
of renal cell adenoma and preneoplastic kidney lesions [Tsuda et al1984a & b] and ethoxyquin 
alone induced preneoplastic changes in the kidney cortex, possibly exerting a carcinogenic 
effect [Manson et al 1987]. Ethoxyquin has also been cited as a possible bladder cancer 
promoter [Shibata et alI991]. 
!1.4: Biochemical action of ethoxyguin 
Rahl [1984] reported that although increasing attention had been given to antioxidants as 
potential protecting agents against carcinogens, ethoxyquin was rarely included in biochemical 
studies of antioxidants. He therefore investigated the biochemical action of ethoxyquin. He 
reponed increases in liver and kidney weights, increased enzyme induction of liver and some 
kidney enzymes (cytochrome P450 and NADPH:quinone reductase in the kidney), and 
increased endoplasmic reticulum (ER) in the liver. The latter observation supports previous 
Ultrastructural observations in the liver following ethoxyquin treatment [Nafstaad & Skaare 
1978]. 
Ethoxyquin was also found to interfere with the immune response, inhibit lipid peroxidation in 
biOlogical membranes, enhance microsomal hydrogen peroxide production, and inhibit drug 
cO~oxidation during prostaglandin synthesis [Kahl 1984]. The effects of ethoxyquin on 
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prostaglandin production and cyc1o-oxygenase and lipoxygenase activity have been 
investigated, in renal medullary slices and homogenate respectively, and compared with the 
effects of NSAIDS, particularly indomethacin [Zenser & Davies 1978, Bach & Bridges 1984, 
Miyazawa et al 1985]. Ethoxyquin, in connnon with NSAIDS, was shown to inhibit 
prostaglandin synthesis (particularly PGE2) and cyc1o-oxygenase activity. Ethoxyquin was in 
fact found to be a more potent inhibitor of these than indomethacin, and also slightly inhibited 
lipoxygenase activity. The above actions of NSAIDS are implicated in the development of 
RPN, as discussed in Chapter 1 of this thesis. 
!..1.5: Ethoxyguin and renal papillary necrosis 
Ethoxyquin was first reported to induce RPN in studies by Hard & Neal [1990 & 1992]. Early 
toxicity studies with ethoxyquin in Fischer F344 rats showed inflammatory cortical changes, 
accelerated chronic progressive nephropathy and severe proximal tubule hypertrophy 
Suggestive of preneoplastic change (supporting earlier suggestions, mentioned above, that it 
acts as a cancer promoter in the kidney). To clarify this, they fed ethoxyquin to rats (0.5% in 
the diet) over periods ranging from 4 weeks to 20 months [1990]. They found, to their 
surprise, that the primary lesion in male rats was RPN, first apparent at 4 weeks, followed by 
Pyelonephritis in the cortex. Urothelial hyperplasia was also a prominent lesion in males after 
24 Weeks of treatment. Female rats did not show any signs of RPN until 24 weeks, and even 
then only interstitial degeneration was observed. They therefore reported that they had 
demonstrated a previously unrecorded lesion with ethoxyquin (RPN). The early work by 
Wilson & DeEds [1959] reported kidney damage following ethoxyquin treatment but details 
of this damage were not given; it is possible that this may have included RPN. 
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The second study by Hard & Neal [1992] was a sequential study in Fischer rats with 
ethoxyquin treatment for 4 weeks to 18 months, which also reported RPN as the primary 
lesion in male rats. After 4 weeks of treatment, 3 of 8 males showed interstitial degeneration 
This progressed to RPN after 14 weeks and complete necrosis after 24 weeks with associated 
pyelonephritis. They also reported capillary changes. A marked sex difference was again 
demonstrated, with female rats never progressing beyond interstitial degeneration. 
Manson et al [1992] reported that the degree of ethoxyquin-induced damage was age-
dependent and sex-dependent (supporting the findirigs of Hard & Neal [1990 & 1992]). They 
also used Fischer F344 rats and ethoxyquin at 0.5% in the diet, and compared weanling (3 
Weeks old) and adult (8 weeks old) males with adult females. They reported cortical damage in 
males which was similar in both age groups, but male weanling rats also had extensive RPN 
after 20 weeks of treatment, with increased proteinuria. Proteinuria was also reported in 
Control male rats, but this was greatly exacerbated by ethoxyquin treatment. Female adult rats 
were much less susceptible to the effects of ethoxyquin, as reported by Hard & Neal [1990 & 
1992]. Manson et al [1992] therefore concluded that the extent of damage to the papilla was 
influenced by the initial age of the animal as well as the duration of treatment. Manson & co-
Workers [1992] (and Hard & Neal [1990 & 1992]) reported that the underlying cause of RPN 
induced with ethoxyquin was unknown, but recommended not using weanling rats in any 
carcinogenicity studies with ethoxyquin since their susceptibility to RPN could affect such 
Studies. 
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!.1.6: Aim~ of the studies described in this chapter 
The previous studies with ethoxyquin which investigated RPN involved dosing for at least 4 weeks, 
with ethoxyquin given in the diet at a concentration of 0.5%. Detailed investigations regarding the 
nature of the RPN had not previously been reported. The initial aim of the present experiments was 
therefore to develop a dose regime with ethoxyquin whereby RPN could be reliably and 
reproducibly induced over a shorter titre frame, to allow subsequent assessment of ethoxyquin as a 
model for RPN. Weanling male rats were predominantly used in the experiments described in this 
chapter due to their reported susceptibility to RPN with ethoxyquin [Hard & Neal 1990 & 1992, 
Manson et all992]. Oral gavage was used as a dose route rather than dietary administration as this 
Would allow a more accurate indication of actual doses given to the animals and would make dose-
ranging studies easier to perfonn 
Another aim of these experiments was to further assess the techniques identified by the experiments 
in the previous chapter as potentially useful for studying RPN (SEM and urinary sediments, 
inclUding urine analysis). This would then allow comparison of the results of these techniques using 
2 established models of RPN (BEA and indomethacin) with the results obtained using a new model, 
ethoxyquin. 
For ethoxyquin to have potential as a model for RPN, it was also necessary to investigate whether a 
dose regime could be developed which would produce only RPN, with no cortical damage and 
little or no extra-renal toxicity. Rosner [1976] has emphasised the importance of looking at all 
organs (not just the kidney) to evaluate the real picture of damage with a compound. In 
investigating this, a more detailed picture of any extra-renal effects of ethoxyquin would be 
Obtained, which could be compared with previous work using ethoxyquin and provide more 
inronnation regarding the effects of this compound. 
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Following establishment of an ethoxyquin dose regime which reproducibly induced RPN, it was 
also intended to investigate the development of the lesion using transmission electron microscopy 
(TEM), with the aims of identifying the primary cell type affected and the course of events 
involved. This would then allow comparison of RPN induced by ethoxyquin with that induced by 
other experirrental models and RPN reported in man, and the possible mechanisms involved. 
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4.2 MATERIALS & METHODS 
~.2.1: Materials 
4.2.1.1: Chemicals and suppliers 
Histological chemicals and materials were identical to those described in 3.2.1.1. Electron 
microscopy fixatives, chemicals, speci.rren stubs and grids were obtained from Agar Scientific Ltd, 
Essex. Dyes used in the Toluidine blue and Methylene Blue/Azure II staining methods were 
obtained from BDH Merck Anaesthetics and perfusion solutions were as described in 3.2.1.1. 
Ethoxyquin and corn oil were obtained from Sigma-Aldrich Ltd., Di.rrethyl sulphoxide (DMSO) 
was obtained from BDH Merck. 
The Multistix 10SG dipstick tests used in urine analysis, all assay kits used in the clinical chemistry 
investigations and staining kits used in the haernatology investigations were obtained from Bayer 
Diagnostics, Bayer PLC, Hampshire. 
u'1.2: Animals. housing conditions and dosing regimes 
AU strains of rat were obtained from Charles River (UK) Ltd; the strains used in each experimental 
phase are detailed in the appropriate methods section. Animals were housed at a temperature of21 
± 2°C, relative humidity of 55 ± 10% and 12 hours light/12 hours dark lighting. Animals were fed 
With a standard certified RMM rodent diet, both this and water were provided ad libitum. The 
Practical work carried out in this chapter was separated over several experiments for logistical 
reasons; the numbers of animals used in each experiment are detailed in Table 4.1. 
Dosing was by oral gavage (oral intubation). The dosing regi.rres and vehicles used for ethoxyquin 
are detailed in the methods sections. Unless otherwise specified, all animals were killed 24 hours 
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Table 4.1: Number of animals used in ethoxyquin experiments and numbers used for each tech.tUque 
Technique Dose Ranging Studies Total Main Total 
Numbers Studies Numbers 
Histology 13 (13) 40 (40) 84 (20) 137 (73) 20 (10) - 10 (10) 30 (20) 
Urine sediIrent - - - - 20 (10) 20 (20) 10 (10) 50 (40) 
Volumes noted Yes Yes Yes 50 (40) 
Urine Chemistry - - - - 20 (10) 20 (20) 10 (10) 50 (40) 
SEM - - - - 20 (10) - - 20 (10) 
Secondary histology Yes 20 (10) 
TEM - - - - 12 (6) 20 (20) - 32 (26) 
Clinical chemistry - - - - - - 10 (10) 10 (10) 
Haematology - - - - - - 10 (10) 10 (10) 






The number of treated animals used for each technique is given first, the number of control animals is given in brackets. The numbers used are split into 
colunms for each separate experiment conducted. Experiments are coded E-J at the bottom of the table. 
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after the last dosing by an intra-peritoneal overdose of sodium pentobarbitone ("Sagatal", 
O.2ml./lOOg body weight). 
1..2.1.3: Grading criteria for histological and electron microscopy (EM) assessment 
The grading system used for assessment of renal papillary necrosis (RPN) is detailed in Table 4.2a. 
Table 4.2a: Grading criteria for assessment ofRPN 
-Grade Histological appearance EM appearance 
-
Degeneration Pre-necrotic change; not seen at Distortion/derangement of cells or 
histological level (classed as NAD) 
-
organelles, vacuolation of cells & 
possible degeneration- pre-necrotic 
changes. 
MinimalRPN Very slight damage to small area of As for Histology 
-MildRPN 
papilla - damage to interstitial cells 
only 
Slight damage to papilla tip- loss of As for Histology 
interstitial cells, possible early damage 
to cells in some loops of Henle and/or 
capillaries (vacuolation of cells), 
preservation of most ducts & tubules 
'--l\1~o::-d:-e-ra-t-e--I-Lo-s-s -o-f-in-te-rs-ti-tial--ce-lls-m-' -are-a-o-f+As-£-or-His-' -to-Io-gy---------i 
QPN necrosis, derangement of some tubules 
(mainly loops of Henle and capillaries) 
but preservation of papilla structure 
r-:--
l\1i:"ar"':'k-e"":'d-:-R-p-N-J-D-es-tru-ct-io-n-o-f-p-a-pilla--stru-c-ture--in-are-a-+-A-s -fo-r-His-· to-l-ogy---------f 
of damage; loss of interstitium, tubules 
and ducts (outline only remaining) 
l(ey: RPN = renal papillary necrosis 
NAD = no abnonnalities detected 
EM = electron microscopy 
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Renal cortical necrosis was graded as detailed in Table 4.2b. 
Table 4.2b: Grading criteria for cortical necrosis 
-Grade Histological appearance 
\ 
-Mild small focal areas with tubular necrosis, but structure preserved. 
Moderate larger area of necrosis with some derangement of tubular structures. 
Marked destruction of tubular structures within area of necrosis, more extensive area 
affected than in moderate, with a diffuse band of necrosis through the cortex. 
i,2.2; Development of Ethoxyguin as a model for RPN 
For all studies involving the development and assessment of ethoxyquin as a model for RPN, 
standard histological evaluation was used to assess all kidney samples for the presence of RPN. The 
methods used are detailed in Chapter 3, Section 3.2.2. 
i2.2.1: Dose-ranlting studies with DMSO. 
The first stage of investigating ethoxyquin as a model for RPN was to assess the tolerability of 
Various doses in rats, when given by oral intubation in dimethyl sulphoxide (DMSO). This was to 
gain infonnation for use in future studies with ethoxyquin to evaluate its use as a papillotoxin. 
I .. 
rutlally, female (6 weeks old, 150-200g) and male (3-4 weeks old, 75-I00g) Sprague-Dawley rats 
Were given a single dose of ethoxyquin by oral intubation at one of the following doses: l00mglkg; 
200rn~g; 300mg/kg; 400mg/kg; 500mg/kg and 600mg/kg. All animals were killed 48 hours post-
dOse and kidneys were removed and processed for histological assessment using a Bayer VIP 
processor as in 3.2.2. 
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Following the initial assessment, a second phase of work was carried out to further assess the dose 
tolerance with ethoxyquin and to investigate the effects of 2 different dose levels (6OOmg/kg and 
800 mg/kg) after both a single dose and 5 daily doses. For this second assessment, 20 male 
Sprague-Dawley rats (3-4 weeks old, 75-100g) were dosed with either vehicle (n=2/control 
group), or ethoxyquin at a dose of 600mg/kg or 800mg/kg (n=4/treatment group). Ten animals 
were given a single dose of the relevant material, the other ten received 5 daily doses. Animals were 
killed 24 hours after completion of dosing and both kidneys removed and processed for histological 
eValuation. 
1..2.2.2: Change of dosing vehicle and investigation of rat strain for model 
FollOwing tolerance studies with concentrations of up to 800mg/kg ethoxyquin (in DMSO), with 
dosing for up to 5 days, the nephrotoxic potential of ethoxyquin was further investigated by 
assessing the effects of twice-daily dosing (totalling 800 mg/kg/day) for up to 28 days, using ~ 
Qil as a vehicle instead ofDMSO. It was felt that DMSO was an undesirable vehicle for this length 
of study due to its noxious smell. 
Two strains of male rat were used in this study to allow inter-strain comparison of any renal effects; 
male Sprague-Dawley and Fischer F344 rats (3-4 weeks of age, 75-100g) were dosed twice daily 
by oral intubation with either com oil vehicle (2 animals!control group/timepoint) or 400mg/kg 
ethoxyquin (4 animals/treatment group/timepoint). 
Scheduled timepoints for tennination were Days 2, 7, 14 and 28. Kidneys were taken at tennination 
from all animals, fixed in 10% neutral buffered fonnalin (NBF) and processed to paraffiri block as in 
3.2.2. Sections were cut and stained with H&E for histological assessment. Any macroscopic 
abnormalities in other organs were also sampled and fixed in 10% NBF for possible histological 
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eXamination. All kidney sections were assessed for renal effects and any damage graded for both 
papilla and cortex as described in section 4.2.1.3. 
~2.2.3; Establishment of optimum dosing regime with corn oil vehicle 
Based on the results from the previous stages of model development, the tolerance of Sprague-
Dawley rats to ethoxyquin was further assessed using a range of dose concentrations and dosing 
periods. Male Sprague-Dawley rats (3-4 weeks of age, 75-100g) were dosed either once or twice 
daily for up to 28 days with either corn oil vehicle or ethoxyquin to give a total dose of 100, 200, 
400, 500 or 600mg/kg/day. 
Scheduled tiIrepoints for tennination were Days 3, 8, 15 and 29 (24h after last dose). Kidneys were 
taken at termination from all animals, fixed in 10% NBF and processed to paraffin block. Any 
tnacroscopic abnormalities present at termination were also sampled, fixed and processed. Sections 
(41lm) were cut and stained with Haematoxylin & Eosin for histological assessment. 
All kidney sections were assessed for renal effects, without knowledge of treatment group, and any 
papillary damage graded as detailed in section 4.2.1.3. A "cumulative score" of papillary necrosis 
Was also determined for each group: the grade of papillary necrosis seen in each animal was given a 
" score", as described in Table 4.3 below, and the cumulative score for each dose group calculated. 
This was to help distinguish between the grades of damage seen rather than just recording the 
inCidence of necrosis in each group, and was used to help determine the optimum dose regime for 
ethoxyquin. 
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Moderate RPN 3 
Any effects on the kidney cortex were also noted, as were microscopic observations on any tissues 
sampled with macroscopic findings . 
.4..2.2.4: Dose regimen used in further work with ethoxyquin 
Following the above work detailing the development of ethoxyquin as a model for RPN, the dose 
regimen used in all further studies with ethoxyquin was 500mg/kg/day in com oil, given as a once 
daily dose by oral gavage. 
~2.3: Urinary sediments 
Drine samples were collected on ice overnight (16.30 to 8.30h) after 1, 2, 3, 4 or 7 daily doses of 
ethoxyquin (Days 2, 3, 4, 5 and 8). Animals were housed in MS&D metabolism cages for urine 
cOllection. Urine volumes were measured with a measuring cylinder and fixed urinary sediments 
were prepared as detailed in Chapter 3.2.3. 
~: Perfusion methods 
The kidneys of some animals were perfuse-fixed for optimal preservation of cells and tubules where 
TranSmisSion Electron Microscopy investigation was performed (4.2.6 below). Under deep 
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anaesthesia, kidneys were perfuse-fixed with modified Kamovsky's solution after a saline wash via 
whole body perfusion, using constant head of pressure apparatus set at 110 mm Hg (as detailed in 
3.2.4). 
~2.5: SEM and correlative histoloeY 
Kidneys were taken at tennination from animals after treatment with ethoxyquin or vehicle 
(controls) for 2 and 7 days, fixed in 10% neutral buffered formalin (NBF) and the papillae 
processed for SEM assessment using a Philips XL20 microscope, as described earlier (3.2.6). Any 
alterations in the papilla structure were noted. 
Following this assessment, all papillae and kidney cortex samples from each animal were processed 
through to paraffin block and H&E sections were prepared to allow comparative histological 
assessment. All kidney sections were assessed for renal effects without knowledge of treatment 
group, and any papillary necrosis graded as detailed in Table 4.2 (Section 4.2.1.3). Any effects on 
the kidney cortex were also noted, as were microscopic observations on any tissues sampled with 
macroscopic findings at necropsy. 
U..6: Time-course of lesion development usine transmission electron microscopy (TEM) 
Animals were killed 24 hours after 1, 2, 3, 4, or 7 daily doses of ethoxyquin (i.e. on Days 2, 3, 4, 5 
and 8). Following perfusion fixation as detailed in 4.2.4, papillae from all animals were dissected 
OUt and immersed in Kamovsky's fixative for a further hour, then post-fixed in 1% osmium 
tetrOxide in O.IM phosphate buffer pH 7.4 for one hour. Samples were then dehydrated through 
graded alcohols to 1,2 epoxypropane (25, 50, 75 and 2 x 100% alcohol, 15 mins each, 30 mins 1,2 
ePoXyPropane), and infiltrated in CY212 araldite resin overnight before embedding and 
POIYmerisation in araldite blocks (48 hours at 60°C). 
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Semi-thin (1 micron) sections were cut and stained with either Methylene blue/Azure II or 
Toluidine Blue for light microscopy assessment; ultrathin (60- 90 run) sections were cut and stained 
with uranyl acetate and lead citrate for conventional TEM assessment using a Philips CMlO 
electron microscope operating at 1ookV. Any effects on cell architecture and ultrastructure were 
noted, and any RPN was graded as detailed in the EM portion of Table 4.2. 
Samples of papillae were also removed fresh, 24 hours after the last dose, from SOlre animals 
treated for 2 and 7 days with ethoxyquin and immerse-fixed for 2 hours in modified Karnovsky's 
fixative before processing as above to resin block. Sections were cut and assessed as above for 
perfuse-fixed samples. This was to allow comparison of perfuse- and immerse-fixed papillae for 
tissue preservation. 
~2.7: Urine analysis 
Basic urine analysis was perfonned on all samples collected for urine sediment preparation (4.2.3), 
'Ibis analysis consisted of semi-quantitative Clinitek "dipstick" analysis of the following pararreters: 
glucose, bilirubin, ketones, specific gravity, blood, pH, protein and urobilinogen. Colour changes in 
MUltistix lOSG dipsticks were analysed by spectrophotometry using an Ames Clinitek 200 
analYser, according to the manufacturer's instructions. 
U.8: Clinical chemistry & haematology 
Samples of blood were taken for analysis from animals at termination 24 hours after 2 and 7 daily 
doses of ethoxyquin. 
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4.2.8.1: Clinical chemistry 
At necropsy, blood samples (1.5mL) were obtained from all animals via the alxiominal aorta into 
tubes containing lithium heparin (32 IV/mL) for the detennination of aspartate aminotransferase, 
alanine aminotransferase, alkaline phosphatase, lactate dehydrogenase, total protein, albumin, 
globulin, glucose, total bilirubin, conjugated bilirubin, cholesterol, triglycerides, urea, creatinine, 
sodium, potassium, chloride, calcium and phosphate. Detennination was camed out on a Bayer 
Technicon Axon analyser, using the recorrnnended Bayer Diagnostics kit for each parameter. 
Statistical analysis methods were applied as detailed in 4.2.10. 
1.2.8.2: Haematology 
At necropsy, blood samples (0.7mL) were obtained from all animals into tubes containing EDTA 
for determination of haemoglobin and platelets using a Sysmex E2500 automated haematology 
analyser. Haemoglobin was measured by spectrophotometry at 535nm, after conversion to the 
stable cyanmethaemoglobin, and blood cells and platelets were counted by detecting a difference in 
conductivity between the particles and the diluent in which they were suspended. Statistical analysis 
methods were applied as detailed in 4.2.10. Moxphological assessment of red blood cells and 
Platelets was also performed using stained preparations (Wright's stain, Bayer Diagnostics) and 
light microscopy. 
12.9: Necropsy & histological assessment 
Animals given 2 and 7 daily doses of ethoxyquin underwent full necropsy following blood sampling 
to identify any non-renal effects of ethoxyquin. All major tissues (brain, spinal cord, liver, kidneys, 
adrenal glands, heart, lungs, stomach, small and large intestines, spleen, pancreas, testes, thymus, 
lYmph nodes, skeletal muscle, bone, skin, thyroid gland, pituitary and salivary glands) were 
Preserved in 10% NBF and samples of each were processed to paraffin block for histological 
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assessrrent as detailed previously (3.2.2). Any macroscopic abnonnalities noted at necropsy were 
also processed for histological assessrrent. 
,4.2.10: Statistical analysis 
Bartlett's test of homogeneity was carried out before statistical analysis to identify any "outliers" in 
the clincal chemistry and haematology results. Dunnett's modified T-test was then applied to test 
the significance of any differences in results between control and treated samples. 
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4.3 RESULTS 
~.3.1: Development of ethoxvguin as a model for renal papillary necrosis 
.4.3.1.1: Dose-ranging studies with DMSO 
AIl doses of ethoxyquin (up to 800 mg/kg) and both dosing periods (single dose and 5 daily doses) 
Were well tolerated. No difference was noted between Sprague-Dawley males and females in the 
initial assessment, so males were selected for future studies with ethoxyquin. The only clinical sign, 
seen in both control and treated animals that were dosed for 5 days, was brown staining of tray 
paper after 2 doses, which did not recur. Upon necropsy, all top dose animals (800mg/kg) treated 
for 5 days showed pale red discolouration of the intestines. Histological assessment ofH&E-stained 
kidney sections did not show any obvious signs of treatment-induced lesions, although kidneys 
from 3 of 4 top dose animals (800mg/kg) did show possible degenerative changes after 5 days 
treatment, consisting' of shrunken nuclei and foamy cytoplasm 
1.3.1.2; Change of dosing vehicle and investigation of rat strain 
In this experiment the vehicle had been changed from DMSO to com oil and the maximum dose of 
800 mg/kg ethoxyquin from the previous experiment was used; this was split into 2 daily doses of 
400 mg/kg to determine whether twice daily dosing increased the nephrotoxicity of ethoxyquin. 
'fwo strains of male rat were investigated to assess the relative sensitivity of these and allow inter-
strain Comparison of any renal effects. Following scheduled tennination of Day 2 animals, all 
remaining animals were killed on Day 4 due to unexpected, unacceptable clinical signs in all treated 
animals (marked lethargy or moribund condition), none of which had been apparent in animals 
given the same dose of ethoxyquin in DMSO. Some animals were killed on day 2 (2 Fischer rats) 
and day 3 (5 Sprague-Dawley and 10 Fischer rats) in a moribund condition. Fischer rats showed 
lllore severe clinical signs than Sprague-Dawley rats. 
145 
Abnonnalities related to clinical signs 
Macroscopic examination of animals revealed stomach ulcers, apparent as small white areas which 
in 3 cases also had dark red foci Pale livers and darkened intestines were also in some treated 
animals (Table 4.4, below). The site of ulceration within the stomach differed between strains; the 
non-glandular region was affected in Sprague-Dawley rats (11/20) whereas in Fischer rats the 
pylorus area of the glandular region was affected (7/20). The degree of ulceration was more severe 
in Fischer rats, in two animals the ulcers had perforated. Histological assessment of the stomachs 
confinned the macroscopic observations (Fig. 4.1), showing inflarmnation and ulceration of the 
gastric mucosa; this had penetrated the stomach wall in those animals where perforated stomachs 
were noted at necropsy. No microscopic abnormalities were seen in the livers and intestines that 
had been sampled with macroscopic findings (pale livers, dark intestines). 
Table 4.4: Clinically-related findings from ethoxyquin-treated animals: incidence table 
Macroscopic Finding Fischer Rats Sprague-Dawley Rats 
STOMACH: Normal 13/20 9/20 
I-
Ulcerated 5/20 11/20 
" 
Perforated 2/20 0/20 
I--. 
LIVER: Normal 14/20 17/20 
I-
Pale 6/20 ' 3/20 
..... 
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Figure 4.1: Stomach lesions induced with ethoxyquin treatment 
" , 
' I "~~  
. ~. ':'\ 
Figure 4.1a: Lesions induced in Fischer F344 rat: ulceration of glandular stomach (arrow). 
H&Ex50. 
Figure 4.1b: Lesions induced in Sprague-Dawley rat: ulceration of non- glandular region of 
stomach (arrow). H&E x 50. 
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Renal observations 
Histological assessment of kidneys revealed RPN in 9/20 Fischer rats and 11/20 Sprague·Dawley 
rats. This RPN was more focal in Sprague·Dawley rats but of similar severity to that seen in Fischer 
rats (Table 4.5, Fig 4.2). Coupled with this RPN, there was also inner cortical necrosis in 8 of the 
10 affected Fischer rats and 10 of the 11 affected Sprague·Dawley rats (Table 4.5, Fig. 4.3). A 
funher 6 Fischer rats and 2 Sprague-Dawley rats from the treated group had inner cortical necrosis 
without RPN. Sprague-Dawley rats were used in future experiments as these had less severe 
clinical signs, a similar incidence of RPN and less cortical involvement when compared with Fischer 
rats. 
Table 4.5: Renal Observations from ethoxyquin-treated animals: incidence table 
Histology Observations Fischer rats Sprague-Dawley rats 
PAPILLA: Normal 11/20 9/20 
RPN; Minimal 1/20 4/20 
Mild 3(20 2/20 
"-
Marked 5/20 5/20 
.... 
Total with RPN 9/20 11/20 
CORTEX: Normal 6/20 8/20 
I-
~crosis; mild 9/20 9/20 
moderate 4/20 2/20 
I--
marked 1/20 1/20 
"-
Total with cortical changes 14/20 12/20 
'-
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Figure 4.2: RPN induced in Fischer and Sprague-Dawley rats with ethoxyquin 
Figure 4.2a: 
Figure 4.2c: 
Fischer rat: control kidney. 
H&Ex 100 
Sprague-Dawley rat: control 
kidney. H&E x 100 
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Figure 4.2b: Fischer rat: Treated kidney. 
Note area offocal necrosis (arrow). 
H&Ex 100 
Figure 4.2d: Sprague-Dawley rat: Treated 
kidney. Note area offocal necrosis (arrow), 
which is larger than Fischer lesion. 
H&Ex 100 
Figure 4.3: 
Figure 4.3: Cortical necrosis induced with ethoxyquin 
Marked cortical lesion induced in Fischer F344 rat following ethoxquin treatment. 
Note area of necrosis (arrow). H&E x 100. 
H&Ex 100. 
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4.3.1.3; Establishment of optimum dosing regime with com oil vehicle 
With doses of up to 600 mg/kg ethoxyquin given in com oil, all but 2 of the animals survived to the 
scheduled tennination points with no adverse clinical signs. No difference was seen between 
animals given ethoxyquin as once-daily or twice-daily doses. One animal given 500mg/kg/day was 
killed in a moribund condition on Day 2 of treatment. and one given 600 mg/mg/day was found 
dead on Day 21. Damp, brown staining fur around the mouth/throat was noted in all treated 
animals after each dosing, but this regressed between doses. 
Extra-renal observations 
Macroscopic examination of animals revealed small white foci in the non-glandular epithelium of 
the stomach in 5 treated animals (Fig 4.4b); 3 on Day 3 (1 at 400mg/kg and 2 at 600 mg/kg) and 2 
On Day 8 (both at 600 mg/kg). Small red foci were also noted on the surface of one or both kidneys 
from 4 treated animals ( 3 at a dose of 100 mg/kg and 1 at 400 mg/kg ethoxyquin). 
lIistological assessment of the macroscopic stomach lesions revealed focal ulceration of the non-
glandular area with associated inflammatory reaction in the affected Day 3 animals (1/4 at 400mg 
and 2/4 at 600mg). Minimal inflammation only was apparent in the stomachs from the affected Day 
8 animals (2/4 at 600mg), indicating a transient effect. Assessment of the lungs from the 500mg/kg 
animal that died on study revealed marked alveolar haemorrhage with a mild inflarrnnatory reaction. 
In addition, a mild inflammatory reaction was present in the mediastinal cavity. The effects in the 
lungs were thought to be due to mis-dosing. 
{{enal observations 
lIistOlogical examination of kidneys identified RPN in some treated animals. The incidence of RPN 
increased with dose group and time (Table 4.6): on Day 3 only 2/12 animals were affected and only 
- . 
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Figure 4.4: Dose ranging ethoxyguin study; evaluation of optimum dose regime 
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4.4b: Incidence of stomach lesions at each timepoint 
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-+- 400 mgJ1<g 
_ 500mgJ1<g 
-.-600 mgJ1<g 
at 500 and 600 mg/kg; by Day 8 half of the 400 mg/kg dose group and all animals at or above 500 
mglkg ethoxyquin were affected. By Day 15 the number of 400 mg/kg animals affected had risen to 
6/8, with all animals affected in this dose group at day 29. Comparing the "cumulative scores" 
calculated for each group, this distinguished well between the extent of RPN seen in each dose 
" 
" 
group (Table 4.6 and Figure 4.4a). 
" 
11Ie severity of RPN at each timepoint varied with all groups from minimal damage where only 
interstitial cells were affected to moderate RPN where derangement and necrosis of loops of Henle 
and capillaries was also evident (Table 4.6; Fig. 4.5). The kidneys of some 600 mg/kg an1mals also 
had minimal tubular degeneration and necrosis in the cortex on Days 15 and 29 (2/4 at each 
timepoint). 
From these results, the dose regime chosen for all future ethoxyquin experiments was 500 mg/kg 
ethoxyquin in corn oil, since this induced RPN in all animals after 8 daily doses with minimal clinical 
signs (Fig. 4.4, chosen dose regime circled). 
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Table 4.6: Severity grading and incidence of RPN in treated animals 
Timepoint and grading lOOmg/kg 200mg/kg 400mg/kg SOOmg/kg 600mg/kg 
ethoxyquin 
Day 3 
Nonnal 4 (100%) 4 (100%) 8 (100%) 3 (75%) 3 (75%) 
Minimal 0 0 0 1 (25%) 1 (25%) 
Mild 0 0 0 0 0 
Moderate 0 0 0 0 0 
TOTAL number of animals 4 4 8 4 4 
Cumulative score 0 0 0* 1 1 
Day 8 
Normal 4 (100%) 3 (75%) 4(50%) 0 0 
Minimal 0 1 (25%) 0 2 (50%) 0 
Mild 0 0 2 (25%) 2 (50%) 4 (50%) 
Moderate 0 0 2 (25%) 0 0 
TOTAL number of animals 4 4 8 4 4 
Cumulative score 0 1 5* 6 8 
Day 15 
Normal 4 (100%) 3 (75%) 2 (25%) 0 0 
Minimal 0 0 1 (12.5%) 0 2 (50%) 
Mild 0 1 (25%) 2 (25%) 3 (75%) 1 (25%) 
Moderate 0 0 3 (47.5%) 1 (25%) 1 (25%) 
TOTAL number of animals 4 4 8 4 4 
Cumulative score 0 2 7* 9 7 
Day 29 
Nonnal - - 0 0 0 
Minimal - - 1 (25%) 2 (50%) 2 (50%) 
Mild - - 1 (25%) 2 (50%) 1 (25%) 
Moderate - - 2 (50%) 0 1 (25%)_ 
TOTAL number of animals 0 0 4 4 4 
Cumulative score 0 0 9 6 7 
Percentage incidence for each grade at each timepoint is given in brackets where applicable. 
Key: - = no animals dosed for this period of time at these dose levels. 
* = cumulative score divided by 2 to account for increased group size at these 
timepoints. 
Cumulative Score: 




Moderate RPN 3 
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Figure 4.5: Grades ofRPN induced in Sprague-Dawley rats following ethoxyquin treatment 
Figure 4.5a: Control kidney. H&E x 250 Figure 4.5b: Treated kidney: Minimal necrosis. 
Figure 4.5c: Mild Necrosis. Note loss of 
interstitium and necrosis of some tubules 
but outlines remaining (arrow). H&E x 250 
, I 
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Note loss of interstitial detail at tip (arrow). 
H&Ex250 
Figure 4.5d: Moderate necrosis. Note loss of 
structural detail in tip region (arrow). H&E x 250 
Figure 4.6: Urinary sediment changes following ethoxyquin treatment 
Figure 4.6a: Urinary sediment from control animal. Sediment is clear apart from squamous 
epithelial cell (arrow). Papanicolau-stained, x 250. 
Figure 4.6b: Urinary sediment from ethoxyquin-treated animal at Day 3: Note large numbers of 
epithelial cells compared to control sediment. Papanicolau-stained, x 250. 
Figure 4.6c: Urinary sediment from ethoxyquin-treated animal at Day 8. Sediment appears 
similar to control animal apart from a small cluster of epithelial cells (arrow). 
Papanicolau-stained, x 250. 
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4.3.2: Urinary Sediments 
An increase in the number of epithelial cells was seen in treated animals on days 3, 4 and 5 (ie. after 
2,3 and 4 days' treatment with 500 mglkg/dayethoxyquin; Table 4.7 and Figure 4.6). There were 
in excess of 50 such cells per x200 microscope field in those animals with increased numbers 
(compared to less than 10 in the whole sediment in control animals). This increase was most 
apparent after 2 days' ethoxyquin treatment (Fig. 4.6). The number of cells was reduced to nearer 
control levels after 7 days' treatment. The type of epithelial cell involved, and exact cell counts, 
could not be clearly distinguished due to indistinct morphology in the preparations, possibly caused 
by technical problems with the staining procedure. Mean urinary volume was increased in treated 
animals at all timepoints (Table 4.7, Fig. 4.7); this increase was significant at days 5 and 8 where 
only 1 animal per timepoint was within the relevant control range for urine volume. 
Table 4.7: Urine analysis results 
Group/ Increased Mean 
Timepoint cells in urine 
sediment * volume, m1 ±SD 
Control: Day 2 0/5 4.96 ±1.63 
Day 3 0/5 3.97 ±O.89 
Day 4 0/5 3.58 ±O.6O 
Day 5 0/5 4.32 ±1.20 
Day 8 0/10 5.60 ±1.56 
Ethoxyquin: Day 2 0/5 8.54 ±2.76 
Day 3 5/10 8.15 ±4.17 
Day 4 4/5 8.08 ±1.76 
to-
DayS 3/5 13.50±4.99 
Day 8 0/10 12.6O±4.10 
* Number of affected animalsInumber of animals in group. 
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Figure 4.7: Urine volumes and incidence of increased cells in sediment following ethoxyguin 
25 r ..... ·.................•... . ....................•.....•........... 
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Key: 0 = Nonnal number of cells in urine; • = increased numbers of cells in urine; - = mean 
Points on the graph represent individual animals 
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Figure 4.8: 
A = SEM photograph of papilla from ethoxyquin-treated animal, showing thickening of surface 
epithelia (arrow). 
B = Subsequent H&E section (x 250) from same papilla, showing hyperplasia and hypertrophy of 
surface epithelial cells (arrow). Note also moderate RPN in area behind tip. 
Figure 4.9: 
A = SEM photograph of papilla from ethoxyquin-treated animal, showing activated platelets, with 
cellular extensions, adherent to capillary wall (arrow). Note sub-endothelial collagen fibres (*). 
B = Subsequent H&E section (x 250) from same papilla, showing mild RPN. Note small, 
eosinophilic platelets adherent to walls of capillaries (arrows). 
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4.3.3: Perfusion methods 
All kidneys cleared and perfused well macroscopically. Microscopic evaluation of kidney sections 
showed perfusion to be incomplete in some animals; some blood cells were present in a few 
capillaries. Preservation of tissues was generally very good, however, and better than with irmnerse-
fixed material (see 4.3.5). 
4.3.4: SEM and correlative histology 
The results of combining SEM and subsequent histology are detailed in Table 4.8. SEM highlighted 
some effects of ethoxyquin which have not previously been reported. The surface epithelium at the 
papilla tip was often thickened due to hypertrophy and/or hyperplasia of epithelial cells; subsequent 
histology performed on the same sample showed the surface epithelium to be several cells thick or 
have much thicker epithelial cells than papillae from control animals (hyperplasia and hypertrophy 
respectively: Fig 4.8 compares SEM and histology). 
SEM also highlighted some capillaries in 2/10 papillae from animals treated for 7 days which 
Contained large numbers of activated platelets with mutliple cytoplasmic processes; these were 
often adherent to capillary walls. Activated platelets were apparent in the H&E sections from the 
SEM material within capillaries in areas of papillary necrosis (Fig. 4.9 compares SEM and 
histology). Some "distortion" was noted in the papillae of some treated animals during SEM 
assessment, this was seen in histological sections as a slight alteration in interstitial structure 
("tangled" appearance) without obvious cell loss or necrosis. 
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Table 4.8: Observations from SEM and Correlative Histolo!!V 
- --- ------ ---
I 
Observations Controls Day 3 ethoxyquin-treated Day 8 ethoxyquin-treated 
SEM Histology SEM Histology SEM 
NAD 10/10 10/10 1/10 1/10 0/10 
Distortion 0/10 0/10 5/10 5/10 0/10 
Thickened epithelium 0/10 0/10 3/10 3/10 10/10 
RPN 0/10 0/10 4/10 4/10 10/10 
Platelets present 0/10 0/10 0/10 0/10 3/10 
Kidney cortex N/A NAD N/A NAD N/A 
The numbers in the tables represent the incidence within a group for each finding, where N=lO animals in each group. 
KEY: NAD = no abnonnalities detected 
RPN = renal papUlary necrosis 









Table 4.9: Summary ofTEM observations in ethoxyquin-treated arrimals 
Incidence of RPN 
. 
Tirrepoint Thickened smface Increased NAD Degeneration Minimal Mild Moderate 
epithelium platelets present 
Day 2 5/5 0/5 2/5 3/5 0/5 0/5 0/5 
Day 3 5/5 1/5 0/5 4/5 1/5 0/5 0/5 
Day 4 5/5 1/5 0/5 3/5 1/5 1/5 0/5 
DayS 5/5 4/5 0/5 2/5 2/5 1/5 0/5 
Day 8 5/5 5/5 0/5 0/5 2/5 2/5 1/5 
---.~ 
The group size per timepoint was 5 animals, the numbers in the table are incidences of findings. 
NAD= no abnormalities detected. 
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4.3.5: Time-course of lesion development using TEM 
Controlanimals 
TEM of control animals showed slight shrinkage of cells with occasional interstitial gaps, but 
otherwise structures were well preserved (Figures 4.10, 4.11, 4.12). Some dark cells were present 
among collecting duct cells and sUlface epithelial cells (these were also seen in some areas of 
sections from treated animals). Flattened platelets were occasionally present in some capillaries. 
Ethoxyquin-treated animals 
The findings from ethoxyquin-treated animals over the time-course are sunnnarised in Table 4.9. 
nay 2 ethoxyquin-treated animals 
Surface epithelial cells were thickened in all animals. Gaps were observed in interstitial areas and 
vacuolation of some interstitial cells was evident nearer the papilla tip - this was cell "distortion" 
(derangement) and degeneration (pale outlines) rather than definite necrosis, and was present in 3/5 
animals (Figure 4.13). Some dark cells were present among collecting duct cells and surface 
epithelial cells; these were also seen in control animals. 
Qay 3 ethoxyquin animals 
Gaps and distortion (degeneration) of interstitial areas were evident near the papilla tip in 4/5 
animals, as seen in the affected Day 2 animals. This had progressed to foca~ minimal necrosis in the 
remaining animal with definite necrosis of interstitial cells; cells were pyknotic or absent, leaving 
only cellular debris in the interstitium (Figure 4.14). Possible early necrosis was also evident in 
so~ capillary endothelial cells in capillaries (Figure 4.15). Epithelial cells on the papilla surface 
were thickened or 2-deep in all animals, as noted in the histology observations. Platelets were seen 
in so~ capillaries of the animal with RPN, these did not have an activated ~rphology. 
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Egure 4.10: Electron micrograph of 
control papilla, showing well preserved 
interstitial cells (large arrow) and 
capillaries (small arrow). x 3500. 
Bgure 4.12: Electron micrograph of 
Control papilla showing nonna! 
collecting duct epithelium x 3500. 
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Figure 4.11: Electron micrograph of 
control papilla, showing nonna! ultrastructural 
appearance ofloop of Henle (arrowed) in 
addition to nonna! interstitium x 3500. 
Figure 4.13: Electron micrograph of 
Day 2 ethoxyquin-treated papilla, showing 
degeneration of interstitium (arrow) with 
gaps apparent in interstitial space (*). x 3500. 
Eigure 4.14: Electron micrograph of 
Day 3 ethoxyquin-treated papilla, showing 
necrosis of interstitial cells (arrowed) 
and interstitial debris. x 5850. 
Emure 4.16: Electron micrograph of 
Day 4 ethoxyquin-treated papilla, showing 
damage to capillary endothelium (arrow) 
and loops of Henle (arrowhead). x 3500. 
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Figure 4.15: Electron micrograph of 
Day 3 ethoxyquin-treated papilla, showing 
early damage to capillary endothelial cells (arrow). 
x 3500. 
Figure 4.17: Electron micrograph of 
Day 4 ethoxyquin-treated papilla, showing 
activated platelets present within damaged 
capillary (arrow). x 5850. 
Day 4 ethoxyquin animals 
Surface epithelial cells were thickened or several cells deep in all animals. Gaps and distortion of the 
interstitia (degeneration) were evident in 3/5 animals; this had progressed to focal RPN in the 
remallrlng 2 animals, one with minimal and one with mild RPN. Early damage (loss of some 
endothelial or tubule epithelial cells) was observed in some capillary walls and loops of Henle, this 
Was more obvious in the animal with mild RPN (Figure 4.16). Activated platelets were also 
apparent in capillaries within the area of necrosis in the papilla with the highest grade RPN. These 
platelets had cytoplasmic processes which were often in contact with the endothelial surface, and 
often had a more rounded appearance than tlnonnaltl platelets (Figure 4.17). 
Day 5 ethoxyquin animals 
Surface epithelial cells were thickened or several cells deep in all animals. Gaps and distortion of the 
interstitia (degeneration) were apparent in 2/5 animals, this had progressed to RPN in the remaining 
3 animals, where only interstitial debris was observed (Figure 4.18). Platelets were observed in 
Some capillaries in those animals with RPN; these were activated in 2 animals with RPN, one of 
Which had the highest grade RPN. Early damage (loss of sOlm endothelial or tubule lining cells) 
Was observed in capillary walls and loops of Henle in the areas of interstitial necrosis, as seen in 
Day 4 animals. Occasional dark cells were present in some collecting ducts. 
~ 8 ethoxyquin animals 
By Day 8, thickened surface epithelial cells were apparent in all animals, collecting duct cells also 
appeared thicker near the tip. Some surface epithelial cells also contained troderate numbers of 
highly electron dense particles which were bounded by a single membrane and were probably 
IYSosomes. These epithelial cells also had increased intercellular spaces at the cell junctions (Figure 
4.19). RPN was present in all animals, this ranged from minimal to moderate in severity (Table 4.9), 
j • 
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Figure 4.18: Electron micrograph of 
Day 5 ethoxyquin-treated papilla, showing 
further necrosis of interstitial cells with 
fibrillar material within interstitial debris 
. x 4425 
Ogure 4.20: Electron micrograph of 
Day 8 ethoxyquin-treated papilla, showing 
marked interstitial damage (arrow) and 
activated platelets present within damaged 
capillaries, often adherent to endothelium 
(arrowhead). x 4425. 
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Figure 4.19: Electron micrograph of 
Day 8 ethoxyquin-treated papilla, showing 
increased intercellular spaces between surface 
epithelial cells (arrow). x 4425 . 
Figure 4.21: Electron micrograph of 
Day 8 ethoxyquin-treated papilla, showing 
more obvious necrosis in loops of Henle, with 
sloughing of epithelial cells (arrows). Note also 
platelets within capillaries (arrowhead). x 3500. 
where very few interstitial structures were apparent. Increased numbers of platelets were seen in all 
animals, these were often activated (Figure 4.20). Necrosis of endothelial cells was apparent in 
some capillary walls and loops of Henle were also affected in areas of necrosis (Figure 4.21). 
Occasional shrunken/dark collecting duct cells were seen. 
Lnnnerse-fixed material 
Papillae that were immerse-fixed from animals treated for 2 and 7 days showed· similar changes to 
those seen in the perfused samples, although the preservation of cells and tubules was not as good; 
an increase in the amount of shrinkage of cells and structures was apparent compared to the 
petfuse-fixed material from the same timepoints. 
!.3.6: Urine Analysis 
levels of conjugated bilirubin were raised in the urine samples from treated animals relative to 
Controls at all timepoints (Table 4.10 and Figure 4.22). No other positive findings were noted: there 
Were no treatment-related changes in glucose, ketones, specific gravity, blood, pH, protein or 
urobilinogen (Table 4.11). 
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Table 4.10: Urine clinical chemistly results: Bilirubin changes as indicated by Clinitek analysis 
Groupffimepoint Urine Bilirubin 
Negative Small Moderate Large 
Control: Day 2 415 (80%) 115 (20%) 0/5 0/5 
Day 3 5/5 (100%) 0/5 0/5 0/5 
Day 4 215 (40%) 3/5 (60%) 0/5 0/5 
Day 5 115 (20%) 415 (80%) 0/5 0/5 
Day 8 6110 (60%) 4110 (80%) 0/5 0/5 
EQ: Day 2 0/5 115 (20%) 215 (40%) 215 (40%) 
Day 3 0/10 0/10 4110 (40%) 6110 (60%) 
Day 4 0/5 115 (20%) 3/5 (60%) 115 (20%) 
Day 5 0/5 215 (40%) 0/5 3/5 (60%) 
Day 8 0/10 1110 (10%) 6110 (60%) 3/10 (30%) 
Key: EQ - ethoxyquin 
The numbers in the table are number of animals, group size is denoted to the right of the / 


















MillIe 4.22: Bilirubin leyels in urine 







Table 4.11: Urine clinical chernistty parameters unaffected by ethoxyquin treatment 
Group/ Glucose Ketones Specific Blood pH Protein Urobil-
Timepoint (mmoJ/L) (mmoVL) gravity present (gIL) inogen 
(umo1/L) 

















































7.0-8.0 trace 16 (1/5) 
Key: C = Controls; EQ = ethoxyquin-treated; - = negative 
The numbers in brackets under urobilinogen are the numbers of animals in the group with this 
value. All other animals had values of 3.2 umo1/L. 
4.3.7: Clinical chernistry/Haematology 
4.3.7.1: Clinical chemistry 
The results from the clinical chemistry assays did not indicate any obvious liver or renal 
toxicity (Table 4.12). There were slight alterations in some parameters in ethoxyquin-treated 
animals: decreased albumin, increased total bilirubin and increased sodium at both timepoints; 
increased lactate dehydrogenase, chloride and globulin and decreased potassium and glucose 
were observed on Day 3; and increased aspartate aminotransferase on Day 8 (Table 4.12). 
These changes were mainly due to single animals within the group, with no obvious pattern to 
these changes to indicate damage to a particular tissue. 
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Table 4.12: Results of Clinical chemistty analysis of blood following daily dosing with ethoyquin 
Parameter/units Day 3 Day 
Control ~thoxyquin Control 
Albumin gIL 28.88 ±O.64 27.64* ±O.76 29.82 ±O.91 
AST U/L 89.40 ±12.0 111.60 ±25.30 73.20 ±5.40 
LDR U/L 139.40 ±54.3 276.80* ±132.8 132.20 ±90.6 
Total bilirubin UlmJ/L 1.70 ±O.25 2.28* ±O.45 1.34 ±O.19 
Sodium mmoJ/L 138.95 ±3.42 144.40* ±1.89 143.75 ±O.45 
Potassium mmoJ/L 6.34 ±O.75 5.20* ±O.42 5.17 ±O.98 
Chloride mmoVL 100.26 ±1.45 104.40* ±1.89 99.44 ±2.11 
GlObulin gIL 14.40 ±1.1 16.20* ±O.80 17.60 ±1.50 
Glucose :rrnmJ/L 10.64 ±1.33 8.32* ±O.64 9.09 ±1.32 
ALP U/L 428.00 ±90.5 554.00 ±134.5 522.00 ±150.2 
ALT U/L 64.40 ±5.20 68.00 ±20.30 64.60 ±7.50 
-Urea mmoJ/L 3.78 ±O.43 3.82 ±1.33 3.52 ±O.82 
-Calcium mmoVL 2.79 -+0.09 2.75 ±O.O6 2.75 ±O.12 
"-
. 
Cholesterol mmoJ/L 2.86 ±O.58 3.22 .±O.44 2.80 ±O.73 
to-
Creatinine umoVL 46.80 ±1.30 45.60 ±2.30 51.60 ±3.60 
~ 
Phosphate mmoVL 3.38 ±O.94 2.97 .±O.63 2.59 ±O.95 
~ 
Total protein gIL 43.20 .±O.80 43.80 ±1.1O 47.60 ±2.20 
"-
Triglycerides mmoVL 0.62 ±O.25 0.93 ±O.23 0.53 ±O.16 
....... 






= aspartate aminotransferase 
= lactate dehydrogenase 
= alkaline phosphatase 
= alanine aminotransferase 
= group rrean significantly different from control at p < 0.05 
= If" If It If tf 






















Figure 4.23: Haematology findings following ethoxyquin treatment 
Figure 4.23a: Blood smear from control animal showing normal cell morphology. Note small 
number of platelets (arrow). Wright's stain, x 1250. 
Figure 4.23b: Blood smear from ethoxyquin-treated animal at Day 3. Note crenated appearance of 
some red blood cells (arrow) and slight increase in platelets. Wright's stain, x 1250. 
Figure 4.23c: Blood smear from ethoxyquin-treated animal at Day 8. Note echinocytes ("spikey" 
red blood cells, arrow), and obvious increase in platelets. Wright's stain, x 1250. 
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4.3.7.2: Haematology 
Animals dosed with ethoxyquin for 2 days (sampled on Day 3) had significantly decreased 
haemoglobin levels (lOS gIL v. 115.S gIL, P < 0.01) and significantly raised numbers of platelets 
(1291 v. 70S.3, p < 0.05) compared to controls (Table 4.13). However, the platelet data from this 
timepoint must be interpreted with caution since some control group animals appeared to have 
small clots in their blood, thus lowering their platelet count. Red cell morphology was affected by 
ethoxyquin treatment; cells appeared crenated and in some cases "spikey" (echinocytes) (Figure 
4.23). 
Animals dosed with ethoxyquin for 7 days had marginally lower haemoglobin levels but these were 
not significant (p > 0.05). Platelet levels were significantly increased over control levels, more so 
than after 2 days treatment (p < 0.01). Again, red blood cells were affected morphologically by 
ethoxyquin treatment, and much more so than after 2 doses (Fig. 4.20) 
Table 4.13: Effects of ethoxyquin treatment on haemoglobin and platelets 
Group and timepoint Haemoglobin level gIL ±SD 
Control Day 3 115.S ± 1.5 
ethoxyquin-treated Day 3 IOS.0** ± 3.6 
Control DayS IIS.0 ±S.2 
ethoxyquin-treated DayS 115.0 ±4.1 
, 
Key: 
N = 5 per group at each timepoint 
* = group mean significantly different from control at p < 0.05 
** = group mean significantly different from control at p < 0.01 
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Platelet count x109 ± SD 
70S.3 ±323.3 
1291.3* ± 104.5 
1051.2 ±72.2 
1650.4** ± 169.6 
4.3.8: Necropsy & histological assessment of other organs 
Macroscopic Observations 
The stomachs of so~ treated animals had areas of white discolouration; in so~ animals this was 
in the non-glandular region whereas in others it was noted in the glandular region. 
Histological Assessment 
The only treatrrent-related findings seen during histological assess~nt were in the stomach, where 
there was mild inflammation with focal ulceration in those stomachs where there had been 
macroscopic white non-glandular discolouration (as noted to a greater extent in the earlier dose-
ranging experiments; 4.3.1.2). No abnormalities were seen in the stomach sections from animals 
where white glandular discolouration had been noted at necropsy. It is possible that the latter 
discolouration was due to surface mucus. No effects were seen in the kidney cortex, the liver or any 
other organ in rats given ethoxyquin. 
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4.4 DISCUSSION 
4.4.1: Development of ethoxyguin as a model for renal papillary necrosis 
Dose ranging studies with DMSO 
The results of these studies indicated that doses of ethoxyquin up to 800 mglkg in DMSO (single 
or 5 daily doses) produced no acute effects in the kidney, with no histological evidence of alteration 
or necrosis. No difference was seen between male and female rats so males were selected for future 
experiments as these have been shown to be more susceptible to the renal effects of ethoxyquin 
[Hard & Neal 1992, Manson et al1992] .. Two strains of male rat were selected for the next stage in 
the assessment of ethoxyquin (Sprague-Dawley and Fischer rats) to allow inter-strain comparison 
of any renal effects; Fischer F344 males were used in previous studies which reported RPN 
following ethoxyquin treatment [Hard & Neal 1992, Manson et all992], whilst Sprague-Dawley 
rats were used for BEA and indomethacin studies in the previous chapter. The next stage in 
assessment of ethoxyquin was to assess the tolerability and effects of the same concentrations of 
this compound using a different vehicle (com oil) in Sprague-Dawley and Fischer rats. The vehicle 
Was changed as DMSO was considered an undesirable vehicle for dosing periods longer than 5 
days; peanut oil had been used as a vehicle for ethoxyquin in previously reported studies [Rudra 
1974 (vehicle for diet), Skaare & Naftsaad 1979 (oral gavage)] so it was considered that com oil 
Would be a suitable vehicle to substitute for DMSO. 
Change of dosing vehicle and investigation of rat strain for model 
The marked lethargy and moribund condition of ethoxyquin-treated animals from Day 2 onwards 
Was totally unexpected and unacceptable; the previous experiment using the same dose 
concentration, 800 mglkg, in DMSO for 5 days had produced no clinical signs or histopathology. 
Furthenrore, doses equivalent to up to 1200mglkg/day, given in the diet for up to 28 days, 
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produced no adverse clinical signs but did induce RPN [Hard & Neal 1992, Manson et alI992]. It 
is possible that the use of corn oil as vehicle markedly increased the bioavailability of ethoxyquin, or 
perhaps the oil retained the compound in the stomach for a prolonged period, causing the 
ulceration as a direct irritant effect. This suggestion is supported by Wallig et al [1989] who 
reported that corn oil delays gastric emptying, and that it can enhance the toxic effects of some 
compounds. 
Witheyet al [1983] compared the uptake of phannacokinetics of lipophilic substances when given 
by gavage in water or corn oil and showed that the vehicle effects on systemic uptake can be 
substantial (although they reported that corn oil decreased the rate and extent of uptake of 
substances when compared to water). Interestingly, Lenz & Carlton [1991] compared the 
papillotoxicity of diphenylamine (DPA) in male hamsters, when given as an oral dose in DMSO or 
peanut oil. They also pre-treated hamsters with DMSO before giving DPA in peanut oil to see if 
DMSO had any protective effects. They found RPN was present in only 1 of 90 hamsters given 
DPA orally in DMSO and 1 of 30 hamsters pre-treated with DMSO before dosing with DPA in 
peanut oil. In comparison, DPA given orally in peanut oil induced RPN in 17 of 30 hamsters. 
They therefore suggested that DMSO protected against DPA-induced RPN, since no RPN was 
seen in hamsters compared to dosing in peanut oil by the same route. In contrast to the findings of 
lenz & Carlton [1991], Wolf et al [1992a] investigated the protective effects ofDMSO against the 
papillotoxin BEA in Mongolian gerbils, but found that DMSO did not reduce the incidence of 
RPN. However, in Wolfs study [1992a], DMSO and BEA were injected simultaneously rather 
than pretreating with DMSO, so the difference in results between the two investigations could be 
due to this, or there may have been species differences. 
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The difference in incidence ofRPN in Lenz & Carlton's study [1991] could be due to the difference 
in vehicle, as highlighted by the results of the present expe~nts where a dose of ethoxyquin that 
induced no RPN in DMSO proved very toxic and induced RPN in over half the animals when given 
in com oil. However, it is possible that DMSO does have a protective effect as proposed by Lenz 
& Carlton [1991], and that no RPN was seen with DMSO in the present expe~nts because of 
this. Lenz & Carlton [1991] reported that DMSO can decrease the vasoactive mechanisms 
associated with ischaemia as it is a hydroxyl free radical scavenger in vitro and in vivo, and 
suggested that this may be how it protects against RPN. Ethoxyquin is an antioxidant and also acts 
as a free radical scavenger, so it is possible that DMSO prevented any papillary effects of 
ethoxyquin by also scavenging available free radicals and thus reducing the action of ethoxyquin. It 
would be interesting to further investigate this by pre-treating rats with DMSO, then dosing with 
ethoxyquin in com oil to detennine whether the incidence of RPN was reduced. The marked 
difference in the effects of ethoxyquin produced with the different vehicles also highlights a 
comrmn problem in toxicology, the choice of an appropriate vehicle. 
Both strains of rats were affected by RPN although Sprague-Dawley rats were less severely 
affected by stomach ulceration and renal cortical necrosis, and consequently were less affected 
clinically. Using this strain would therefore be of benefit in helping to develop a dose regiIre which 
Would exclude extra-renal toxicity, so Sprague-Dawley rats were chosen for future work with 
ethoxyquin. The strain differences seen in this experiment demonstrated an issue that can arise in 
th~ safety evaluation of a compound when susceptibility differs between strains. However, this 
strain susceptibility can also be used to advantage when investigating the particular effects of a 
cOmpound, by selecting the strain that is most susceptible. 
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Bokehnan et al [1971] looked at Charles River Sprague-Dawley (CD) and Manor Fanns SPF rats· 
given NSAIDS and found RPN and haematuria in both control and treated SPF rats, although 
these findings were more marked in treated animals. They also reported focal hyperplasia of the 
covering epithelium of the papilla. Examination of Sprague-Dawley control rats showed no RPN or 
haernaturia, but slight interstitial necrosis was seen in the papilla of treated rats, without haematuria. 
This work demonstrated a problem that can arise in safety evaluation where the presence of strain-
specific lesions can make interpretation more difficult. 
Of more direct relevance are the findings of Owen & Heywood [1986], who investigated strain-
related susceptibility to nephrotoxicity induced by aspirin and phenylbutazone. They compared male 
and female Fischer F344 and Sprague-Dawley CD rats, those used in the work detailed in this 
chapter, as well as Wistar and Lister-Hooded rats. They found that although there were no strain 
differences between Sprague-Dawley and Fischer F344 rats in the appearance of the papillary 
changes induced by phenylbutazone, the incidence of this necrosis was slightly greater in Sprague-
Dawley rats. Furthennore, Fischer F344 rats were more susceptible to the gastrointestinal effects 
of this compound, necessitating a reduction in dose for this strain. The results reported by 
Bokelman et al [1971], and particularly those of Owen & Heywood [1986], are similar to the 
difference in lesion severity seen between Fischer and Sprague-Dawley rats in the work described in 
this chapter. 
The results of the work described in this chapter suggested that ethoxyquin could be a good model 
for focal necrosis with the potential to be more "reliable" than indorrethacin, provided the extra-
-------------------------
• No further information is given in the reference as to the exact strain of this rat 
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renal toxicity could be ameliorated. The clinical signs were recognisable at an early stage and the 
course they would take was known, so that animals could be monitored carefully for the 
appearance of the early signs. The aim of the next phase of work, a dose-ranging study with 
reduced concentrations of ethoxyquin in com oil, was to attempt to induce RPN without stomach 
ulceration and no cortical damage. It was also hoped to clarify, if possible, whether the effects of 
ethoxyquin seen with this experiment were due to the change in dose regime (twice daily) or 
vehicle (com oil) or a combination of both. 
Establishment of optimum dosing regime with com oil vehicle 
The histology findings showed a direct relationship between treatment level, duration of dosing and 
incidence of RPN. However, the severity of lesions was not obviously dose-related and the extent 
of the lesion varied between minimal and moderate in all dose groups. It proved possible to induce 
RPN in all animals from the higher dose groups (500 and 600 mg/kg) after 8 days and in all 
ethoxyquin-treated animals above a dose of 400 mg/kg after 15 days, without the adverse clinical 
signs or cortical necrosis seen in the kidney in the previous experiment. 
The one death on study was due to acute alveolar haemorrhage and mild inflaImnation. Mis-dosing 
via gavage was the most likely cause but it is possible that ethoxyquin could have a systemic effect 
Which affects the lungs. However, this was not seen in any other animal treated with ethoxyquin in 
any of the experiments conducted, nor has it been reported in the literature. 
The highest dose level of ethoxyquin, 600 mg/kg, whilst giving 100% incidence of RPN after 8 
days, also caused stomach and renal cortex lesions. The stomach ulceration appeared to' be an acute 
but transient effect of ethoxyquin in com oil since it was present at day 3 (2 doses), less marked at 
Day 8 and absent by Day 15. It is apparent that ethoxyquin in com oil at higher doses h~ an irritant 
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effect on the stomach lining. This is supported by the findings of the previous experiment where 
ethoxyquin in com oil at 800 mg/kglday caused severe stomach ulceration after 2-3 days treattrent. 
A dose level of 500 mglkg ethoxyquin induced RPN in one animal at day 3 and in all animals from 
Day 8 onwards. No other effects of treatment were seen in the cortex or stomach. An ethoxyquin 
dose of 400 mglkg induced RPN in 6 of 8 animals after 8 days and all animals after 15 and 29 days. 
The lower doses of ethoxyquin only induced RPN in one animal (200 mglkg) or not at all (100 
mg/kg). The results of this time-course study supported the results of the previous experiments 
which indicated that ethoxyquin could be a good future model for inducing and studying focal 
RPN. The lesions produced with ethoxyquin appear reproducible and inducible in all animals at the 
appropriate dose level and dosing period. A dose of 400mglkg for 15 days or 500mglkg for 8 days 
would appear to induce 100% RPN without any other effects; further investigations were aimed at 
cOnfirming this. 
A dose regimen of 500 mglkg for 8 days was chosen for the subsequent studies with ethoxyquin. 
The investigations were aimed at evaluating the techniques identified as potentially useful in the 
previous chapter, SEM and urinary sediments, and investigating whether this dose reghre induced 
any other effects. So far little (or nothing) has been reported about the sequence of events and 
possible mechanisms of RPN induced with ethoxyquin; TEM evaluation of papillae was included in 
future work to provide important basic knowledge about this modeL including the primary cell type 
affected and the sequence of events in development of the lesion. Clinical chemistry, haematology, 
and full necropsy with histological sampling of all organs were included in later experiments with 
ethoxyquin to determine whether any extra-renal effects of ethoxyquin were apparent or to clarify 
any findings noted in the course of prior experiments. These investigations were to assess whether 
ethoxyquin was a site-specific toxin and therefore a suitable model for future use. 
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4.4.2: Urinary sediments and urine analysis 
Preliminary urine analysis in tenns of urine appearance, urinary sediment examination and basic 
clinical chemistry tests (Clinitek analysis) showed sOlm differences between treated and control 
animals. There was an increase in urinary volume and in brown discolouration of urine in treated 
animals. Increases in urine volume associated with RPN have been noted with some other 
papillotoxins, such as BEA [Murrayet al1972, Stonard et al1987, and the experiIrents described 
in Chapter 3], and d:Onnaplatin [Kolaja et al1994]; the increased urine volume (POlyuria) probably 
occurs due to reduced urine concentrating ability in renal disease, but the mechanism has not been 
investigated. Reduced urine concentrating ability is one of the features of analgesic and NSAID-
induced RPN [Bach & Bridges 1982 & 1985] 
The brown discolouration of urine in treated animals may be due to the presence of a metabolite of 
ethoxyquin. Wilson & DeEds [1959] and Wilson et al [1959] also reported dark urine in 
ethoxyquin-treated rats, which they said was due to a metabolite of ethoxyquin, although they 
didn't expand on this. This metabolite could be ethoxyquin nitroxide (EQN) which was proposed 
as the major metabolite of ethoxyquin by Lin & Olcott [1975]. However, the brown discolouration 
may reflect increased conjugated bilirubin observed in the urine of treated animals. The liver has 
been reported as a target organ for ethoxyquin toxicity [Nafstaad & Skaare 1978, Sigma 
Diagnostics data sheet for ethoxyquin], so it is possible that this increase in bilirubin is due to liver 
effects (increased bilirubin glucuronide may be present in the urine with hepatocellular damage), 
lfistological sampling of liver and clinical chemistry were therefore included in the subsequent 
ethoxyquin experiIrent to determine what other effects of ethoxyquin, if any, were present. 
lIowever, no obvious liver effects were detected (histological and clinical chemistry findings are 
discUssed in Irore detail in 4.4.5 and 4.4.6). 
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Increased numbers of epithelial cells were seen in the urine sediments; this increase in cells was not 
apparent before Day 3 and peaked at Day 4; fewer animals were affected at Day 5 and by Day 8 
numbers were back to control levels. The period over which increased numbers of cells were 
present correlated well with the time-fratre over which ethoxyquin damage was first seen by 
electron microscopy; most of the changes leading to RPN developed between Days 2 and 5, so it 
may be expected that more cells would be present in the seditrent over this period (The TEM 
findings are discussed in detail later, in section 4.4.4). The exact cell type involved (transitional or 
tubular) could not be distinguished due to similarity in morphology between the two and indistinct 
morphology within the preparations. Whichever type was present, this indicated shedding of cells 
from either the bladder, the kidney tubules or both. Histological examination of the bladder was 
included in the subsequent experitrent to clarify this. However, no treaurent-related effects were 
seen in the bladder on histological examination (as discussed below) so it seems highly likely that 
the cells carre from the kidney. 
t4.3: SEM and correlative histology 
The techniques evaluated in the previous chapter appeared to be useful in identifying the effects of 
ethoxyquin. SEM proved successful in identifying all animals with either structural distonion or 
RPN, confinned by subsequent ("secondary") histology, with no false negatives. Furthennore, it 
also identified an effect not previously seen with ethoxyquin, that of thickening of the surface 
epithelium of the papilla. Subsequent histology of the SEM samples further clarified this thickening 
of the surface epithelium, showing it to be thickened or even 2-3 cells deep in the more affected 
papillae. SEM has been used for examination of the bladder epithelium of Fischer F344 rats 
follOwing ethoxyquin treatnxnt [Shibata et al 1991], where ethoxyquin was investigated as a 
POtential bladder cancer prOIroter. It was found that ethoxyquin caused increased pleOIrorphism of 
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the microvilli on the sunace epithelium of the renal pelvis, suggesting transient hyperplasia. This is 
consistent with the observations reported in the papillary epithelium in these experiments, which 
also suggest hypertrophy and hyperplasia following ethoxyquin treatment. 
The combination of SEM and "secondary" histology has proven to be useful in gleaning more 
infonnation from a single sample, as suggested by the work in the previous chapter with BEA and 
indorrethacin. SEM appears to be a very promising, rapid technique for screening samples for 
abnonnalities, which can be followed by histological examination of the tissues if required. SEM 
also showed the presence of high numbers of activated platelets in sorre capillaries in the papillae 
from 2 treated animals at Day 8, which was further borne out by the TEM examinations as detailed 
below. The use of SEM for the assessrrent of papillary damage with RPN has not previously been 
reported, although SEM has been used to look at sloughing of the papillary epithelium following 
bacterial infection associated with RPN [Cohen et al 1979, 1981], and to investigate bladder 
epithelial changes with RPN [Okamura et al1992]. The use of SEM and correlative histology for 
the investigation of RPN with any compound, or for the investigation of any other tissues, has not 
previously been reported in the literature. 
!..4.4: Time-course of lesion development using TEM 
The TEM evaluation gave important infonnation about the titre-course of lesion developrrent with 
ethoxyquin and the cell types affected. It also highlighted some previously unseen changes as noted 
in the SEM assessment, narrely the sunace epithelial thickening and presence of increased numbers 
of activated platelets. The results suggest that the sequence of events in the developrrent of RPN 
starts with interstitial "distortion" and some surface epithelial thickening, apparent at Day 2 (24 
hours after treatrrent). By Days 4 and 5 this progresses to RPN in around half of the treated 
animals with early damage to sorre capillary walls and then loops of Henle. At this stage activated 
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platelets are also seen in those animals with RPN. By Day 8, RPN is seen in all animals, with 
corresponding increases in the numbers of activated platelets present. Haematology investigations 
were carried out in the final ethoxyquin experiIrents to investigate the effect of ethoxyquin on 
erythrocytes and platelets with sampling points at Day 3 and Day 8; the results supported this 
observation, showing there to be a possible increase in numbers of platelets in the blood at Day 3, 
and a definite increase at Day 8 (haematology resuhs are discussed further below). 
The cause of the surface epithelial thickening (hypertrophy and hyperplasia) and platelet activation 
seen with both TEM and SEM is unknown, although there are various possibilities. Ethoxyquin or 
its metabolites may have some effect on growth factors or prostaglandins (for example, PG~ is the 
major prostaglandin produced in the papillla and inhibits platelet aggregation, but its production is 
inhibited by NSAIDS such as indomethacin and naproxen [Zusman & Keiser 1977]) which could 
then induce hypertrophy and hyperplasia in surface epithelial cells and cause platelet activation 
[DeGroot & Sixma 1990]. Alternatively, these may be independent events. The hypertrophy and 
hyperplasia may be due to a direct action of ethoxyquin or its metabolites on the epithelial cells as 
they are excreted from the papilla. Subtle damage may occur in capillary walls during development 
of RPN with ethoxyquin, causing exposure of underlying cellular material (eg collagen) which 
induces platelet activation [DeGroot & Sixma 1990]. The results of the early time-points from this 
stUdy suggest that the presence of increased platelets occurs after the surface epithelial thickening 
and interstitial cell damage and may be secondary to early damage to the capillary endothelial cells. 
Increased numbers of activated platelets have been reported with other compounds used to induce 
experimental RPN, including analgesics. Levin & Abrahams [1968] used TEM to show platelets 
adherent to the intima of capillaries in rats fed aspirin by gavage, and Burrell et al [t991al also 
reported increased platelets in the damaged capillaries of rats treated with aspirin. Gregg & Bach 
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[1990] demonstrated platelets adherent to the capillary endothelium in nude mice treated with 
BEA, and Wolf et al [1992a] also showed platelet aggregates with degenerate endothelium in 
gerbils treated with BEA. 
It has been suggested that the presence of increased number of platelets adherent to the endothelia 
is a precursor to thrombi formation, thus providing evidence to support the theory that ischaemic 
necrosis is the cause ofRPN. However, the results of the present experiments with ethoxyquin and 
those with BEA which showed platelets adherent to degenerate endothelia [Burrell et al1991, Wolf 
1992a] would suggest that the presence of increased platelets (which may lead to thrombosis) is 
secondary to damage to the endothelia and necrosis of interstitial cells. It could not be determined 
whether thrombi were present in the present experiments because of the fixation technique used 
(perfusion with heparinised saline prior to fixative may have dislodged any small thrombi). 
Hyperplasia of the surface epithelium of the papilla associated with RPN has previously been 
reported in rats following treatment with the analgesics phenacetin [Johansson & Angervall1976] 
and aspirin [Molland 1976], and with other papillotoxins, such as dimethylarsinic acid [Murai et al 
1993]. Johansson & Angervall reported that vascular changes (thrombus formation) and epithelial 
hyperplasia were often simultaneously present following phenacetin treatment, but proposed that 
these were independent events. They said that although the exact mechanism for the hyperplasia 
reported was unknown, it could be a direct action of metabolites of the compound 
i.4.s: Haematology & Clinical chemistry of blood 
The haematology and cell morphology investigations which were included to further investigate the 
Platelet effects seen with SEM and TEM gave some interesting results. The increased number of 
platelets seen in the blood samples from ethoxyquin-treated animals was consistent with the 
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increased numbers of platelets seen in capillaries of the papilla with SEM and TEM. The slight 
decrease in haemoglobin may have been due to haemolysis, although the red blood cell changes 
(crenation and acanthocytosis) were not accompanied by increased polychromasia (juvenile red 
blood cells). A more sensitive indicator of red blood cell regeneration would have been to measure 
reticulocytes; however, an accurate assay for reticuloctyes was not available at the tUre of this 
experiment. 
It is feasible that ethoxyquin exerts an effect on the red cell membrane that is sufficient to cause 
haemolysis in a small cohort of more sensitive (older) red blood cells. For the remaining population, 
it may be that ethoxyquin induces a mild effect on red cell membrane integrity which is not 
sufficient to cause haemolysis in vivo, but induces the morphological effects seen when a blood film 
is made (ex-vivo). This suggestion is supported by work which reported that ethoxyquin at a 
dosage of 500 mg/kg (the same dose as used in the present studies) had a marked effect on red 
blood cell membrane integrity, although it did not produce lysis in vivo [Kumar et alI979]. 
Kosaka & Yoshida [1973] also found that ethoxyquin caused increased haemolysis in weanling rats 
(the age of the rats in these studies) and in chick red blood cells, and Hernandez et al [1993] 
. reported haemolysis in marmosets given an accidental overdose of ethoxyquin in the diet. 
FUrthermore, Kagan et al [1986] examined the effects of various natural and synthetic antioxidants 
which are widely used as stabilisers of biomembranes against lipid peroxidation. They found that 
synthetic antioxidants devoid of hydrocarbon tails exerted toxic effects on red blood cell 
Irembranes, inducing haemolysis, and caused changes in endoplasmic reticulum and platelet 
Irembranes (also initiating calcium-dependent platelet aggregation), whereas antioxidants with long 
hydrocarbon tails did not induce these effects. Ethoxyquin has only a short hydrocarbon tail, so it is 
possible that it could induce such effects to a lesser degree, especially if it is oxidised to its more 
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potent metabolite, ethoxyquin nitroxide [Lin & Olcott 1975]. 
Jayanthi & VaraJakshrni [1992] looked at alterations in red blood cell membranes with a potent 
antioxidant (DL a-lipoic acid) with regard to its protective effects against calcium oxalate lithiasis. 
They found that it caused a decrease in the structural changes nonnally seen with lithiasis as a result 
of decreased lipid peroxidation. They did not investigate whether the antioxidant alone, in the 
absence of the countering effects of calcium oxalate lithiasis, would cause any membrane effects 
because of this decreased peroxidation. It seems likely that this would be the case, given the 
findings with ethoxyquin and those reported with other antioxidants [Kagan et al1986]. 
The clinical chemistry findings showed slight changes in several parameters (increased AST & LDH 
and decreased albumin), although these did not give an obvious characteristic pattern for anyone 
organ being affected. Red blood cells are a source of lDH and AST (but not ALT), therefore 
increases in lDH and AST alone may reflect mild haemolysis. Haemoglobinuria was not evident 
but since plasma haptoglobin must be saturated before haemoglobin is lost via the urine, 
haemoglobinuria is not a very sensitive marker and its absence does not exclude the presence of in-
Yivo haemolysis. These changes could therefore be further indication of a minor effect of 
ethoxyquin on red blood cells. 
Increased AST & lDH and decreased albumin could also indicate that there may be some effects in 
the liver, although these changes were small with no alteration in ALT and no histological changes. 
Hepatic effects have previously been reported with ethoxyquin [Nafstaad & Skaare 1978] so the 
changes seen in AST and lDH in the present experiIrents may indicate minor hepatic damage. If 
there is an effect of ethoxyquin treatnX!nt on the liver, it is subtle and not sufficient at this dose to 
induce any obvious necrosis (discussed further in 4.4.6). It is also possible that the decreased 
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albumin levels, raised sodium and chloride and decreased potassium could be related to the renal 
lesions caused by ethoxyquin. 
4.4.6: Full necropsy and histological assessment 
The indication that ethoxyquin did not cause any obvious liver effects at the dose used to induce 
RPN is important for the use of ethoxyquin as a model for RPN, since any additional toxicity would 
affect its potential as a model The liver has been reported as a target organ for ethoxyquin [Sigma 
Diagnostics data sheet for ethoxyquin, Nafstaad & Skaare 1978], so it may be expected that it 
would induce some liver changes, although these may have been too subtle to be detected by light 
microscopy. Nafstaad & Skaare [1978] reported no histological liver effects following a single dose 
of 500 mg/kg (the dose concentration used in these experiments), but did detect slight liver changes 
using electron microscopy. The effects reported were proliferation of smooth endoplasmic 
reticulum (SER) , dilated cisternae of endoplasmic reticulum, and disorganised mitochondrial 
membranes (the latter could be the origin of the increased AST noted in the present experiIrents). 
Kahl [1984], looking at the biochemical action of ethoxyquin, also found increased ER in the liver 
and increased enzyme induction. He also reported inhibition of lipid peroxidation in biological 
membranes with ethoxyquin treatment. The reported hepatic effects of ethoxyquin may therefore be 
related to the membrane effects noted with several antioxidants, including ethoxyquin [Kumar et al 
1979, Kahl1984, Kagan et al1986]. These membrane effects may also be responsible for the red 
blood cell findings in the present experiments. 
No microscopical effects were seen in any other tissues except for minimal inflannnation and focal 
ulceration in the non-glandular portion of some stomachs. This finding had been noted in the 
preceding experiIrents performed with ethoxyquin in corn oil and was shown ~o be a transient, 
probably irritant effect of ethoxyquin in corn oil on the stomach. No histological abnonnalities were 
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seen in the glandular area of the stomach where white discolouration had been noted at necropsy. It 
is possible that this discolouration of the glandular area was due to the presence of surface mucus. 
4.4.7: Comparison of findings with previous ethoxyguin work 
The first reported work regarding developtrent of RPN following ethoxyquin treattrent [Hard & 
Neal 1990 & 1992] found that RPN was first observed in male F344 rats after 4 weeks of treatment 
with ethoxyquin, given as 0.5% in the diet. Interstitial degeneration in 3 of 8 males was noted at 4 
weeks, which had progressed to RPN after 14 weeks, with complete necrosis and pyelonephritis 
after 24 weeks. They also reported capillary changes following ethoxyquin treattrent. Manson et al 
[1992], in studies which highlighted the age- and sex-dependent nature of RPN induced with 
ethoxyquin, also reported RPN in male weanling rats following 20 weeks of treattrent, with 
increased proteinuria. 
The dose regimen developed in the current experiments (500 mg/kglday) resulted in reproducible 
RPN in all male rats by 8 days of treatment, with interstitial degeneration first appearing at Day 2 
(after 1 dose of 500 mg/kg). The broad sequence of events reported in the study by Hard & Neal 
matches that seen in the present experiments, but in much less detail, and over a much longer time-
frame. The study by Manson et al [1992] showed the Satre severity ofRPN as Hard & Neal's study 
after 20 weeks [1992], but the proteinuria noted by Manson et al [1992] was not seen in these 
experirrents. The average daily dose for the rats in Hard & Neal's studies [1990, 1992](and 
Manson & co-workers [1992]) would equate to between 1000 and 1200 mg/kglday, which is twice 
that used in these experiments. However, ethoxyquin was given "diluted" as part of the diet mix, 
which would be eaten gradually over several hours, rather than as a single direct dose by oral 
gavage as was the case in these experiments. Any toxic effects may therefore be expected to be 
reduced and delayed in comparison, although no pharmacokinetic profiling with eth~xyquin has 
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been reported by anyone to confinn this hypothesis. 
It has therefore proved possible to develop a dose regime using ethoxyquin which reliably and 
reproducibly induces RPN over a relatively short period. Dosing by oral gavage rather than in the 
diet meant that the arrount of ethoxyquin given could be more easily controlled and a more 
accurate assessment of the dose-ranging effects with ethoxyquin could be made. Also, a detailed 
investigation of the sequence of events involved in the development of RPN with ethoxyquin was 
easier to perfonn, and comparisons with the effects of other models, given over short periods of 
treatment, could then be made more easily. 
The results of the experiments carried out with ethoxyquin suggest that, using the dose regime 
developed, ethoxyquin is a site-specific toxin for the kidney with no obvious extra-renal pathology 
and minimal effects on red blood cells. It therefore has strong potential as a model for studying 
RPN. If longer periods of dosing were required, for example to assess ethoxyquin as a model for 
sub-chronic/chronic RPN, this could be achieved by reducing the dose of ethoxyquin, as 
demonstrated by the results of the dose-ranging experiments where 400 mg/kg induced RPN in all 
rats and 200 mglkg induced RPN in 1 of 4 rats after 14 days of treatment. Ethoxyquin therefore 
also has potential as a more "flexible" model for studying RPN than other current models such as 
. SEA, which is used as a single dose to induce RPN and causes secondary cortical damage and 
infection after prolonged periods, and indomethacin, which induces marked extra-renal toxicity. 
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Figure 5.1: Schematic flow diagram of the experimental work carried out during the project 
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CHAPTER 5. DISCUSSION AND RECOMMENDATIONS 
The experimental work carried out during the project is surmnarised in the schematic flow diagram 
in Figure 5.1; this work can be divided into two main phases: 
1. Development and assessment of techniques to help identify and study focal lesions. Perfusion 
fixation and dye perfusion techniques were initially evaluated in the brain. Two well-established 
models of RPN were then used to develop these and other techniques in the kidney. Those 
techniques which showed promise were then used to investigate a new modelofRPN. 
2. Development of a new model for RPN. The techniques identified in the first phase of the work 
were used to help investigate the utility of the antioxidant ethoxyquin as a model for RPN. Other 
investigations (TEM, clinical chemistry, haematology, full necropsy) were also included at this 
stage to study the pathological changes induced with this model and determine its potential. 
As a consequence of this work, comparisons could then be made between the changes induced 
with, and possible mechanisms of, the three experimental models of RPN and those seen in man. 
~1: DEVELOPMENT AND ASSESSMENT OF TECHNIQUES 
S.I.I: Perfusion fixation 
The work carried out in the brain showed that perfusion fixation could successfully be used in 
tOxicology studies for light and electron microscopic examination of brain tissue. After optimising 
perfusion rates for evaluation of brain tissue using perfusion pump apparatus, the technique was 
applied to the kidney. Perfusion pump (local perfusion) and fixed head of pressure (whole body 
perfusion) techniques were evaluated and both methods gave successful results, although the fixed 
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head of pressure method was more rapid and straightforward. However, local perfusion is 
reconnrended where kidneys need to be treated differently to allow greater control (e.g. one kidney 
left unfixed as a negative control), or where perfusion of the kidneys (or brain and upper body) only 
is required and other tissues must be unfixed for other toxicological investigations (e.g. biochemical 
analysis). 
Whole body perfusion is recommended for rapid perfusion with minimal intervention; this is 
particularly suitable for transmission electron microscopy investigations, and was used for the 
ultrastructural investigations with ethoxyquin to investigate the time course of lesion development 
with this model of RPN. The whole body perfusion technique (fixed head of pressure) developed 
for these experiments has also subsequently been applied with success to the brain, and used in a 
recent toxicology study in the hamster enabling the ultrastructural details of a specific effect in the 
brain to be studied (unpublished observation). 
5.1.2: Dye perfusions 
Dye perfusion of the brain gave promising results for examination of the vasculature in the 
brain work, especially when combined with "clearing" slices of tissue in cedarwood oil and 
subsequent histology. One of the great advantages of perfusing with dye and fixative is that it 
allows histological material to be processed from tissue previously prepared to display the 
vasculature, with very high quality results. When dye is perfused in conjunction 'Nith fixative, 
electron microscopy can also be performed. This technique could be used in future mechanistic 
studies where ischaemic hippocampal lesions occur, or in other tissues where the vasculature is 
implicated in the occurrence of a lesion. Using this Irethod it should be possible· to visualise 
alterations and identify the vessels involved, and to identify whether the vasculature is primarily 
involved in the development of a lesion. 
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The dye perfusion technique used with the brain was developed and further assessed in the 
kidney work. The technique of dye perfusion, and subsequent histology, was modified slightly 
by using a different dye (trypan blue) and assessing various routes of perfusion to evaluate this 
as a means of identifying necrotic cells in the kidney rather than highlighting alterations in the 
vasculature. However, perfusion of the kidney with trypan blue was of little success; it did not 
highlight necrotic areas, and although trypan blue had been successfully perfused into the kidneys, it 
was retained in some healthy cells rather than excluded by them The results of the kidney 
experiIrents using BEA and indomethacin indicated that trypan blue was too unreliable for use in 
routine studies, and trypan blue was not investigated further for use in the identification of necrotic 
rena11esions. Cedarwood oil was also used for the examination of cleared slices of kidney, prior 
to histological assessment, to assess its use in aiding visualisation of vessels and damaged 
tubules, but this was not always useful due to the thickness of slices required for subsequent 
histology. 
5.1.3: Assessment of standard histology technique for identifying RPN 
The suitability of the standard technique used for identification ofRPN, a single section through the 
kidney, was assessed prior to evaluating techniques which might help in this identification. This 
initial work reinforced the importance of standardising sectioning for assessment of necrosis [Bach 
& Bridges 1982 & 1985]. Step-serial sectioning of BEA-treated kidneys, carried out to detennine 
how much the distance from the papilla tip affected the extent of necrosis, showed that damage was 
most extensive in the papilla tip region, supporting the general assumption that papillary necrosis 
induced with BEA is most extensive at the tip [Hill et al1972, Duggin 1980, Bach & Bridges 1982 
& 1984]. Furthennore, the standard technique used to assess the extent of damage, a histological 
section near the papilla tip, was shown to be robust, since the section did not have to be exactly 
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through the tip, just within 60 J..lIll, to give a reliable estimate of the extent of damage. The histology 
findings from the kidneys of indOlrethacin-treated animals highlighted the relatively high number of 
false negatives obtained when relying on a single histological section through the tip with a focal 
model This infonnation was important in highlighting both the limitations of relying on a single 
section for studies involving focal necrosis and reinforced the need for more reliable techniques in 
identifying such damage [Arnold et al1974, Bach & Bridges 1982 & 1985, Price et all996]. 
5.1.4: Urinary sediments 
Urinary sediments gave promising results in helping to identify RPN with BEA, indomethacin and, 
subsequently, ethoxyquin-treated animals when the total number of transitional cells excreted in the 
urine was calculated (correcting for urine volume gives a more reliable estimate of any effects in the 
urine, as stressed by Fent et a1 [1988] and Zbinden et al [1988]). The results generally showed that 
more cells were present in the sediments of animals with RPN and indicated that urine cytology 
might be useful to help identify RPN, supporting the findings of Jackson et al [1978], who found 
sediments useful in screening for carcinoma and dysplasia in analgesic abusers and suggested that 
urinary sediments might also be useful to help detect RPN in patients. 
However, it has been emphasised that cell excretion following kidney damage can fluctuate or 
disappear with continued treatment [Davies et al1968, Kennedy & Gail Saliya 1970, Fent et a1 
1988, Zbinden et al1988]. The work carried out in this project, particularly the time course studies 
with ethoxyquin, supported this. Stonard et al [1987] recormnended frequent collection of urine 
samples to enable the onset of, and recovery from, renal lesions to be followed so that transient 
effects are not overlooked. Similarly, Fent and Zbinden and co-workers [1988] recommended a 
SCreening program based on repeated urinalysis as a useful procedure to detect nephrotoxic 
chemicals acting by a variety of mechanisms. Such a procedure would hopefully hig~ght those 
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individuals (animals or patients) where necrosis was present at an early stage in the developrrent of 
the lesion. In toxicity studies, combining this with histopathology, would provide the maximum 
infonnation on the renal effects of a compound.; whereas in patients, treatrrent with the offending 
compound could be stopped in the early stages of lesion development when the chances of recovery 
are greatest. 
5.1.5: SEM and correlative histology 
Scanning electron microscopy (SEM) gave promising results with all three models, particularly 
when combined with secondary histology (reprocessing of SEM tissue for histology) thus providing 
more information from a single sample. All kidneys identified as having RPN or degeneration by 
SEM were confinred as such by secondary histology of the samples. Perhaps the most important 
observation is that SEM did not produce any false negatives, even with very sma11lesions. SEM 
also highlighted important effects on the surface epithelium following BEA and ethoxyquin 
treatrrent, which in the case of ethoxyquin had not previously been reported. 
SEM appears to be a promising, rapid technique for screening samples for abnonnalities, which can 
be followed by histological examination of the tissues if required. The use of SEM for the 
assessrrent of papillary damage with RPN has not previously been reported; the use of SEM and 
correlative histology for the investigation of RPN with any compound, or for the investigation of 
any other tissues, has not previously been reported in the literature. This technique also has potential 
for other tissues; SEM (and subsequent histology) can be perfonned on standard study material (Le. 
tissue immerse-fixed in fonnalin) with no loss of detail, which makes this technique applicable to 
any routine studies where RPN or any other type of necrosis may be suspected. SEM may also have 
potential for investigating focal lesions in the brain following ischaemia; perfusion with latex instead 
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of dye, and preparation of corrosion casts could be used to study any effects on vasculature [Coyle 
1976, 1978] as a complement to the techniques developed here. 
5.2: ETHOXYQUIN AS A MODEL FOR RPN 
The experimental work carried out to investigate ethoxyquin and assess its potential as a model 
for RPN raised some very interesting issues, which contribute to what is currently known 
about this compound in both its reported effects on the renal papilla [Hard & Neal 1990 & 
1992, Manson et al 1992] and its proposed effects on other tissues or structures such as the 
liver and erythrocytes [Kosaka et al 1973, Nafstaad & Skaare 1978, Kumar et al 1979, 
Hernandez et alI993]. The differences observed in species susceptibility and subsequent extra-
renal effects in the preliminary dose-ranging studies with ethoxyquin (Fischer F344 and 
Sprague-Dawley rats) support previous work reporting differences in species sensitivity to 
RPN [Owen & Heywood 1986, Bokelman et a11986, Lcnz & Carlton 1991]. The differences 
in species sensitivity highlight the importance of selecting the appropriate species for toxicity 
studies with a compound, and the marked increases seen in clinical signs and lesion incidence 
following a change in vehicle (from DMSO to corn oil) emphasise the importance of selecting 
the appropriate vehicle. 
A dose regimen was successfully developed with ethoxyquin which reliably and reproducibly 
induced RPN in male rats over a relatively short period. A dose level of 500 mg/kglday resulted in 
reproducible RPN in all male rats by 8 days of treatment, with interstitial degeneration first 
appearing at Day 2 (after 1 dose of 500 mg/kg). The results of the experitrents carried out with 
ethoxyquin suggest that, using the dose regimen developed. ethoxyquin is a site-specific toxin for 
the kidney with no obvious extra-renal pathology and minimal effects on red blood cells. It therefore 
has strong potential as a rrodel for studying RPN. The broad sequence of events reported in 
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previous studies with ethoxyquin [Hard & Neal 1990 & 1992, Manson et al 1992] matches that 
seen in the current experirrental work, but in much less detail and over a much longer tirre-frame. 
Dosing by oral gavage rather than in the diet, which had been used by others in investigations of 
RPN with ethoxyquin [Hard & Neal 1990, 1992, Manson 1992] rreant that the amount of 
ethoxyquin given could be more easily controlled and a more accurate assessrrent of the dose-
ranging effects with ethoxyquin could be made. Also, a detailed investigation of the sequence of 
events involved in the development of RPN with ethoxyquin was easier to perfonn, and 
comparisons with the effects of other models, given over short periods of treatment, could be made 
more easily. 
If longer periods of dosing were required, for example to assess ethoxyquin as a model for sub-
chronic/chronic RPN (as in analgesic-induced RPN in man), this could probably be achieved by 
reducing the dose of ethoxyquin as demonstrated by the results of the dose-ranging experiments. It 
would be interesting to further investigate ethoxyquin as a chronic model for RPN, to enable the 
development of chronic RPN and long tenn effects of treatment to be studied and related to the 
effects seen in man. Ethoxyquin therefore also has potential as a more "flexible" model for studying 
RPN than other current models such as BEA, which is used as a single dose to induce RPN but 
causes secondary cortical damage and increases the incidence of infection after prolonged periods, 
and indomethacin, which is also used as a single dose but induces marked extra-renal toxicity. 
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Table 5.1: Comparison of the pathological changes found with the various models of experimentally-induced RPN and those found in man, based 
on results of experiments and reported findings 
Type of renal papillary necrosis 
BEA-induced Indomethacin- Ethoxyquin- analgesic-associated 
Morphological or functional changes induced induced RPNinman 
(single dose) (single dose) (multiple doses) (multiple doses) 
Necrosis of the papillary tip yes yes yes yes 
Loss of interstitial cells yes yes yes yes 
Loss of vasa recta! capillaries yes yes yes yes 
Loss of thin loop of Henle yes yes yes yes 
Platelets adherent to damaged endothelium yes yes yes yes 
Hyperplasia of covering epithelia yes yes yes yes 
Loss of collecting ducts and covering epithelia yes yes ? at later stages yes 
Lipid changes (e.g. increased in epithelial cells) yes yes yes yes 
secondary cortical changes yes yes yes at higher doses yes 
Urine cytology changes associated with RPN yes possibly yes possibly 
Decreased urine concentrating ability yes possibly yes yes 
Extra-renal pathology no yes yes at high doses yes 
Postulated mechanisms for lesion Renal Metabolic Metabolic Metabolic activation, 
concentration & activation, + PG activation, + PG + PG inhibition: 
. activation, inhibition inhibition ischaemia? 
? vasoconstriction 
----- - - - - - - --- ---- ------
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5.3: COMPARISON OF MODELS AND PROPOSED MECHANISMS 
5.3.1: Pathological changes 
The development of RPN induced with ethoxyquin appears to follow the Satre course as that seen 
in the two well-established models of RPN, BEA and indomethacin, and agrees with the sequence 
of events reported in man [Arnold et al1974, Molland 1978, Kincaid-Smith 1979, Bach & Bridges 
1982 & 1985, Bach & Hardy 1985, Gregg et al1989c, Burrell et all990]. Table 5.1 sununarises 
the morphological and functional effects of the various models, using the results of the experiments 
carried out during this project and those reported in the literature. It is generally agreed that the 
renal tredullary interstitial cells are the first structures affected with RPN, followed by degeneration 
and necrosis of the endothelial cells of capillaries/vasa recta and the thin loops of Henle. The surface 
epithelia and collecting ducts of the papilla are spared initially but become affected as the lesion 
progresses. The lesion may then progress to affect the rest of the papilla and eventually the cortex. 
The extensive papillary effects seen in the later stages with BEA and analgesic nephropathy were 
not seen with ethoxyquin, nor was there loss of the surface epithelium as is seen with BEA and 
analgesics [Bach & Bridges 1982 & 1985, Bach & Hardy 1985, Gregg et al1989c]. However, the 
dose regimen for ethoxyquin was designed to investigate the early development of the lesion rather 
than its progression to end stage necrosis, so it may be that with continued dosing these changes 
would occur. Hypertrophy of the surface epithelial cells was evident with ethoxyquin. Such 
hypertrophy has also been reported prior to loss of the surface epithelial cells following treatment 
with BEA and analgesics [Molland 1976, Bach et al1983, Elliot 1986, Gregg et al1989a & c, 
1990a & b, Gregg & Bach 1990, Bach 1991], so it seems reasonable to expect that loss of epithelial 
cells would also occur with ethoxyquin as the lesion progressed. 
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Ethoxyquin, in contrast to the other experimental models used, induces RPN following 
multiple dosing, with RPN gradually developing over the dosing period. The other two models, 
BEA and indomethacin, cannot be given for longer periods as they induce acute RPN and also 
cause marked cortical effects and secondary infection (BEA) or marked gastrointestinal effects 
(indomethacin) in animals after 24-48 hours. Ethoxyquin therefore has more in common with 
analgesic nephropathy in man in this respect, which also develops as a consequence of multiple 
dosing and is usually sub-chronic/ chronic in its onset. 
5.3.2: Proposed mechanisms for RPN 
The currently proposed mechanisms for development of RPN with the different compounds are 
summarised in Table 5.1. The most common model used for studying RPN, BEA, is generally 
considered to have a different mechanistic pathway than that proposed for analgesics and NSAIDS 
[Hill et al1972, Solez et al1974, Bach et al1980 & 1986, Davies & Tange 1982, Bach & Bridges 
1985, Powell et al1985 & 1991, Wilks et al1986, Thieleman et al1990, Wolf et al1990, Stewart 
1995]. The proposed mechanistic pathways for the different compounds are illustrated in Figure 
5.2. 
Development of RPN with BEA is believed to occur as a consequence of accumulation of BEA in 
the papilla (particularly the interstitial cells) via the counter-current concentration mechanism This 
accumulation promotes cyclisation of BEA into potent alkylating agents (reactive intermediates) 
which induce lipid peroxidation, initiating a cascade of events leading to cellular damage and 
necrosis (Fig. 5.2). Vasoconstriction has also been proposed to play an important role in BEA-
induced RPN by some investigators, although this has been disputed by others [Wyllie et al1972, 
Solezet al1974, Molland 1978, Cuttino et a11981, Wolfet alI991b]. 
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Figure 5.2: Schematic representation of the arachidonic acid cascade, including the proposed 
activation pathways for NSAIDS (including indomethacin), analgesics, BEA and ethoxyquin, 
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This proposed difference in mechanism for BEA-induced RPN suggests that it is not an ideal model 
for analgesic-induced RPN, particularly for studies aimed at preventing the developtrent of this 
lesion by influencing the treehanisms involved. However, since the sequence of events leading to 
RPN with BEA mirrors that induced with analgesics and NSAIDS, BEA has been very important in 
establishing the site of initial damage and the early changes associated with this lesion, and is useful 
in evaluating techniques aimed at identifying RPN [Bach & Bridges 1982 & 1985, Mattingleyet al 
1984, Sabatini 1984, Wilks et al1986, Bach et al1986, Bach & Kwizera 1988, Gregg et al1989a 
& b, 1990a & b]. 
The currently proposed mechanisms for analgesic and NSAID-induced RPN are metabolic 
activation and possibly inhibition of prostaglandin synthesis (Fig. 5.2) [Dunn & Zambraski 
1980, Bach & Bridges 1984, Marnett et a11984, Bach & Hardy 1985, Bach 1991, Kirkova et 
al 1992 & 1995, Hawksworth et al 1994]. Some investigators have also proposed an 
involvement for ischaemia, possibly due to the reported effects of these compounds on 
prostaglandins [Jackson & Lawrence 1978, Henrich et al1978, Bach & Bridges 1984, Heyman 
et al1988 & 1991]. 
Metabolic activation can occur via the prostaglandin synthetase (paS) or lipoxygenase 
pathways. These pathways are involved in the co-oxygenation of xenobiotics in association 
with the metabolism of arachidonic acid (Figure 5.2). Analgesics and NSAIDS produce much 
of their therapeutic and adverse effects through the inhibition of prostaglandin synthesis, by 
inhibiting cyclo-oxygenase. Inhibition of cyclo-oxygenase may reduce vasodilation and lead to 
the metabolism of arachidonic acid (AA) via the lipoxygenase pathway (Figure 5.2), resulting 
in the production of both fatty acid peroxides which can act as substrates for the prostaglandin 
hydroperoxidase step of pas, leading to subsequent lipid peroxidation. Metabolism of AA via 
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lipoxygenase may also lead to the production of leukotrienes, which can have profound effects 
on renal haemodynamics. 
Indomethacin and aspirin are both well-documented inhibitors of prostaglandin synthesis, and 
indomethacin has been shown to have an inhibitory effect on prostaglandin synthetase, 
lipoxygenase and cyclo-oxygenase, present within the interstitial cells of the papilla [Molland 
1978, Dunn & Zambraski 1980, Clive & Stoff 1984, Marnett et al 1984, Zenser & Davies 
1984, Bach & Bridges 1985, Gregg et al1989a, Hawksworth et alI994]. The presence of high 
levels of polyunsaturated fatty acids in the interstitial cells predisposes these cells to lipid 
peroxidation in the presence of locally generated reactive intermediates. The reactive 
intermediates produced via PGS or lipoxygenase therefore have the potential to cause lipid 
peroxidation and lead to cell death, as illustrated in Figure 5.2 [Bach & Bridges 1984]. 
Normally, reduced glutathione (GSH) protects the cell from alkylating agents (e.g. BEA) and 
lipid peroxidation but the medulla and papilla have low levels of endogenous aSH, so once 
reactive intermediates are generated these will not be readily inactivated (as shown in Figure 
5.2) [Duggin 1980, Mohandas et a11984, Gregg 1989a]. 
In comparison with analgesics and NSAIDS, ethoxyquin has also been shown to inhibit drug 
co-oxidation during prostaglandin synthesis [Kahl 1984]. Furthermore, the effects of 
ethoxyquin on prostaglandin production and cyclo-oxygenase and lipoxygenase activity have 
been investigated, in renal medullary slices and homogenate respectively, and compared with 
the effects of NSAIDS, particularly indomethacin [Zenser & Davies 1978, Bach & Bridges 
1984, Miyazawa et al1985]. Ethoxyquin, in common with NSAlDS, was show·n to inhibit 
prostaglandin synthesis (particularly PGE2) and cyclo-oxygenase activity. Ethoxyquin was in 
fact found to be a more potent inhibitor of these than indomethacin, and also slightly inhibited 
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lipoxygenase activity. The similarity of ethoxyquin to NSAIDS and analgesics in this respect, 
coupled with the fact that the sequence of pathological events leading to RPN follows the same 
course, suggests that ethoxyquin induces RPN by the same mechanism as analgesics. 
Ethoxyquin therefore has great potential as a model for further studying the mechanisms 
leading to RPN, and extrapolating the results to the lesions seen in man. As mentioned in the 
introductory chapter of this thesis, there is still much discussion and research involved in 
detecting RPN at an early stage and elucidating the mechanistic basis of this lesion. The use of 
ethoxyquin as a model may help in this, and provide important information for the 
identification and subsequent management of RPN in man, and in the design of new drugs 
which do not induce such effects. 
5.4: SUGGESTIONS FOR FURTHER WORK 
5.4.1: Technique-based 
• Apply the techniques developed in these experiments to general toxicity studies where 
appropriate. The perfusion techniques developed have already been successfully used in 
regulatory and investigative toxicity studies in these laboratories to examine effects in the brain 
(using whole body perfusion) and the kidney (using whole body and local perfusion, where only 
one kidney was perfused). 
• Evaluate the application of a "urinary screen" (as recommended above) for future studies with 
possible renal toxins. If this proved valuable, urine samples could then be collected at intervals 
throughout a study to identify any renal effects early in the course of treatment, rather than 
, collecting samples only at the end of a study as is currently the case. 
• Evaluate the application of SEM, already used for the kidney, to investigations involving brain 
tissue (depending on the site of interest), e.g. SEM combined with latex corrosion casts may be 
useful for investigation of the vasculature in the brain, as used by Coyle [1976 & 1978]. 
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• The combination of SEM and correlative histology proved very useful in these experiments and 
is applicable to any tissue; use this combination of techniques in future toxicity studies where 
changes on epithelial or endothelial surfaces are of interest (e.g. bile duct changes in the liver, 
glomerular effects in the kidney, endothelial changes). 
• Investigate the use of TEM for examination of urinary sediments. This technique, used by 
Mandai and co-workers [1985 & 1988], may have helped in the identification of cell types 
present in the sediments that were not discernible by light microscopy. Similarly, SEM may also 
be of use in studying the appearance of these cells. However, such techniques (particularly TEM) 
would be more time-consuming than the standard light microscopy preparation and assessment, 
and may therefore not be feasible for routine use in toxicity studies. 
5.4.2: Further development of ethoxyguin / Investigation of mechanisms 
• Investigate ethoxyquin as a chronic model for RPN, to enable the development of chronic RPN 
and the long tenn effects of treatment to be studied. The results could then be related to the 
effects seen in man with analgesic nephropathy, which is primarily a chronic lesion. 
• Use histochemical and immunocytochemical techniques, e.g. lipid staining methods in kidney 
sections, renal antibodies to specific cell types in kidney sections or possibly urine [as suggested 
by Bornhard et al 1994], to investigate the lesion induced with ethoxyquin and compare the 
results with the other models. TEM and SEM provided very detailed information about the early 
development of the lesion in these experiments, and the histochemical changes associated with 
RPN in other models are well-documented [Hill et al1972, Gregg et al1989c & 1990a, Bach et 
, al1983 & 1991], so ~e~use of histochemical techniques may not have provided any additional 
information. However, the application of these techniques may be useful if further studies were 
conducted with ethoxyquin as a chronic Irodel for RPN, since in this case they could provide 
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extra information from paraffin sections to supplement the standard H&E sections in the absence 
of ultrastructural investigations. 
• Further investigate the effects of RPN induced with ethoxyquin on renal prostaglandins by 
conducting measurements of urinary prostaglandins, specifically PG~, following ethoxyquin 
treatment and comparing the results with the effects of indomethacin [Melendez & Reyes 1982, 
Clive & Stoff 1984, Rainsford et al 1988]. However, since it is unclear whether the known 
effects of analgesics on prostaglandins are primarily involved in the development of RPN, this 
information, although interesting, may not help in further investigating the mechanisms involved. 
• Further investigate the effects of ethoxyquin on lipid peroxidation. Lipoxygenase measurements 
may provide useful further information regarding the pathogenesis of this lesion and allow 
further comparison . of this model with the effects induced by indomethacin and aspirin 
[Miyazawa et al1985, Krrkova et all992 & 1995], and possible extrapolation to the effects of 
analgesics in man. Furthermore, investigation of the effects of lipoxygenase and/or PGS 
inhibitors (hydroperoxidase) on the development of RPN induced with ethoxyquin and 
indomethacin would provide the opportunity to investigate whether one or both of these 
pathways is involved in the development ofRPN (as suggested by Hawksworth et al [1994] and 
Stewart et al [1994]). Such investigations would also provide further information regarding the 
mechanisms involved in the development of RPN with ethoxyquin and consequently its 
suitability as a model for RPN. 
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APPENDIX 1: STAINING METHODS AND BUFFER RECIPES 
Haematoxylin and eosin stain for histological sections: 
Reagent Time 
Xylene 2 x 5 minutes 
100% alcohol 2 minutes 
95% alcohol 1 minute 
70% alcohol 1 minute 
Distilled water 1 minute 
Harris' haematoxylin 5 minutes 
Distilled water 1 minute 
1 % acid alcohol 1 second 
Distilled water 30 seconds 
Scotts tap water (arrnnonia water) 2 minutes 
Distilled water 30 seconds 
Eosin 3 minutes 
95% alcohol 2 x 30 seconds 
100% alcohol 2 x 1 minute 
XyIene:l00 alcohol (50:50 mix) 2 minutes 
Xylene 2 x4minutes 
Mount in DPX mountant. 
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Xylene: alcohol (50:50) 
Xylene 











1 min 30 seconds 
30 seconds 
1 min 30 seconds 
2 x 30 seconds 
2 x 1 minute 
2 minutes 
2 x4minutes 
O.2M Sorensons phosphate buffer <stock concentration} 
, Solution A: Disodium hydrogen orthophosphate (anhydrous); 28.4g in 1.0L distilled water. 
Solution B: Sodium dihydrogen orthophosphate (anhydrous); 24g in 1.0L distilled water. 
For O.IM phosphate buffer: 70mL solution A + 30mL solution B, add lOOmL distilled water, 
adjust pH to 7.4. 
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Toluidine Blue stain for semi-thin sections 
Reagent TUne 
1 % toluidine blue in 1 % sodium tetraborate 45 seconds. 
Dry on hotplate at 60°C and coverslip with DPX mountant 
Methylene blue/Azure II stain for semi-thin sections 
Reagent 




90 seconds at 60°C 
15 seconds 
45 seconds 
Water wash 30 seconds 
dry on hotplate at 60°C, coverslip with DPX mountant. 
Uranyl acetatellead citrate stain for ultrathin sections 
Reagent TUne 
Saturated uranyl acetate in 50% alcohol 
Distilled water 
Dry on fibre-free tissue 
Reynolds lead citrate solution 
Distilled water 
Dry on fibre-free tissue, store in grid box. 
5 minutes 
3 x 30 seconds 
30 seconds 
5 minutes 
3 x 30 seconds 
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